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SCIENTIFIC OPINION 
Scientific Opinion on risk based control of biogenic amine formation in 
fermented foods1 
EFSA Panel on Biological Hazards (BIOHAZ)2, 3 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
A qualitative risk assessment of biogenic amines (BA) in fermented foods was conducted, using data from the 
scientific literature, as well as from European Union-related surveys, reports and consumption data. Histamine and 
tyramine are considered as the most toxic and food safety relevant, and fermented foods are of particular BA 
concern due to associated intensive microbial activity and potential for BA formation. Based on mean content in 
foods and consumer exposure data, fermented food categories were ranked in respect to histamine and tyramine, 
but presently available information was insufficient to conduct quantitative risk assessment of BA, individually and 
in combination(s). Regarding BA risk mitigation options, particularly relevant are hygienic measures to minimize 
the occurrence of BA-producing microorganisms in raw material, additional microbial controls and use of BA-
nonproducing starter cultures. Based on limited published information, no adverse health effects were observed 
after exposure to following BA levels in food (per person per meal): a) 50 mg histamine for healthy individuals, 
but below detectable limits for those with histamine intolerance; b) 600 mg tyramine for healthy individuals not 
taking monoamino oxidase inhibitor (MAOI) drugs, but 50 mg for those taking third generation MAOI drugs or 6 
mg for those taking classical MAOI drugs; and c) for putrescine and cadaverine, the information was insufficient in 
that respect.  Presently, only high-performance liquid chromatography (HPLC)-based methods enable simultaneous 
and high sensitivity quantification of all BA in foods, hence are best suited for monitoring and control purposes. 
Monitoring of BA concentrations in fermented foods during the production process and along the food chain would 
be beneficial for controls and further knowledge. Further research on BA in fermented foods is needed; particularly 
on toxicity and associated concentrations, production process-based control measures, further process hygiene 
and/or food safety criteria development, and validation of analysis methods. 
© European Food Safety Authority, 2011 
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SUMMARY 
The consumption of food containing higher amounts of toxic biogenic amine(s) may cause food 
intoxication and indicates the need for a better hygiene process and other controls.  Member States 
informed the EFSA that findings of certain levels of toxic biogenic amines (BA) in fermented food 
could be of concern and reported a recent increase of biogenic amines content in some fermented foods. 
The BIOHAZ Panel was asked to address several terms of reference (TORs) that were focused on: 
analysis and evaluation of the current knowledge on BAs in the context of modern food chain with 
particular focus on fermented foods, the BA risks for consumers’ health, BA risk mitigation options, the 
BA monitoring including testing methodologies; as well as on identification of areas where further 
research and data collection are needed.   
The BIOHAZ Panel conducted a qualitative risk assessment of BA in fermented foods using data from 
the scientific literature, as well as from relevant surveys, reports and consumption data from the MS. 
Based on this assessment, the BIOHAZ Panel concluded that the present knowledge and data on 
toxicity of biogenic amines (BA) individually and in combination(s) are limited: nevertheless, 
histamine and tyramine are considered as most toxic and particularly relevant for food safety. The main 
pre-requisites for the presence of BA in foods include: availability of free amino acids, the presence of 
microorganisms producing BA enzymes (mainly from raw materials and/or added starter cultures), and 
conditions allowing their growth (particularly temperature, pH), as well as conditions affecting the 
enzyme production and activity (particularly low pH). Fermentation of foods provides the conditions 
indicated above allowing intensive microbial activity and therefore has the potential for BA formation. 
Storage and distribution conditions (in particular temperature) for fermented foods are variable in 
practice and may be relevant for BA accumulation.    
Among groups of foods and within each group indicated below there is variability in amounts of BA 
found. Data are inadequate for differentiating individual products within each group. Based on the 
mean content of the most toxic BA (histamine and tyramine), the food safety relevance of the 
considered food categories can be ranked in following decreasing order - for histamine: ‘dried 
anchovies’, ‘fish sauce’, ‘fermented vegetables’, ‘cheese’, ‘other fish and fish products’ and ‘fermented 
sausages’; and for tyramine: ‘fermented sausages’, ‘fish sauce’, ‘cheese’, ‘fermented fish’ and 
‘fermented vegetables’. Based on the consumer exposure to the most toxic BA, the food safety 
relevance of the considered food categories can be ranked in following decreasing order - for 
histamine: ‘other fish and fish products’, ‘fermented sausages’, ‘cheese’, ‘fish sauces’ and ‘fermented 
vegetables’; and for tyramine: ‘beer’, ‘cheese’, ‘fermented sausages’, ‘fermented fish meat’ and 
‘preserved meat’. For quantitative risk assessment, further information and data on BA (individually 
and in combination(s)) including toxicity, concentration and consumption of fermented foods are 
required.  
BA accumulation in fermented foods is a complex process affected by multiple factors and their 
interactions, the combinations of which are numerous, variable and product-specific. Hence, risk 
mitigation options, which are based on controlling those factors/interactions, could not be considered 
and ranked individually. Rather, they were considered at general principles level. Minimizing the 
occurrence of BA-producing microorganisms can be achieved through ensuring the good hygienic 
status of the raw material and, where possible, additional microbial controls. Microorganisms intended 
to be used as starter cultures in any fermented food should be confirmed as not producing BA and able 
to outgrow autochtonous microbiota under conditions of production and storage. All aspects of 
fermented food processing (including ingredients, fermentation and ripening regimes), distribution and 
storage should be adjusted and balanced in each particular product to avoid/minimize potential 
enhancing effects on BA formation and to enable dominance of starter culture(s) where used. 
Estimating safe levels of the total amounts of BA ingested is the key issue to understand health effects 
to consumers. Consumption data and the exposure assessment were used by the Panel to define the 
concentrations in food that would be allowable, however these will vary between individuals, regions 
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and countries. Therefore, for the purpose of this document, the focus was on total amounts of BA 
ingested in relation to estimated threshold levels for BA. For histamine, currently, available information 
needed for establishing NOAEL and ARfD in humans is based only on limited number of healthy and 
sensitive individuals. Based on limited published information, no adverse health effects have been 
observed in healthy volunteers exposed to a level of 25 to 50 mg of histamine per person per meal. This 
level may be occasionally exceeded by consumption of one or more food items containing high 
amounts of histamine during the same meal. In patients with histamine intolerance, even small amounts 
of histamine in ingested food may cause adverse health effects, so only levels below detectable limits 
can be considered as safe. For tyramine, there is currently insufficient information related to 
establishing a NOAEL in humans. Based on limited published information, no adverse health effects 
have been observed in healthy individuals not taking monoamino oxidase inhibitor (MAOI) drugs 
exposed to a level of 600 mg of tyramine per person per meal. This level would not be exceeded even 
by a combined high intake of the five main food sources of tyramine during the same meal. In 
individuals taking third generation MAOI drugs, no adverse health effects have been observed after 
exposure to a level of 50 mg of tyramine per person per meal. High consumption of some fermented 
foods (beer, cheese, fermented sausages and fermented fish meat) can lead to tyramine exposure 
exceeding this level. For individuals taking classical MAOI drugs, no adverse health effects have been 
observed after exposure to a level of 6 mg of tyramine per person per meal. This would be easily 
exceeded by the consumption of fermented food. For putrescine and cadaverine, presently available 
information is insufficient to identify concentrations that directly cause acute adverse health effects 
and/or potentiate the toxic effects of histamine and other biogenic amines. 
Presently, high-performance liquid chromatography (HPLC)-based methods are the only methods 
which reliably and with high sensitivity can simultaneously quantify concentrations of all BA in 
fermented food, therefore, are most suitable for analysis of fermented foods. Currently, there is 
insufficient information in order to recommend detailed monitoring schemes and methods. Monitoring 
of BA concentrations in fermented food during the production process could be used as one of the 
parameters for the process hygiene assessment.  Monitoring of raw materials and products at multiple 
points along the food chain is necessary to evaluate the relevance of various factors contributing to BA 
formation and accumulation in fermented foods.  
The BIOHAZ Panel recommended that further research is needed on: the toxicity and associated 
concentrations of histamine and tyramine in different foods, as well as related potentiating effects of 
putrescine and cadaverine,  in particular concerning food involved in outbreaks and sporadic cases; the 
consumption data of fermented foods, especially cheese; the production process-based control measures 
for BA in fermented food including monitoring and verification aspects and the development of 
challenge tests; the evaluation of the need for and, if/where necessary, development of process hygiene 
criteria for histamine and tyramine in fermented foods, as well as food safety criteria for histamine in 
fermented foods other than fish. Also, validation of methods for BA analysis is recommended for all 
relevant food types including standardisation and harmonisation of procedures, external quality 
assessment and availability of certified reference materials.   
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BACKGROUND AS PROVIDED BY EFSA 
Member States informed the EFSA Advisory Forum in June 20094 that findings of certain levels of 
toxic biogenic amines in fermented food could be of concern. The same Member States reported a 
recent increase of biogenic amines content in some fermented foods at the EFSA Network meeting on 
Microbiological Risk Assessment held also in early June 20095.    
The consumption of food containing higher amounts of toxic biogenic amine(s) may cause food 
intoxication with symptoms including flushing, headaches, nausea, cardiac palpitations, and increased 
or decreased blood pressure; in extreme cases the intoxication may have fatal outcome.  
Biogenic amines are non-volatile low-molecular weight nitrogenous organic bases, derived through 
decarboxylation of corresponding amino acids. They can be both formed and degraded as a result of 
normal metabolic activities in humans, animals, plants and microorganisms. The responsible enzymes, 
amino acid-decarboxylases, are widely present in spoilage and other microorganisms e.g. in naturally 
occurring and/or artificially added lactic acid bacteria involved in food fermentation. Biogenic amines 
are thermo-stable and are not inactivated by heat treatments used in food processing and preparation. 
Presence of higher concentrations of toxic biogenic amines in food is undesirable and indicates the 
need for a better hygiene process and control.  
Formation of biogenic amines in all foods of animal origin having high protein contents, as well in 
foods of plant origin, has been reported.  It can occur as a result of activities of spoilage microflora 
and/or intentionally added microorganisms. Therefore, microbial starter cultures should be selected and 
controlled so that, during the fermentation process, they do not produce biogenic amines of concern.  
While histamine has received much attention (also tyramine although to a lesser extent) due to higher 
toxicity, there are numerous reports in the literature concerning other biogenic amines such as 
putrescine, phenylethylamine and cadaverine; the latter three at least can potentiate the negative effects 
of the former two. Normally, amine-oxidising enzymes catabolise and inactivate ingested biogenic 
amines; however, activity of these enzymes can be suppressed by some factors. The toxic effects of 
biogenic amines from foods have been observed particularly in individuals having dysfunctional 
biogenic amines-degrading mechanisms either naturally or due to intake of alcohol or certain 
medications. 
As indicated above, amongst the biogenic amines, histamine has attracted particular attention, as it has 
been implicated as the causative agent in a number of outbreaks of food poisoning. Histamine 
poisoning is a foodborne intoxication following the ingestion of foods containing excessive amounts of 
a microbial metabolite - histamine. Although it is commonly associated with the consumption of 
scombroid-type fish, other foods such as cheese and wine have also been implicated in outbreaks of 
histamine poisoning. Nevertheless, it should be noted that some concern exists also with respect to 
potentially toxic effects of excessive amounts of tyramine that can be present in some foods such as 
fermented sausages and cheeses.   
Formation of biogenic amines can occur during food processing and storage as a result of bacterial 
activities. Consequently, higher amounts of certain amines may be found in foods as a consequence of 
the use of poor quality raw materials, microbial contamination and inappropriate conditions during food 
processing, and microbial contamination and inadequate conditions during storage. There is evidence 
that as the hygienic quality of the product decreases, the biogenic amine content increases. Therefore, a 
number of published studies explored possibilities of using the amine concentrations as a parameter of 
process hygiene and food spoilage/quality. 
                                                     
 
 
4  Minutes of the thirty second meeting of the Advisory Forum, 24-25 June 2009, p. 8 
5  Minutes of the 3rd meeting of the EFSA Network on Microbiological Risk Assessment, June 2009 
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Commission Regulation (EC) 2073/20056 lays down food safety criteria for histamine in fishery 
products from fish species associated with a high amount of histidine between 100 mg/kg (m) and 200 
mg/kg (M) (n=9, c=2) and for fishery products which have undergone enzyme maturation treatment in 
brine, manufactured from fish species associated with a high amount of histidine between 200 mg/kg 
(m) and 400 mg/kg (M) (n=9, c=2). 
Regulation (EC) No 853/20047 provides for fishery products a possibility to lay down freshness criteria 
and limits with regard to histamine and places the responsibility on food business operators to ensure 
that the limits with regard to histamine are not exceeded in the context of health standards for these 
products.  
 
TERMS OF REFERENCE (TOR) AS PROVIDED BY EFSA 
ToR1 Carry out a review of the available published scientific information on biogenic amines in 
foods with regards to production, processing, transport, storage/retail (i.e. during the shelf-life 
of the products) until consumption; including on consumer exposure and potential health 
implications.  
ToR2 Carry out a risk profiling of relevant fermented foods regarding biogenic amine formation from 
production to consumption (within their ‘use-by’ date). Include data from additional sources 
where applicable. The profiling should also result in identification of data needs to support a 
quantitative risk assessment. 
ToR3 Identify and rank possible risk mitigation options and their anticipated impact to prevent or 
limit biogenic amines formation in fermented foods.  
ToR4 Characterise concentration levels of biogenic amine in relevant fermented foods that are not 
associated with adverse health effects of defined consumer groups including susceptible 
consumers.  
ToR5 Give advice regarding the analytical method to measure biogenic amine concentrations in 
fermented foods. 
ToR6 Recommend the monitoring methods in fermented foods that are most relevant from the public 
health point of view. These recommendations may refer to, among other aspects, the fermented 
food categories, the stages during food production until consumption within the shelf-life of a 
product to be sampled, as well as the type of sample to be collected. 
                                                     
 
6 OJ L 338, 22.12.2005, p. 11,12. Commission Regulation (EC) No 2073/2005 on microbiological criteria for foodstuffs 
amended by Regulation (EC) No 1441/2007 (OJ L 322, 7.12.2007, p.17,18)   
http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:32005R2073:en:NOT 
7  OJ L 139, 30.4.2004, p. 30, 68, Corrigendum to Regulation (EC) No 853/2004 of the European Parliament and of the 
Council of 29 April laying down specific hygiene rules for food of animal origin 
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ASSESSMENT 
1. Introduction  
The primary relevance of biogenic amines (BA) is that intake of foods or beverages containing high 
concentrations of biogenic amines can present a health hazard through the direct toxic effect of these 
compounds and their interaction with some medical treatments; but also they may have a role as 
indicators of quality and/or acceptability in some foods (Shalaby, 1996; Ruiz-Capillas and Jiménez-
Colmenero, 2004). As food safety is the main focus of this document, attention will primarily be on the 
former aspect. As neither the most toxic (histamine and tyramine) nor other BAs are significantly 
affected by normal cooking or other processing of food or beverages makes food safety assurance in 
respect to BA more challenging. Presently, the main BA control strategies are focused on prevention of 
BA formation in foods at all relevant points in the food chain. 
However, despite extensive research on food safety aspects of BA including risk mitigation options for 
most relevant foods, some related aspects are still poorly understood. Also, risk assessment of 
consumer’s health-relevant concentrations of biogenic amines in foods (especially fermented foods) has 
been difficult because published information on toxic effects, dose-response and the actual 
concentrations in foods is quite limited. Furthermore, the conditions in food production-storage-
retailing-preparation chain have changed including modifications in some traditional practices and the 
use of new/emerging technologies, which may produce differences in the formation and/or 
concentrations of different compounds including BAs in related food types. Furthermore, global food 
trade and consumers’ eating habits – both food safety relevant factors - are changing. Therefore, there 
is a need to periodically re-visit the BA-related food safety issues and consider any new related 
knowledge, data and trends which may enable further improvements of BA risk reduction strategies.   
Therefore, the main scope of this document is, briefly, to analyse and evaluate: the current knowledge 
on BAs in the context of modern food chain with particular focus on fermented foods, the BA risks for 
consumers’ health, BA risk mitigation options, the BA monitoring including testing methodologies; as 
well as to identify areas where further research and data collection are needed.   
2. Hazard Identification 
2.1. Background 
Biogenic amines (BA) are organic, basic, nitrogenous compounds of low molecular weight, mainly 
formed by the decarboxylation of amino acids and with biological activity. According to their chemical 
structure, they can be classified as heterocyclic (histamine and tryptamine), aliphatic (putrescine and 
cadaverine) or aromatic (tyramine and phenylethylamine) (Figure 1). According to their number of 
amine groups they can be divided into monoamines (tyramine and phenylethylamine) and diamines 
(histamine, putrescine and cadaverine). BAs are naturally occurring in animals and humans. They are 
involved in natural biological processes such as synaptic transmission, blood pressure control, allergic 
response and cellular growth control. Nonetheless, BA may be hazardous to human health if their levels 
in foods or beverages reach a critical threshold (Ladero et al., 2010a). The main source of exogenous 
amines is dietary, through the uptake of foods or beverages containing high concentrations of these 
compounds (Shalaby, 1996; Silla Santos, 1996; Premont et al., 2001). Foods likely to contain high 
levels of biogenic amines include fish, fish products and fermented foodstuffs (meat, dairy, vegetables, 
beers and wines). The most important BAs found in food are histamine, tyramine, putrescine, 
cadaverine and phenylethylamine, which are products of the decarboxylation of histidine, tyrosine, 
ornithine, lysine and phenylalanine, respectively. Putrescine can also be formed through deimination of 
agmatine. Microorganisms possessing the enzyme decarboxylases, which convert amino acids to 
amines, are responsible for the formation of biogenic amines in foods (Beutling, 1996).  
Biogenic amines in fermented foods
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BA production in foods requires the availability of precursors (i.e. amino acids), the presence of 
bacteria synthesising amino acid decarboxylases, and favourable conditions for their growth and 
decarboxylating activity (Ten Brink et al., 1990; Stratton et al., 1991). The amount and type of biogenic 
amines formed in foods is strongly influenced by the intrinsic food characteristics including pH, water 
activity, composition, microbiota and by extrinsic parameters such as storage time and temperature, 
which allow bacterial growth during food processing and storage.  
The biogenic amine content (particularly) of some foods has been widely studied because of their 
potential toxicity. Histamine has been implicated as the causative agent in outbreaks of food poisoning 
where intoxication results from the ingestion of foods containing excessive amounts of histamine. 
Although commonly associated with the consumption of scombroid-type fish, other foods such as 
cheese have also been associated with outbreaks of histamine poisoning. Tyramine and 
phenylethylamine have been identified as the initiators of hypertension during treatment with 
monoamino oxidase inhibitor (MAOI) drugs and of dietary-induced migraine in susceptible individuals. 
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Figure 1:  Structure of histamine, tyramine, 2-phenylethylamine, putrescine and cadaverine 
2.2. Microorganisms with amino acid decarboxylase activities 
Biogenic amines in food are mainly formed by bacterial decarboxylation of the corresponding amino 
acids through substrate-specific decarboxylase enzymes (Figure 2). Biodegradative decarboxylases do 
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not show a strict specificity towards the substrates and when the primary amino acid substrate is absent, 
structurally similar amino acids may be decarboxylated to form other biogenic amines. For instance, 
ornithine-decarboxylases generate cadaverine from lysine (Bardocz, 1995), arginine-decarboxylases 
decarboxylate ornithine at slow rate (Tabor and Tabor, 1985), and tyrosine-decarboxylases form 
phenylethylamine from phenylalanine (Joosten, 1988). The lack of substrate specificity of amino acid 
decarboxylases provides a mechanism for ‘emergency’ pH homeostasis since this shows some 
independence from the available extracellular amino acids (Foster and Hall, 1991, Park et al., 1996). 
The production of biogenic amines has been associated with some groups of microorganisms. For 
example, putrescine and cadaverine production is frequently found in enterobacteria, and tyramine 
production is reported in the majority of enterococci. Within microbial groups, the capacity to produce 
biogenic amines is, however, a strain-specific characteristic, more widely distributed among certain 
genera or species, suggesting that horizontal gene transfer may account for their dissemination between 
strains (Coton and Coton, 2009; Lucas et al., 2005; Marcobal et al., 2006a). Moreover, great variation 
has been reported in the type and quantity of biogenic amines produced between different strains of the 
same species. Some strains are even able to simultaneously produce more than one amine 
simultaneously, either due to the presence of different decarboxylases or to the action of a single 
enzyme which decarboxylates different amino acids (Bover-Cid and Holzapfel, 1999).    
2.2.1. Decarboxylases 
Decarboxylases belong to the pyridoxal-phosphate-dependent enzyme group, whose members use 
pyridoxal-5`-phosphate (PLP) as a coenzyme. Histidine decarboxylases fall into two different classes: 
those from eukaryotic cells and Gram-negative bacteria, which require pyridoxal phosphate as a 
cofactor (Guirard and Snel, 1987), and those from Gram-positive bacteria, which use a covalently 
bound pyruvoyl moiety as the prosthetic group (Recsei and Snell, 1984).  
Tyrosine decarboxylase (TDC) converts tyrosine to tyramine and also catalyses L-dopa 
decarboxylation. TDC enzymes are usually also able to use phenylalanine as a substrate to produce 
phenylethylamine; this enzyme is therefore also responsible for the phenylethylamine content detected 
in some food products. This dual activity has recently been confirmed with the expression of TDC 
enzyme from Enterococcus faecium RM58 in E. coli, which showed phenylalanine and tyrosine 
decarboxylase activities (Marcobal et al., 2004a; Marcobal et al., 2006b). TDC in Lactobacillus brevis 
is highly specific for tyrosine (Moreno-Arribas and Lonvaud-Funel, 1999).  
Cadaverine can be formed from lysine by the lysine decarboxylase activity. Cadaverine production has 
been generally associated either with Gram-negative bacteria, though some Gram-positive bacteria have 
also been described to be able to produce cadaverine in a lysine-rich medium (Bover-Cid and 
Holzapfel, 1999).  
Putrescine can be formed from ornithine by ornithine decarboxylase. Alternatively, arginine can be 
converted to agmatine by arginine decarboxylase and agmatine can be converted to putrescine by the 
agmatine deiminase system which is formed by three enzymes: agmatine deiminase, putrescine 
carbamoyltransferase and carbamate kinase (Arena and Manca de Nadra, 2001).  
2.2.2. The transporter proteins 
After amino acid decarboxylation, the second component in the aminogenesis process is an inner 
membrane antiporter used to deliver the amino acid substrate into the cell and to remove (excrete) the 
decarboxylated product from the cytoplasma. In the amino acids/amines antiporter, the uptake of 
substrate and excretion of products are coupled events (Figure 2).  
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The presence of a Histidine/Histamine antiporter (HdcP) was reported in Lactobacillus buchneri ST2A 
(Molenaar et al., 1993). In whole cells of this bacterium, the coupled reactions of histidine 
decarboxylation and histidine/histamine exchange generated a transmembrane pH gradient (inside 
alkaline) and an electrical potential (inside negative), i.e., a proton motive force (PMF) (secondary 
metabolic energy generation). Similar mechanisms for the other amino acid/biogenic amine have also 
been characterised in other microorganisms, for instance the tyrosine/tyramine transport mechanism on 
Lactobacillus brevis (Wolken et al., 2006) or the putrescine and cadaverine transport proteins (PotE 
and CadB respectively) have been well characterised in Escherichia coli (Soksawatmaekhin et al., 
2004).  
 
 
 
 
 
 
 
 
 
 
 
Figure 2:  Biogenic amine biosynthesis pathways in bacteria. Amino acid decarboxylase (aaDC). The 
membrane antiporter protein delivers the amino acid substrate into the cell and removes (excretes) the 
decarboxylated product from the cytoplasm. (Adapted from Bover-Cid, 2000a) 
 
2.2.3. Histamine producing microorganisms 
The ability to produce histamine has been found in both Gram-negative and in Gram-positive bacteria. 
Many Gram-negative bacteria which commonly contaminate food are able to produce histamine. The 
strongest histamine producers Hafnia alvei, Morganella morganii, Klebsiella pneumonia and, more 
recently, Morganella psychrotolerans, Photobacterium phosphoreum, Photobacterium psychrotolerans 
and have been isolated from fish incriminated of scombroid poisoning incidents (Özogul and Özogul, 
2006; Kanki et al., 2004; Emborg et al., 2006; Dalgaard et al., 2008).  
In fermented food, for example strains of Oenococcus oeni, Pediococcus parvalus, Pediococcus 
damnosus, Tetragenococcus species, Leuconostoc species, Lactobacillus saerimneri 30a, Lactobacillus 
hilgardii, Lactobacillus buchnerii and Lactobacillus curvatus, are known to produce histamine 
(Vanderslice et al., 1986; Spano et al., 2010; Beutling, 1996; Kimura et al., 2001; Lucas et al., 2005). 
Histamine producing Lactobacillus parabuchneri or Lactobacillus rossiae strains have been found as 
contaminating microbiota in starter culture preparations used in winemaking (Costantini et al., 2009). 
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In the recent years, histamine formation, or the occurrence of the hdc gene, have been occasionally 
described for some specific species previously unrecognised as being able to produce biogenic amines, 
such as Streptococcus salivarius subsp. thermophilus (Calles-Enríquez et al., 2010) and Lactobacillus 
sakei (Coton and Coton, 2005). However, the proportion of decarboxylase-positive strains is low and 
their histaminogenic potential is weak or not proven in food. 
Kanki et al. (2007) suggested that the enzymatic activity of histidine decarboxylase was responsible for 
histamine formation and its action could continue even after bacterial autolysis. This was confirmed in 
experiments using recombinant histidine decarboxylase (HDCs) of the histamine-producing bacteria 
Photobacterium phosphoreum, P. damselae, R. planticola, and M. morganii in which the bacteria 
themselves were absent (Kanki et al., 2007).  
2.2.4. Tyramine and phenylethylamine producing microorganisms 
The main tyramine producers in cheese and fermented sausages are Gram-positive bacteria within the 
genera Enterococcus (e.g. Enterococcus faecalis and Enterococcus faecium), Lactobacillus (e.g. 
Lactobacillus curvatus and L. brevis) (Bover-Cid et al., 2000b,c)), Leuconostoc and Lactococcus 
(Fernandez et al., 2004; Fernandez et al., 2007a,b) and Carnobacterium spp. (Masson et al., 1999). 
Staphylococcus may also have a role in the production of tyramine (Ansorena et al., 2002; Martin et 
al., 2006; de las Rivas et al., 2008; Latorre-Moratalla et al., 2010a,b).  In  fermented  beverages,  L. 
brevis,  L.  hilgardii,  Lactobacillus  plantarum  and  Leuconostoc  species  have  been  described  as 
tyramine producers (Coton et al., 2010a). 
Phenylethylamine production has been described during food fermentations and has been suggested to 
be formed as a result of the activity of tyrosine decarboxylating bacteria towards this structurally 
related amino acid. Usually, phenylethylamine production is associated with tyramine production as 
demonstrated for Enterococcus, Lactobacillus curvatus, Staphylococcus, (Bover-Cid et al., 2001a,b,c; 
Bover-Cid et al., 2003; Moreno-Arribas and Lonvaud-Funel 2001; Suzzi and Gardini 2003). However, 
purified tyrosine decarboxylase from L. brevis does not demonstrate the ability to decarboxylate 
phenylalanine; instead it is tyrosine specific (Moreno-Arribas and Lonvaud-Funel, 2001). 
Interestingly, some strains of S. carnosus from fermented sausages have been reported to produce 
considerable amounts of phenylethylamine without producing tyramine (Ansorena et al., 2002; de las 
Rivas et al., 2008; Latorre-Moratalla et al., 2009). 
2.2.5. Putrescine and cadaverine producing microorganisms 
Putrescine and cadaverine production has mainly been related to Gram-negative bacteria, especially in 
the families Enterobacteriaceae, Pseudomonadaceae and Shewanellaceae, generally associated with 
spoilage (Lopez-Caballero et al., 2001). Enterobacteria genera Citrobacter, Klebsiella, Escherichia, 
Proteus, Salmonella and Shigella are associated with production of considerable amounts of putrescine 
and cadaverine in food (Paleologos et al., 2004; Kim et al., 2009; Rezaei et al., 2007; Chytiri et al., 
2004). The ornithine and lysine decarboxylase phenotypes within Enterobacteriaceae isolates have 
been traditionally used for taxonomic purposes (Moeller, 1954).  
Putrescine is one of the most common BA found in fermented products. Lactic acid bacteria, 
lactobacilli mainly, and staphylococci have also been reported to be able to produce putrescine and/or 
cadaverine (Arena et al., 2001; Beneduce et al., 2010; Coton et al., 2010b). 
Putrescine has been described to be produced mainly by the dominant malolactic fermentation (MLF) 
species in wine, Oenococcus oeni, although strains belong to L. hilgardii and L. plantarum species are 
able to produce putrescine during wine fermentation (Nannelli et al., 2008; Arena et al., 2001; 
Marcobal et al., 2004b; Lucas et al., 2007).  
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2.2.6. Physiological role of decarboxylases in microorganisms 
In microorganisms, two types of amino acid-decarboxylase enzymes have been described having 
different physiological roles: biosynthetic (constitutive) mainly associated with microbial growth 
(Kamio et al., 1986; Kamio and Nakamura, 1987) and biodegradative (inducible by a number of 
environmental factors) that fulfil a number of physiological roles depending on the microorganisms 
(Tabor and Tabor, 1985; Applebaum et al., 1977). The constitutive biosynthetic decarboxylases are 
present in considerably less quantities than that of the induced biodegradative forms (Suzuki et al., 
1991) whereby the latter are responsible for the biogenic amine accumulation in foods. 
In prokaryotic cells, the physiological role of BA synthesis by biodegradative decarboxylases mainly 
appears to be related to defence mechanisms used by bacteria to withstand acidic environments (Lee et 
al., 2007, Rhee et al., 2002). Decarboxylation increases survival under acidic stress conditions via the 
consumption of protons and the excretion of amines and CO2, helping to restore the internal pH (Figure 
2). BA production may also offer a way of obtaining energy, since the electrogenic amino acid/amine 
antiport can lead to generation of proton motive force (Molenaar et al., 1993). This function is 
particularly important to microorganisms lacking a respiratory chain for generating high yields of ATP 
(Vido et al., 2004).  
A role of amino acid-decarboxylases in the pathogenesis of certain bacteria is to contribute to survival 
in the acid contents of the stomach and food containing acidic materials. Also, some reports suggest 
that decarboxylases may prevent the acidification of the macrophage/phagosome after invasion of 
macrophage cells (Park et al., 1996). Production of tyramine may even contribute to the survival and 
colonisation mechanism of Enterococcus durans in the human colon (de Palencia et al., 2011). As this 
mechanism could also apply to other biogenic amines and other bacteria, this hypothesis about the 
production of amines (histamine and tyramine) as a protective mechanism against acidic environment 
was originally suggested for Gram-negative intestinal bacteria (Hanke and Koessler, 1924). 
Some studies suggest new and interesting hypotheses on the physiological role of amines in 
microorganisms (Tkachenko et al., 2001). In Escherichia coli, the expression of oxyR, the gene that 
protects E. coli against oxidative stress, was enhanced by physiological concentrations of the BA 
putrescine. Moreover, putrescine was shown to produce a protective effect if the DNA is damaged by 
reactive oxygen species (Tkachenko et al., 2001). Putrescine may be involved in osmotic stress 
tolerance in E. coli (Schiller et al., 2000). Therefore, bacteria which possess amino acid decarboxylase 
activity could overcome or reduce the effects of factors that induce stress responses in the cell, such as 
oxygen and NaCl, with the production of putrescine. 
Since histamine is a potent vasodilator, it may alter the physiology of the host to the advantage of 
bacteria, for instance resulting in transfer of essential nutrients from host to bacteria via secretion into 
the gut lumen as a result of capillary dilation (Recsei and Snell, 1984; Poelje and Snell, 1990). Those 
bacteria capable to produce histamine may cause tissue damage that, in turn, facilitates the colonization 
and invasion of the host (Barancin et al., 1998). Similarly, the activation of the tyramine biosynthetic 
pathway may be involved in enhancement of the adhesion between LAB and epithelium cells. These 
results are in agreement with those previously reported by Lyte (2004) who demonstrated an improved 
adhesion to the intestinal mucosa of Escherichia coli O157:H7 in the presence of tyramine. 
Some decarboxylases may be implicated as a possible virulence factor for certain foodborne pathogens. 
A plasmid encoded histidine decarboxylase has been described in Vibrio anguillarum (Barancin et al., 
1998), which may play a role in the biosynthetic pathway of its siderophore and consequently in 
conferring the high virulence to this bacterium (Tolmasky et al., 1995). Similarly, putrescine has been 
described as an essential precursor for alcaligin siderophore biosynthesis in Bordetella species 
(Brickman and Amstrong, 1996). 
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2.3. Conditions supporting the formation of BAs 
2.3.1. Substrate availability 
The availability of substrate amino acids is one of the prerequisites for BA synthesis. Proteolysis is a 
crucial factor, because it is directly related to availability of free amino acids that provide a substrate 
for BA formation. It has been reported that conditions of accelerated or enhanced proteolysis increases 
BA formation (Leuschner et al., 1998a; Innocent and D`Agostin, 2002; Fernández et al., 2007a; 
Komprda et al., 2008).  
2.3.2. Conditions allowing growth of BA producers, enzyme production and activity  
2.3.2.1. Effect of temperature 
The quantitative production of biogenic amines is usually reported to be temperature and time 
dependent (Zaman et al., 2009). Generally the amine production rate increases with the temperature. 
Conversely, biogenic amine accumulation is minimised at low temperatures through inhibition of 
microbial growth and the reduction of enzyme activity. The optimum temperature for the formation of 
BA by mesophilic bacteria has been reported to be between 20 to 37 °C, while production of BA 
decreases below 5 °C or above 40 °C. For instance, Morganella morganii is known to be a powerful 
histamine producer in seafood, though at storage temperatures above 7-10 ºC (Kim et al., 2002; Lehane 
and Olley, 2000). Klebsiella pneumoniae was reported to produce cadaverine more extensively at 20ºC 
than at 10ºC, whereas Enterobacter cloacae was able to produce putrescine at 20ºC but not at 10ºC 
(Haláz et al., 1994). In refrigerated foods (e.g. chilled fresh fish stored in ice) psychrotolerant bacteria 
can actively contribute to the amine accumulation at high rates even during storage below 5ºC, 
Photobacterium phosphoreum and Morganella psychrotolerans (a psychrotolerant variant of M. 
morganii) being the most relevant bacteria (Lakshmanan et al., 2002; Emborg et al., 2005; Emborg et 
al., 2006; Daalgaard et al., 2006; Rezaei et al., 2007). 
Prolonged storage periods, in particular at abuse temperatures make the food more susceptible to amine 
formation. Some BA such as tyramine, putrescine, and cadaverine can be formed during the storage of 
food (Bover-Cid et al., 2001c; Suzzi and Gardini, 2003; Maijala, 1993; Ferreira and Pinho, 2006; 
Kosson and Elkner, 2001). For this reason, low temperatures should be applied during storage to reduce 
proteolytic and decarboxylase activities and growth of bacteria (Hernández-Orte et al., 2008; Rezaei et 
al., 2007). However, the occurrence and activity of psychrotrophic bacteria can result in biogenic 
amines formation also in properly chilled stored fish (Middlebrooks et al., 1988; Kim et al., 2009; 
Bakar et al., 2010).  
2.3.2.2. Effect of pH 
The pH level is an important factor influencing amino acid decarboxylase activity (Silla Santos, 1996). 
There are two pH related mechanisms acting simultaneously. One is affecting the growth by acidity 
which inhibits the growth of microorganisms (Maijala et al., 1993; Maijala, 1994; Masson et al., 1999; 
Bover-Cid et al., 2000c). The other affects the production and activity of the enzyme because in low pH 
environment, bacteria are more stimulated to produce decarboxylase as a part of their defence 
mechanisms against the acidity (Molenaar et al., 1993; Bover-Cid et al., 2006b; Fernández et al., 
2007a). These opposing factors interfere with each other and the net result depends on their balance.  
2.3.2.3. Other factors 
Sodium chloride influences the activity of amino acids decarboxylase involved in biogenic amine 
production. Histidine decarboxylase activity of Staphylococcus capitis, Enterobacter cloacae and 
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Pantoea agglomerans are retarded by the high concentration of salt. In contrast, sodium chloride 
enhanced activity of histidine decarboxylase of halotolerant Staphylococcus spp. isolated from salted 
anchovies. Hence, it can be assumed that the effect of sodium chloride either inhibiting and stimulating 
biogenic amines production is strain specific (Taylor and Woychik, 1982; Taylor and Speckard, 1984; 
Hernandez-Herrero et al., 1999; Rodriguez-Jerez et al., 1994). 
Oxygen availability also appears to have a significant effect on the biosynthesis of BA. Enterobacter 
cloacae produces about half the quantity of putrescine under anaerobic as compared with aerobic 
conditions, and Klebsiella pneumoniae synthesizes significantly less cadaverine but acquires the ability 
to produce putrescine under anaerobic conditions (Halász et al., 1994). The redox potential of the 
medium also influences BA production. Conditions resulting in a reduced redox potential stimulate 
histamine production, and histidine decarboxylase activity seems to be inactivated or destroyed in the 
presence of oxygen (Karovičová and Kohajdová, 2005). In contrast, oxygen availability (aerobic or 
anaerobic growth) had little influence on the tyramine, phenylethylamine and putrescine production by 
Lactobacillus curvatus (Bover-Cid et al., 2006b). 
Some other factors including tartaric acid and sugar concentration may play a role in some foods but 
information on their actual contribution and mechanisms of action are relatively limited. The presence 
of tartaric acids appears to increase the amount of putrescine produced by L. hilgardii. However, an 
inhibitory effect by sugars on the HDC catalytic activity has been reported (Arena et al., 2008; 
Lonvaud-Funel, 2001).  
2.4. Main scenarios leading to the occurrence of BA in food  
2.4.1. Preformed BA in raw materials  
Some amines identified in fermented food are already found at low levels in raw materials of good 
hygienic quality such as putrescine in meat, fish, milk and fruits. Blood and offal can contain 
physiological concentrations of histamine, hence it can be found in products containing these raw 
materials such as blood sausages (Mariné-Font et al., 1995). 
From a practical perspective, prediction of biogenic amine accumulation in foods as a function of time 
and temperature, as well as other relevant environmental factors, can be used to avoid conditions that 
result in unacceptable biogenic amine levels. This approach has already been developed for histamine 
accumulation in seafood, particularly associated with growth and histamine formation by Morganella 
psychrotolerans and M. morganii (Emborg and Dalgaard, 2008), and included within the Seafood 
Spoilage and Safety Predictor tool (http://sssp.dtuaqua.dk). This validated predictive tool can be used 
by the seafood industry within a HACCP program, since this provides valuable predictions to determine 
critical combinations of storage conditions enabling control of histaminogenesis in fish (Dalgaard et al., 
2008). 
2.4.2. Spoilage  
Spoilage microorganisms may strongly contribute to BA formation in fermented food even though food 
is not spoiled. Indeed, as results of their microbiological origin, BAs have been used as a criteria to 
evaluate the hygienic quality and freshness of certain foods, especially fish, but also meat products. For 
this purpose, a number of the so called Biogenic Amine Indices (BAIs) have been suggested, which 
may include one (e.g.Vinci and Antonelli, 2002) or multiple biogenic amines (e.g. Veciana-Nogués et 
al., 1997), even combination with other parameters (Jørgensen et al., 2000). 
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2.4.3. Fermentation 
The main aim of lactic acid fermentation is the conversion of carbohydrates to lactic acid. Therefore the 
action of lactic acid bacteria is desirable for the production of fermented sausages, cheese, sour dough 
bread and also for malolactic fermentation of wine. However, some of the bacteria involved in 
fermentation can produce BAs.  
There is no evidence about massive formation of biogenic amines by yeast and moulds, although they 
may bear constitutive amino acid decarboxylase enzymes involved in a number of physiological 
functions. The occurrence of considerable amounts of histamine and tyramine in yeast extracts 
(“Marmite”) was reported (Tabor and Tabor, 1985; Blackwell et al., 1969), although a potential 
bacterial contamination as the source of these toxic biogenic amines was identified. Therefore, 
alcoholic fermentation is not of concern for BA formation unless spoilage with lactic acid bacteria 
occurs. 
2.5. Possible in situ formation of biogenic amines in the gut 
In addition to the ingestion of BAs formed in food, there is a possibility of BA production in the human 
intestine due to the microbiota both from the intestine or the food (de Palencia et al., 2011). Intestinal 
bacteria may also be capable to degrade biogenic amines, either ingested with food or produced by 
other intestinal bacteria (Hanke and Koessler, 1924). The actual relevance for public health of BAs 
produced in the intestine is presently unclear and not proven.   
3. Hazard characterisation 
3.1. Histamine 
3.1.1. Synthesis and metabolism in humans 
Histamine is synthesized by the pyridoxal phosphate containing L-histidine decarboxylase from the 
amino acid histidine in mast cells, basophils, platelets, histaminergic neurons, and enterochromaffine 
cells (Maintz and Novak, 2007). It can be metabolised by oxidative deamination by diamino oxidase 
(DAO) and by ring methylation by histamine-N-methyltransferase (HNMT) depending on its 
localization (Jarisch, 2004). Monoamine oxidase (MAO) is also involved in the HNMT products 
pathway. DAO has been shown to be a secretory protein predominantly synthesized in renal proximal 
tubular and intestinal epithelial cells and it is stored in plasma membrane associated vesicular 
structures. Therefore, it has been proposed that DAO might be of primary importance for inactivation 
and scavenging of extracellular histamine originating from ingested histamine rich food (Schwelberger 
et al., 1998; Schwelberger and Bodner, 1998; Klocker et al., 2005). On the contrary, HNMT a cytosolic 
protein with high expression in liver, kidney, lymph nodes, eye and lung can convert histamine only in 
the intracellular space of cells (De Santi et al., 1998; Klocker et al., 2005). High doses of alimentary 
histamine and malfunction or reduced activity of DAO can result in high histamine blood levels, which 
consequently overload the internal hepatic inactivation system of HNMT (Jarisch, 2004). A number of 
drugs containing DAO-inhibitors and alcohol is known to reduce DAO activity (Sattler et al., 1988; 
Sessa et al., 1984). Individual differences in enzyme activities besides varying histamine concentrations 
in food may account for different tolerance levels (Jarisch, 2004). 
3.1.2. Physiological role in humans 
Histamine acts both as local hormone and neurotransmitter. Mast cells, blood cells (e.g. basophilic 
granulocytes and thrombocytes), and neurons in the brain have been found to contain histamine (Forth 
et al., 2001). By interacting with specific receptors (H1, H2, H3, H4) on target cells, histamine 
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modulates a variety of functions. Its physiological role includes gastric acid secretion, cell growth and 
differentiation, circadian rhythm, attention and cognition. In addition, histamine is involved in the onset 
of allergic reactions by binding onto specific receptors which effect the contraction of smooth muscle 
cells (intestines, lung, uterus), dilatation of blood vessels and, thus, an efflux of blood plasma into 
surrounding tissues like mucous membranes and subcutis (Jarisch, 2004; Jørgensen et al., 2007; 
Rangachari, 1992). 
3.1.3. Toxic effects in humans 
In healthy persons, dietary histamine is rapidly detoxified by amine oxidases but they may develop 
severe symptoms of histamine intoxication as a result of its high amounts ingested with food such as 
scombroid fish or matured cheese (Taylor, 1986; Lehane and Olley, 2000). Impairment of DAO activity 
either due to genetic predisposition, gastrointestintal diseases, or due to medication with DAO 
inhibitors results in histamine excess and leads to histamine intolerance causing numerous symptoms 
mimicking an allergic reaction even after the ingestion of small amounts of histamine tolerated by 
healthy individuals (Maintz and Novak, 2007). Intoxication is characterized by an incubation period 
ranging from a few minutes to hours, with symptoms that are usually noticeable for a few hours only. 
The symptoms of histamine poisoning relate to effects on blood vessels and smooth muscles, and 
include headache, nasal secretion, bronchospasm, tachycardia, extrasystoles, hypotension, edema 
(eyelids), urticaria, pruritus, flushing and asthma (Jarisch, 2004; Maintz and Novak, 2007). 
Dietary histamine has also been implicated in the pathogenesis of migraine in susceptible individuals 
suffering from DAO deficiencies (Maintz and Novak, 2007). Histamine-rich food has been reported by 
migraine patients to trigger headache which are alleviated by a histamine-free diet (Wantke et al., 
1993). 
3.1.3.1. Dose-response relationships  
Only a limited number of studies have been reported on the dose-response relationships of alimentary 
histamine, principal data originating either from volunteer studies or from clinical cases, albeit that the 
findings are not always conclusive (Rauscher-Gabernig et al., 2009).  
Healthy volunteers exhibited no symptoms after consumption of 25 – 50 mg histamine with solid food 
like fish or non-alcoholic drinks (Motil and Scrimshaw, 1979; Van Gelderen et al., 1992; Lüthy and 
Schlatter, 1983). In some volunteers histamine levels ranging from 75 to 300 mg in fish or non-
alcoholic beverages could provoke mostly headache and flushing (Motil and Scrimshaw, 1979; Van 
Gelderen et al., 1992; Clifford et al., 1989, Wöhrl et al., 2004). In trials with histamine containing 
alcoholic beverages like wine no significant effects were observed in healthy volunteers, whereas 12 
out of 40 patients with histamine intolerance demonstrated clear symptoms like dizziness, headache, 
nausea and itching (Lüthy and Schlatter, 1983; Menne et al., 2001; Table 1). 
Instillation of 120 mg histamine into the duodenum was well tolerated in healthy volunteers; in patients 
with chronic urticaria symptoms such as urticaria, headache, tachycardia, hypotension, nausea and 
diarrhoea were observed (Kanny et al., 1993; 1996; Table 1). 
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Table 1:  Dose-response relationship of histamine in humans after oral administration 
Administration Histamine  
*amount ingested 
Symptoms Number of subjects 
showing symptoms /  
total number of subjects 
Reference 
Solid foods     
tuna 25 mg no symptoms 0/8 healthy volunteers Motil and Scrimshaw, 1979
herring paste 45 mg no effect level 0/8 healthy volunteers Van Gelderen et al., 1992 
tuna 50 mg no symptoms 0/8 healthy volunteers Motil and Scrimshaw, 1979
herring paste 90 mg warm face, flushing, headache 2/8 healthy volunteers Van Gelderen et al., 1992 
tuna 100 mg mild headache, flushing 1/8 healthy volunteers Motil and Scrimshaw, 1979
tuna 150 mg mild headache, flushing 2/8 healthy volunteers Motil and Scrimshaw, 1979
tuna 180 mg mild to severe headache, flush 4/8 healthy volunteers Motil and Scrimshaw, 1979
mackerel 300 mg headache, flushing, oral tingling 
(no significant effects) 
n.i.a /7 healthy volunteers Clifford et al., 1989 
Non-alcoholic drinks    
apple juice 25 mg no statistically significant effects n.i.a /25 healthy volunteers 
and 2 migraine patients 
Lüthy and Schlatter, 1983 
grapefruit juice 25 mg no significant effect 0/4 healthy volunteers Motil and Scrimshaw, 1979
grapefruit juice 50 mg no significant effect 0/4 healthy volunteers Motil and Scrimshaw, 1979
peppermint tea 75 mg diarrhoea, headache, sneezing, 
flatulence 
5/10 healthy females Wöhrl et al., 2004 
grapefruit juice 100 mg mild headache, flushing 2/4 healthy volunteers Motil and Scrimshaw, 1979
grapefruit juice 150 mg mild headache, flushing 2/4 healthy volunteers Motil and Scrimshaw, 1979
grapefruit juice 180 mg severe headache, flushing 1/4 healthy volunteers Motil and Scrimshaw, 1979
Alcoholic drinks     
wine 0.12 - 4.2 mg no statistically significant effects n.i.a /20 healthy volunteers Lüthy and Schlatter, 1983 
wine 100 mg no effects 0/2 healthy volunteers Lüthy and Schlatter, 1983 
sparkling wine 4 mg dizziness, headache, nausea, 
itching 
12/40 patients with 
histamine intolerance 
Menne et al., 2001 
Digestive histamine challenge    
Instillation into 
the duodenum 
120 mg No symptoms 0/8 healthy volunteers Kanny et al., 1993 
Instillation into 
the duodenum 
120 mg urticaria, headache, accelerated 
heart rate, drop in blood 
pressure, nausea, diarrhoea 
26/32 patients with chronic 
urticaria 
Kanny et al., 1993; 1996 
a n.i. = not indicated 
3.1.3.2. Outbreak data 
Fish 
Fish have been incriminated in the majority of incidents of histamine poisoning, whereas tuna, skipjack, 
and mackerel seem to be the most commonly implicated food types (Taylor, 1985). Histamine is the 
main toxin involved in scombroid fish poisoning, also called histamine fish poisoning. It is generally 
associated with high levels of histamine (≥500 mg/kg) in fish. Although there is compelling evidence to 
implicate histamine as the causative agent in histamine fish poisoning, there is not a straightforward 
dose-response relationship, as spoiled fish containing histamine tends to be more toxic than the 
equivalent amount of pure histamine dosed orally (Lehane and Olley, 2000). The main evidences 
supporting the involvement of histamine in histamine fish poisoning are the identical symptoms of 
histamine poisoning to those of intravenous histamine administration and the efficacy of antihistamines 
in histamine fish poisoning therapy (Koutsoumanis et al., 2010). Histamine poisoning was also reported 
at histamine concentrations lower than 500 mg/kg, e. g. in one outbreak tuna burgers with histamine 
levels of 213 mg/kg were implicated (Becker et al., 2001) and another case of scombroid poisoning was 
linked to canned anchovies containing 365 mg/kg histamine (NSW Food Authority, 2010). In the 
European Rapid Alert system for Food and Feed (RASFF) database adverse effects to consumers were 
recorded at various histamine concentrations in fish samples (reported concentration ranges in different 
sub-samples of the same sample e.g. 50 – 500 mg/kg, 102 – 180 mg/kg, 27 – 152 mg/kg, of 147 mg/kg, 
below 5 to 208 and below 10 to 1000 mg/kg; see section 4.1.1.).  
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Histamine analysis was carried out on 240 fish samples from incidents of histamine fish poisoning in 
the UK between 1976 and 1986. The symptoms most consistently reported were rash, diarrhoea, 
flushing, and headache. Of fish samples with more than 200 mg/kg histamine, 94% were from incidents 
in which histamine poisoning symptoms were characteristic. Based on the interpretation of quantitative 
histamine analysis of these fish samples the following recommendations were made: fish containing 
less than 50 mg/kg histamine is rated as normal and safe for consumption, between 50 and 200 mg/kg 
histamine the fish is regarded as mishandled and possibly toxic, concentrations between 200 and 
1000 mg/kg histamine are classified as unsatisfactory and probably toxic, and those above 1000 mg/kg 
histamine are rated as toxic and unsafe for consumption (Bartholomew et al., 1987; Table 2).  
More recently, in a Danish survey of histamine fish poisoning outbreaks and cases, most of them 
caused by seafood with histamine concentrations of more than 500 mg/kg. Only in 10% of these cases 
was seafood with less than 500 mg/kg involved. But for 80% of these cases no plate-sample of the fish 
actually consumed was available, and therefore, only a sample from the same batch of fish was 
analysed. This is important to point out because the concentration of histamine can vary considerably 
from fish to fish within a batch and even between different portions of a single fish. Hence, it cannot be 
excluded that in some situations where seafood with very low concentrations of histamine have been 
reported to cause histamine fish poisoning, the seafood-sample actually consumed contained a much 
higher concentration of histamine (Dalgaard et al., 2008). 
Table 2:  Concentrations in fish samples related to histamine fish poisoning  
Histamine concentration Fish quality Health effects Reference 
<50 mg/kg normal safe for consumption Bartholomew et al., 1987 
50-200 mg/kg mishandled possibly toxic Bartholomew et al., 1987 
200-1000 mg/kg unsatisfactory probably toxic Bartholomew et al., 1987 
≥500 mg/kg not reported toxic Dalgaard et al., 2008 
>1000 mg/kg unsafe toxic Bartholomew et al., 1987 
 
Cheese 
After fish, cheese is the next most commonly implicated food item associated with histamine poisoning 
(Stratton et al., 1991; Silla-Santos, 1996). Reported outbreaks include cheeses made from raw as well 
as from pasteurized milk (Lund et al., 2000). Cheeses that are associated with outbreaks of histamine 
poisoning were Gouda, Swiss cheese, Cheddar, Gruyere and Cheshire (Doeglas et al., 1967; Taylor et 
al., 1982; Shalaby, 1996). Several cases of histamine poisoning have been described in patients on 
isoniazid therapy (Kahana and Todd, 1981; Uragoda and Lodha, 1979). A histamine outbreak related to 
grated cheese in Spain was reported via the RASFF in 2006 (see Chapter 4.1.1 RASFF data on 
histamine). The histamine concentrations in cheeses that were implicated in outbreaks ranged between 
850 and 1870 mg/kg. 
Other foods 
Foods other than fish and cheese can contain high concentrations of histamine and its potentiators, such 
as sauerkraut. But these are rarely reported to be implicated in histamine poisoning. Chicken, shellfish, 
and ham were implicated in one outbreak each, and for sauerkraut, one incident is reported. But in each 
of these cases, evidence linking these foods with histamine poisoning was incomplete. For example, the 
possible incident of histamine poisoning associated with sauerkraut may be questionable, since the only 
symptom noted was headache with an absence of other clinical symptoms of histamine poisoning, such 
as urticaria (Taylor, 1985; Mayer and Pause, 1972). No cases of histamine poisoning have implicated 
sausages as the causative food, even though the products may occasionally contain histamine at levels 
as high as those observed in some fish related outbreaks (Stratton et al., 1991; see section 4.1.3.1).  
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Wine is a common cause for food adverse reactions and may elicit a range of allergy-like symptoms 
including flushing, itching, headache, rhinitis, meteorism, diarrhoea, as well as urticaria and asthma 
which will mimic hypersensitivity to sulphites. Histamine and other biogenic amines are considered the 
most important reason for wine intolerance (Konakovsky et al., 2011). In susceptible individuals, 
histamine intolerance was triggered by the intake of 4 mg histamine due to consumption of 0.2 l of 
sparkling wine containing 20 mg/l (Menne et al., 2001; see section 4.1.3.1). 
Traditionally fermented soy bean products, like Miso and soy sauce, can contain high concentrations of 
histamine and other biogenic amines. Although neither miso nor soy sauce have been incriminated in an 
incident of histamine poisoning, many cases in Japan have involved fish that had been seasoned with 
soy sauce or eaten with miso. Even though the incriminated fish were the source of the majority of 
histamine, the amines present in the soy sauce or miso may have also contributed to the toxicity of the 
fish (Stratton et al., 1991). 
3.1.3.3. Indication for a threshold level of adverse health effects 
The critical endpoint in acute histamine intoxication is an allergy like reaction comprising symptoms 
like headache, flushing, itching and urticaria. Results from the limited number of studies suggested a 
potential no-observed-adverse-effect-level (NOAEL) of 50 mg histamine for the symptoms headache 
and flushing, but this was based on limited number of individuals: 66 healthy and 74 sensitive. Some 
healthy individuals did not show symptoms at concentrations up to 6 times higher than the NOAEL. 
Also in some sensitive individuals no negative effects were observed at concentrations up to 2.4 times 
higher than the NOAEL. Therefore, it was assumed that the NOAEL may be already a conservative 
approach and no factor for intraspecies variations was applied. The information on outbreak data was 
not taken into account, since the actual amount ingested leading to acute effects is often unknown and 
several other factors such as potentiation of acute effects by other biogenic amines, alcohol or 
medication could not be excluded. The limited published information available suggested a potential 
acute reference dose (ARfD) of 50 mg of histamine per healthy person. 
3.1.4. Community Summary Report (CSR) data on histamine 
In the Community Summary Report including foodborne outbreaks in the European Union in 2008, data 
were collected on a mandatory basis for the eight zoonotic agents and on a voluntary basis data 
concerning compliance with microbiological criteria were also reported for histamine (EFSA, 2010a). 
In this report data concerning ‘other causative agents’ include histamine, marine biotoxins and 
mushroom toxins as well as unspecified toxins are presented.  
Seventeen MSs reported a total of 167 food-borne outbreaks due to ‘other causative agents’ (histamine, 
marine biotoxins and mushroom toxins) which constituted 3.1% of the total number of reported 
outbreaks. Two non-MSs reported two outbreaks. In 2008, outbreaks occurring in France accounted for 
37.7% of ‘other causative agents’ outbreaks. Of the reported outbreaks caused by ‘other causative 
agents’ 68 (40.7%) were verified. However, detailed information on outbreaks was only available for 
45 outbreaks because some MSs reported aggregated data (23 outbreaks). 
The verified outbreaks were primarily histamine outbreaks in France and Spain. The type of evidence 
verifying the outbreaks was detection of the agent in implicated foodstuffs in 32 outbreaks and 
analytical epidemiological evidence was presented in 45 of the outbreaks. Several MSs reported more 
than one type of evidence. Histamine was the responsible agent for 37 outbreaks in five Member States 
involving 166 cases of which 12 were hospitalised (Table 3).  
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Table 3:  Verified food-borne outbreaks caused by histamine in 2008 (source: EFSA, 2010a) 
Country Number of 
outbreaks 
Human cases 
number 
Human cases 
hospitalised 
Number of 
deaths 
Belgium 1 2 2 0 
France 18 82 6 0 
Germany 2 6 0 0 
Hungary 1 3 3 0 
Spain 15 73 1 0 
EU Total 37 166 12 0 
Switzerland 1 11 3 0 
 
Information on the implicated foodstuff was provided in 38 of the verified outbreaks. Seventeen 
outbreaks were caused by histamine in fish and fish product. For histamine outbreaks, the contributory 
factors were unprocessed contaminated ingredients (11 outbreaks), storage time (two outbreaks), and 
inadequate chilling (three outbreaks). Histamine concentrations involved in the outbreaks were not 
reported. 
 
3.2. Tyramine, phenylethylamine and tryptamine 
3.2.1. Synthesis and metabolism in humans 
The so-called ‘trace amines’ are synthesised in humans from their corresponding amino acids (tyrosine, 
phenylalanine and tryptophan, respectively) by decarboxylation. Their catabolism is mainly mediated 
by monoamine oxidase (MAO). Two MAO isozymes exist, A and B, with different locations and 
substrate specificity. MAO-A predominates in the stomach, intestine and placenta and has polar 
aromatic amines (as noradrenalin and octopamine) as preferred substrates. MAO-B predominates in the 
brain and selectively deaminates non-polar aromatic amines (as phenylethylamine and dopamine). 
Tyramine is a substrate for either form of MAO, MAO-A is responsible for intestinal metabolism of 
tyramine, thereby preventing its systemic absorption (Azzaro et al. 2006; Broadley, 2010). Tyramine 
and phenylethylamine are also subjected to N-methylation by N-methyltransferases, generating the 
sympathetic neurotransmitter, noradrenaline. Tyramine can be further converted into octopamine 
(Broadley, 2010). 
3.2.2. Physiological role in humans 
All biogenic amines are considered a trace amine in humans related to neuromodulating functions, 
being structurally and functionally associated to catecholamines (Broadley, 2010). They are believed to 
play a role in human disorders such as schizophrenia, depression, attention deficit disorder and 
Parkinson’s Disease (Branchek and Blackburn, 2003). The mechanisms of action may depend on their 
localisation. In the brain, trace amines act as indirect sympathomimetics through the release of 
noradrenalin, which cause vasoconstriction and transient hypertension. It has been hypothesised that 
dietary tyramine and trace amines cause vasodilatation of the mesenteric vascular bed, increasing blood 
flow at the gastrointestinal level and thus facilitating their absorption (Broadley, 2010). Direct effects 
associated with specific receptors have also been reported at the cardiovascular level, causing an 
increase in heart rate (Frascarelli et al., 2008). 
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3.2.3. Toxic effects in humans 
The vasoconstriction effect of tyramine, phenylethylamine and tryptamine cause hypertension, but 
other symptoms such as headache, perspiration, vomiting, pupil dilatation, etc. have been described. 
The clinical signs appear between 30 minutes to a few hours following consumption of biogenic amines 
and usually disappear within few hours and recovery is usually complete within 24 hours. 
Hypertensive crises, but also in a minority of migraine cases, caused by the consumption of food 
potentially rich in tyramine have been recorded in scientific publications and databases about food and 
drug interactions particularly with monoamino oxidase inhibitor (MAOI) drugs (e.g. Stockley's Drug 
Interactions, 2011).  
3.2.3.1. Dose-response relationship 
The clinical studies dealing with the interaction between dietary tyramine and MAOI drugs allow the 
assessment of the specific toxicity for the vasopressor effect of tyramine in terms of the amount of 
tyramine needed to provoke a clinically significant increase of systolic blood pressure of at least 30 
mmHg (PD30). Studies on phenylethylamine and tryptamine are limited. For the present document, 
outputs from trials in which tyramine was administrated orally accompanying a meal have been taken 
into consideration, since they are those most closely reproducing the actual situation of food-borne 
tyramine intake in comparison with pure tyramine in fasting conditions or intravenous injection. 
Indeed, it has been reported that increasing mainly lipid but also protein content of the meal 
significantly reduce the tyramine blood pressor response (Audebert et al., 1992). Bioavailability of 
tyramine when administered with food or as a dietary constituent seems to drastically be reduced and 
systematic concentrations are reduced by approximately 2- to 3-fold (Patat et al., 1995; Van den Berg et 
al., 2003; Azzaro et al., 2006). 
Information available in the literature is summarised in Table 4. The results from literature showed that 
from 600 mg up to 2,000 mg of tyramine administrated in a meal would be needed to cause a minimal 
systolic blood pressure increase (of at least 30 mmHg). Therefore the intestinal barriers to tyramine in 
non-medicated healthy volunteers (placebo groups) seem to be effective to avoid tyramine intoxication 
from food (Korn et al., 1988a; Berlin et al., 1989; Zimmer et al., 1990; Patat et al., 1995). A dose-
response curve was generated by Patat et al. (1995), in which 1100 mg of tyramine correspond to the 
effective dose (ED50) as the tyramine dose at which 50% of the individuals responded. According to 
Bieck and Antonin (1988) intraindividual coefficient of variation was around 10% in repeated tests and 
there was no correlation with sex, age or weight.  
The situation is different in those individuals medicated with MAOI drugs. The impaired function of 
MAO enzyme does not allow a complete metabolism of tyramine, leading to elevated plasma tyramine 
levels after ingestion of tyramine-rich food. In these cases, much less dietary tyramine is needed to 
produce similar effects (dose-response curve considerably shifts to the left lowering the ED50 value). 
The intensity of the MAOI enhancing action depends on the nature of the drugs. A high potentiating 
factor, from 20 to 56-fold increase in tyramine sensitivity, has been described for the first generation 
classical MAOIs (irreversible and non-selective, such as tranylcypromine) (Korn et al., 1988b; Bieck 
and Antonin, 1989). However, the presently most commonly used new generation drugs represent a 
progress in safety, since their action is reversible and/or selective for the MAO-A or MAO-B 
isoenzyme. In these cases, the increase in tyramine sensitivity has been reported to range from 2-5-fold 
(selegiline), 5-7-fold (moclobemide) to 13-fold (phenelzine) depending on the MAOI dosage (Prasad el 
al., 1988; Bieck and Antonin, 1988; Bieck and Antonin, 1989; Berlin et al., 1989; Zimmer et al., 1990). 
According to the literature, 6 mg of tyramine could provoke mild crisis and 10 - 25 mg severe headache 
with intracranial haemorrhage in patients treated with classical MAOI (McCabe, 1986), whereas from 
50 up to 150 mg of tyramine would be well tolerated by patients under new generation MAOI 
treatment, so called RIMA (reversible inhibitors of MAO-A) (Korn et al., 1988b; Dingemanse et al., 
1998; Patat et al., 1995). 
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Table 4:  Dose-response relationship of tyramine in humans after oral administration with food 
(experiments performed in fasting conditions were not taken into account). 
Tested sample Tyramine dose Hypertensive effects* Reference 
Healthy subjects (placebo groups) 
n=8 50-150 mg No effect Dingemanse et al. (1998) 
n=5 600 mg No effect Barrett et al. (1997) 
n=8 100-800 mg No effect for n=4/8 Provost et al. (1992)  
 800 mg PD30 for n=4/8  
n=16 
 
1200 mg 
(1000 – 1600 mg) 
Mean PD30 
(range PD30) 
Berlin et al. (1989) 
n=30 1100 mg 
1220 mg  
(600-1800 mg) 
ED50 
mean PD30 
(range PD30) 
Patat et al. (1995) 
n=16 
 
1450 mg 
(800 – 2000 mg) 
mean PD30 
(range PD30) 
Berlin et al. (1989) 
Subjects under treatment with classical MAOI drug  
Tranylcypromine 
(20 mg/day); n=16 
35 mg 
(20 – 50 mg) 
mean PD30 
(range PD30) 
Berlin et al. (1989) 
Subjects under treatment with RIMA (reversible MAO-A inhibitors) 
Brofaromine  
(150 mg/day); n=10 
25 -75 mg No effect Bieck & Antonin (1988) 
Moclobemide 
(450 mg bid) n=8 
50 mg  
 
No effect 
 
Dingemanse et al. (1998) 
Moclobemide  
(3x200 mg/day); n=6 
200 mg 
 
PD30 for n=2/6 
Tolerated by n=4/6 
Korn et al. (1988a)  
 
Moclobemide  
(3x100 mg/day) 
n=6 
 
150 mg 
200 mg 
250 mg 
300 mg 
PD30 for n=1/6 
PD30 for n=1/5 
PD30 for n=1/3 
Tolerated by n=1/1 
Korn et al. (1988b)  
Moclobemide  
(450 mg bid); n=8 
100 mg 
150 mg 
PD30 for n=3/8 
PD30 for n=1/8 
Dingemanse et al. (1998) 
Moclobemide  
600 mg bid;  
n=8 
  50 mg 
100 mg 
150 mg 
PD30 for n=1/8 
PD30 for n=4/8 
Tolerated by n=1/8 
Dingemanse et al. (1998) 
Moclobemide 
(600 mg/day); n=8 
250 mg  
(150-400 mg) 
mean PD30  
(range PD30) 
Audebert et al. (1992) 
Moclobemide 
(200 mg t.i.d); n=16 
306 mg 
(150 – 500 mg) 
mean PD30 
(range PD30) 
Berlin et al. (1989) 
Befloxatone  
(20 mg twice/day) 
n=10 
120 mg 
150 mg  
(100 – 250 mg) 
ED50 
mean PD30 
(range PD30) 
Patat et al. (1995) 
Befloxatone  
(10 mg twice/day) 
n=10 
200 mg 
250 mg  
(100 – 300 mg) 
ED50 
mean PD30 
(range PD30) 
Patat et al. (1995) 
Befloxatone  
(20 mg once daily); n=10 
250 mg 
290 mg  
(150 – 500 mg) 
ED50 
mean PD30 
(range PD30) 
Patat et al. (1995) 
Toloxatone 
(n=8) 
≤ 200 mg No effect Provost et al. (1992)  
 
Toloxatone 
(400 mg 3-times/day) 
(n=8) 
400 mg 
800 mg 
Increase in blood pressure  
PD30 for n=2/8 
PD30 for n=5/6 
Provost et al. (1992) 
 
Toloxatone 
(200 mg 3-times/day); (n=8) 
800 mg Increase in blood pressure  
PD30 for n=4/8 
Provost et al. (1992) 
Subjects under treatment with irreversible inhibitors of MAO-B 
Selegiline,  
(transdermal system 12mg/day); n=8 
172 mg  
(75-300 mg) 
mean PD30  
(range PD30) 
Azzaro et al. (2006) 
*No effect: no increase (or less than 30 mmHg increase) in systolic blood pressure  
  ED50: median effective dose (dose affecting 50% of tested population sample) 
  PD30: pressor doses of tyramine to raise systemic blood pressure by 30 mmHg (minimal pressor response) 
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Tyramine has also been incriminated as a causative agent of certain food-induced migraines, together 
with phenylethylamine. However, migraine is a multifactorial problem, not only affected by one 
component of the diet but also by other environmental, physiological and psychological factors. 
However, only limited data from previous research is available on the migraine triggering threshold 
dose of biogenic amines. Hannington (1967) pioneered by conducting several challenge studies. He 
concluded that the ingestion of 125 mg of tyramine was responsible for an overall headache rate of 
80%, compared with 8% in case of the placebo (lactose) ingestion. According to Jansen et al. (2003) 
the experimental design of their studies was not sufficiently accurate and the results can not be 
considered conclusive. Similar effects occur with the amount of phenylethylamine presumably causing 
migraine. In healthy volunteers, 5 mg may provoke headache, dizziness and discomfort according to 
Lüthy and Schlatter (1983). In migraine suffers, the activity of the MAO-B isoenzyme (main 
responsible for phenylethylamine oxidation) seems significantly reduced and 3 mg were reported to 
potentially trigger an attack (Sandler et al., 1974). No dose-response curve has been estimated.  
3.2.3.2. Cases of food and drug interactions 
Information about adverse health effects caused by dietary tyramine is scarce, although some sporadic 
cases of food and MAOI drug interaction can be found in the scientific medical literature. Several types 
of food have been incriminated in these types of interactions, cheese being the most frequently 
implicated product, although yeast extract, pickled herrings, avocados, beef livers, chicken livers, 
caviar, soused herrings, tinned fish, tinned milk, peanuts, soy sauce, miso, powdered protein diet 
supplement, packet soup, sour cream, prickly spinach and beer have also been recorded (Stockley's 
Drug Interactions, 2011). Unfortunately, the occurrence of tyramine is not always demonstrated in the 
investigated products and in many other cases the amount of tyramine is not reported.  
3.3. Putrescine and Cadaverine 
3.3.1. Synthesis and metabolism in humans 
Putrescine and cadaverine are diamines that can be formed either as natural polyamines during de novo 
polyamine biosynthesis or as biogenic amines by decarboxylation (Bardocz, 1995). Putrescine 
formation in animals and microorganisms requires the free amino acid ornithine and the enzyme 
ornithine decarboxylase. Alternatively putrescine can be produced from arginine via agmatine and 
carbamylputrescine (Lucas et al. 2007).  
The amino acid lysine is decarboxylated by lysine decarboxylase to form cadaverine. Different bacteria 
species exhibit decarboxylases with high activity. During degradation putrescine and cadaverine are 
oxidised by diamine oxidases to form aldehydes (Askar and Treptow, 1986). 
3.3.2. Physiological role in humans 
In humans, putrescine acts as a precursor for the physiological polyamines (i.e. spermidine and 
spermine) and all are involved in the regulation of cell growth, cell division and tumour promotion 
(Halasz and Barath, 2002). Putrescine is an important constituent of all mammalian cells and is 
involved essentially in a variety of regulatory steps during normal, adaptive, and malignant cell 
proliferation. Because of high proliferation rates, intestinal and colonic mucosa has a special demand 
for putrescine (Löser et al., 1999). The growth of murine colon tumour cells is also stimulated by newly 
incorporated putrescine (Farriol et al., 2001). 
The role of cadaverine is less known but it could also contribute with the above mentioned diamines 
and polyamines. It has been reported that in some systems, including bacteria, cadaverine can replace 
putrescine (Hölttä and Pohjanpelto, 1983).  
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Experiments with rats showed that putrescine is readily taken up from the gut lumen, probably by 
passive diffusion. More than 80% of the putrescine was converted to other polyamines and non-
polyamine metabolites, mostly to amino acids (Bardocz et al., 1995). 
3.3.3. Toxic effects in humans 
The pharmacological activity of putrescine and cadaverine seems to be less potent than those for 
histamine and tyramine. Adverse effects described are hypotension, bradycardia, lockjaw and paresis of 
the extremities (Shalaby, 1996; Halász and Barath, 2002). Perhaps, the most relevant issue of 
putrescine and cadaverine in relation to food is the potentiation of the toxicity of other amines, 
especially histamine (Hui and Taylor, 1985; Chu and Bjeldanes, 1981) (see 3.3.5.). Finally, these 
diamines can react with nitrite to form carcinogenic nitrosamines (Nebelin et al., 1980). 
3.3.3.1. Dose-response relationship 
In contrast to histamine, tyramine and phenylethylamine no human dose-response data are available for 
alimentary putrescine and cadaverine and only a limited number of animal studies have been published. 
In a subacute oral toxicity study with Wistar rats, the no-observed-adverse-effect level (NOAEL) was 
found to be 180 mg/kg body weight/day for cadaverine and putrescine. Mean body weights, food intake 
and food efficiency were slightly decreased with the highest doses for cadaverine and putrescine. The 
relative brain weights were significantly increased with both putrescine and cadaverine. A significant 
increase in the relative weights of testes was observed with cadaverine only. A dose-related decrease in 
blood pressure was caused by cadaverine and putrescine after intravenous administration only (Til et 
al., 1997). 
3.3.3.2. Potentiation of the toxicity of other biogenic amines 
The amine oxidizing enzymes monoamine oxidase and diamine oxidase are able to metabolise more 
than one biogenic amine, therefore, the degradation of alimentary biogenic amines is retarded 
depending on their number and concentration (Beutling, 1996). Hence, the toxicity of biogenic amines 
will depend on quantitative and qualitative factors associated with the food itself. Additionally, factors 
like individual susceptibility and health status of consumers are relevant. 
Based on in vitro and in vivo studies, two possible theories were developed about the potentiation of 
histamine toxicity. According to the theory of competitive inhibition, simultaneous oral intake of other 
amines, like putrescine and cadaverine, may inhibit the biogenic amine-detoxifying enzymes and 
consequently block histamine and tyramine metabolism. Though the potentiating mechanism would be 
equivalent for both histamine and tyramine, most of the published studies refer to histamine. In vitro 
diamines potentiate contractions of the guinea-pig ileum caused by histamine and inhibit its enzymatic 
destruction by DAO (Mongar, 1957). In rats, metabolism of histamine is inhibited by simultaneous oral 
administration of cadaverine, putrescine or a mixture of biogenic amines. An increase in the amount of 
unmetabolized histamine is seen in the 4-hr urine samples. In the presence of the mixture, inhibition is 
more effective than with single administration (Hui and Taylor, 1985). Besides competing for the same 
enzymes, the barrier disruption theory suggests that the potentiators such as putrescine and cadaverine 
may alter the physical barrier function of the small intestine and allow diffusion of greater quantities of 
histamine into the circulation. In vitro studies with pig gastric mucin showed that histamine binding is 
decreased by cadaverine, putrescine and by a mixture of diamines and polyamines (Chu and Bjeldanes, 
1981). This effect was reported to occur only when the ratio between diamines and vasoactive amines is 
5:1 or higher (Hui and Taylor, 1985).  
In experiments with healthy volunteers no correlation was found between the occurrence of symptoms 
and the concentration of biogenic amines in food samples containing several biogenic amines in 
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varying amounts (Lüthy and Schlatter, 1983; Clifford et al., 1991; Van Gelderen et al., 1992). Further, 
from the scombroid poisoning outbreaks very low levels of diamines have been detected which are 
unlikely to contribute to histamine potentiation (Emborg et al., 2006; Emborg and Dalgaard, 2006). 
Thus, no levels of putrescine and cadaverine in food can be estimated causing acute health effects due 
to the potentiation of histamine toxicity (Joosten, 1988; Hungerford, 2010). 
3.4. Factors increasing sensitivity to biogenic amines 
In general, increased sensitivity against biogenic amines is due to a weakened enzymatic amine 
degradation caused by genetic or acquired impairment of MAO, DAO, HNMT function.  
It was shown that in patients with food allergy, defined as an immune-mediated hypersensitivity to 
ingested allergens, average intestinal DAO activity was significantly lower than in healthy individuals 
(Raithel et al., 1999). Patients suffering from histamine intolerance also exhibit impaired histamine 
degradation based on reduced diamine oxidase activity or even a lack of the enzyme (Jarisch, 2004). It 
has been estimated that 1% of the population has histamine intolerance, 80% of those are female 
middle-aged patients (Jarisch, 2004; Maintz and Novak, 2007). 
Certain physiological status can also modify the sensitivity against biogenic amines. In women, a 
premenstrual decrease in the activity of B-type MAO may cause hypersensibility to both histamine and 
tyramine (Bardocz, 1995). Clinical observations indicate that women are more sensitive to histamine on 
days 12 to 16 of the menstrual cycle (Kalogeromitros et al., 1995). By contrast a physiological increase 
of DAO production (up to 500-fold) has been reported in pregnant woman, which would explain 
remissions of food intolerance frequently observed during pregnancy (Jarisch, 2004; Mainz and Novak, 
2007). 
Individuals with chronic urticaria, atopic eczema, respiratory and coronary problems or those suffering 
from hypertension or vitamin B6 deficiency are particularly at risk because of their sensitivity to lower 
doses of biogenic amines (Borysiewicz and Krikler, 1981; Russell and Maretić, 1986; Taylor et al, 
1989; Bardocz, 1995; Maintz et al., 2006; Mainz and Novak, 2007). 
People with gastro-intestinal problems with altered enterocytes as well as inflammatory and neoplastic 
diseases (gastritis, irritable bowel syndrome, Crohn´s disease, colorectal neoplasmas, stomach and 
colon ulcers) may be at risk because of the lower activity of oxidases in the intestine compared to 
healthy individuals (Bardocz, 1995; Raithel et al., 2003, Jarisch, 2004; Mainz and Novak, 2007). 
Acquired sensitivity to biogenic amines can be transient and reversible after the elimination of causes. 
Individuals on medication which acts as a blocker of MAO or DAO activity can be affected; as such 
drugs prevent the elimination of amines. These MAO and DAO inhibitors include a variety of drugs 
used for the treatment of stress, depression, Alzheimer´s and Parkinson´s disease (Sattler et al., 1988; 
Bardocz, 1995) as well as painkillers, antihypertensive drugs, mucolytics, antibiotics, and agents 
reducing gut motility, etc. (e.g. acetylcysteine, clavulanic acid, metoclopramide, verapamil, isoniazide, 
cephalospirones, etc.) (Mainz and Novak, 2007). Indeed, Sattler et al. (1988) estimated that 
approximately 20% of population would be taking such DAO inhibiting drugs. Typical symptoms of 
tyramine intoxication can be found in 15% of the population due to genetic enzyme defect or 
medication (Beutling, 1996). 
It has also been reported that tobacco smoke reduce MAO levels by up to 40% and several cigarette 
smoke compounds can also inhibit MAO enzyme activities (Broadley, 2010). 
The capability of detoxifying enzymes (MAO, DAO, HNMT) to degrade ingested amines may be 
reduced by food components, such as other amines, alcohol and its metabolite acetaldehyde, phenols, 
etc., acting as potentiators (Hui and Taylor, 1985; Zimatkin and Anichtchik, 1999). 
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4. Exposure assessment related to fermented foods 
4.1. Occurrence data 
4.1.1. RASFF data on histamine 
The Rapid Alert System for Food and Feed (RASFF) is a network managed by the European 
Commission and used by the EU Member States (MSs) for exchange of information on food safety 
events that do not comply with the existing legislation. As a result of the communication activities, the 
RASFF Database8 was established (RASFF, 2010a). It is updated daily in a timely manner. RASFF 
evolved into a unique collection of food safety events since its creation in 1979. RASFF is a regulatory 
database reflecting the EU legislation in the field of food and feed safety because an event is notified 
when there is a breach in the legislation. Changes of the food/feed safety legislation have an impact on 
the type and the number of the generated notifications. Notifications sent to RASFF depend also on 
national surveillance programs and the efficiency of national laboratories whereby the approaches are 
not fully harmonised between MSs. The database includes detailed information on each notification, 
such as the type and date of notification, the reason for notification (i.e. description of the subject 
related to the hazard and product under concern), the hazard(s) identified, the nature and traceability of 
product(s) involved, the country of notification, the country of origin, the laboratory analyses 
performed with corresponding contamination levels detected, and the size of the consignment.  
Biological and chemical hazards such as some biogenic amines are included in the RASFF system. 
Biogenic amines are represented mainly by histamine in fish. Between January, 2005 and December, 
2010 the recorded histamine notifications are 246. The reasons for generating notifications are ‘border 
controls’ for 119 notifications, ‘official control on the market’ for 80 notifications, ‘food poisoning’ 
(introduced in RASFF since 2008) for 22, ‘consumer complaint’ for 18, ‘company’s own check’ for 
five, ‘official control in non-member country’ for two notifications (RASFF, 2010b). People affected 
by histamine intoxication and reported in RASFF under the search terms ‘consumer complaint’, ‘food 
poisoning’ and ‘foodborne outbreak’ are 151, distributed as follows: nine consumers in 2005, 31 in 
2006, 19 in 2007, 21 in 2008, 38 in 2009 and 33 consumers in 2010 (Table 5). All cases were caused by 
fish and products thereof. Histamine concentrations were reported for the fish products involved in 
‘consumer complaints’ and food poisoning’. 
Table 5:  Consumers affected by histamine intoxication reported in RASFF for the search terms 
‘consumer complaint’, ‘food poisoning’ and foodborne outbreaks’ between 2005 to 2010 (source 
RASFF, 2010a) 
Year Consumer 
complaint 
(notified cases) 
People 
affected 
(number) 
Food poisoning 
(notified cases) 
People 
affected 
(number) 
Foodborne 
outbreaks 
(notified cases) 
People 
affected 
(number) 
2005 2 3 0 0 1 6 
2006 9 24 0 0 3 7 
2007 4 16 0 0 1 3 
2008 1 2 5 12 1 4 
2009 0 0 12 28 2 10 
2010 2 4 5 16 2 13 
Total 17 49 22 56 10 43 
 
Actual histamine concentrations in the fish products involved in adverse consumer health effects were 
reported for ‘consumer complaint’ and ‘food poisoning’ cases and are summarised below (Tables 6, 7). 
                                                     
 
8  https://webgate.ec.europa.eu/rasff-window/portal/ 
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As can be seen from the data there was sometimes a high variability of concentrations in the same sub 
sample of up to a factor of ten. Adverse consumer health effects were observed at reported 
concentrations of around 100 mg/kg histamine in fish. 
Table 6:  Fish products and histamine concentrations and involved for cases notified under 
‘consumer complaint’ (source RASFF, 2010a) 
Year Fish product Histamine concentration (mg/kg) 
2005 Fresh tuna fillets 3485 
 Tuna in olive oil 8299 
2006 Fresh sliced tuna  Not reported 
 Tuna chunks in brine 50 – 500  
 Fresh chilled tuna  2166; counter analyses 234-848  
 Fresh chilled tuna fillets 700  
 Frozen vacuum packed tuna chunks 432; 1753  
 Tuna steaks 190; >240; 80; 170; 240; >250; >240; >240; >240 
 Sliced yellow tuna (Thunnus albacares) 193.2  
 Albacore tuna chunks 1882; 1184  
 Tuna loins 4430; 2097  
2007 Sardine in soya oil 280 to 1660  
 Fresh tuna Not reported 
 Yellow fin tuna loins 102 to 180  
 Fresh sliced red tuna Not reported 
2008 Vacuum packed tuna loins (Thunnus albacares) 496  
2010 Fresh tuna (Thunnus thynnus) 3603  
 Chilled tuna loins (Thunnus albacares) 205  
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Table 7:  Fish product and histamine concentrations involved for cases notified under ‘food 
poisoning’ (source RASFF, 2010) 
Year Fish product Histamine concentration (mg/kg) 
2008 Vacuum packed tuna 5113  
 Tuna in sun flower oil 5024  
 Chilled vacuum packed tuna fillets (Thunnus 
albacares) 
1428; 462; 916; 1636; 1443; 1356; 1428; 998; 
1993  
152; 27; 150; 70; 31; 87; 80; 61; 118  
 Smoked tuna in slices 1557  
 Vacuum packed tuna loins (Thunnus albacares) 496  
 Canned tuna chunks in brine 500  
2009 Canned tuna fillets in olive oil 1910; 2051; 104; 2066; 2229  
 Fresh tuna fillets (Thunnus thynnus) >1000  
 Tuna in sun flower oil 634  
 Fresh tuna loins (Thunnus albacares) 3600  
 Fresh tuna loins 1218; 1378  
 Yellow fin tuna vacuum packed sashimi loins 
(Thunnus albacares) 
488  
 Raw white sashimi tuna carpaccio 147  
 Canned sardine fillets in sun flower oil 
(Sardinella aurita) 
329; 220; 240; 245  
 Escolar fillets (Lepidocybium flavobrunneum) <5 to 208 and <50 to 1000  
 Fresh tuna fillets (Thunnus albacares) Not reported 
 Chilled yellow tuna Not reported 
 Fresh yellowtail amberjack (Seriola lalandi) 1000  
2010 Tuna fillets in oil 4398  
 Tuna fillets in oil  10000  
 Fresh yellow fin tuna loin 1774  
 Tuna (Thunnus alalunga) 3110  
 Chilled yellow fin tuna fillets Not reported 
 
RASFF product categories involved in the histamine notifications are “fish and products thereof” in 
228 notifications, “soups, broths and sauces” in 17 notifications and “milk and milk products” in one 
notification concerning grated cheese. No notifications for histamine or other biogenic amines are 
reported for meat covered in RASFF by the product categories “meat and meat products (other than 
poultry)” and “poultry meat and poultry meat products”. In the product category “soups, broths and 
sauces”, there were 11 notifications concerning fish sauce and six regarding soya sauce. The 
concentration levels vary from 200 mg/kg to 500 mg/kg in eight notifications, from 500 mg/kg to 1000 
mg/kg in eight notifications, from 1000 mg/kg to 2000 mg/kg in one notification. In the product 
category “milk and milk products” there is only one notification. This report, from 17 November 2006 
notified under official control on the market and the hazard histamine, is concerned with grated cheese 
whereby 850 mg/kg histamine were found and 31 persons were recorded as affected in two related 
outbreaks. The reasons for generating notifications for non-fish products are official control on the 
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market for ten notifications and border controls for eight notifications. In 17 out of 18 cases the 
products concerned were imported into the EU.  
4.1.2. Data submitted to EFSA public call for data 
The EFSA published in June 2010 on its website a public call for data on the presence of biogenic 
amines (histamine, tyramine, cadaverine, putrescine, tryptamine, phenylethylamine, spermidine and 
spermine) in food and beverages. Member States, research institutions, academia and other stakeholders 
(e.g. meat industry) were specifically invited to submit data. 
The data collected are presented in Table 8. Some occurrence data was provided also on amines which 
were not explicitly listed in the call for data. For example the Teramo University (Italy), provided data 
also on ethanolamine, ethylamine, isoamylamine, methylamine, serotonine while Budapest University 
of Technology and Economics provided data on agmatine. A total number of 36,583 analytical results 
were collected. 
Data were submitted using different concentration units such as microgram/gram, milligrams/100 gram, 
milligram/kilogram, milligram/litre and milligram/millilitre. To summarise the data, the analytical 
results were all converted to milligram/kilogram (mg/kg). Where the concentrations were expressed in 
unit of volume, the conversion to unit of mass was performed assuming 1 litre = 1 kilogram. 
Concentrations have to be expressed in units of mass to be compatible with consumption data that are 
reported in grams (g). 
Data were submitted for the food categories listed in Table 9 including: ‘alcoholic beverages’, ‘coffee’, 
‘composite food’, ‘sauces’, ‘fish and fish products’, ‘fruit’,  ‘juices’, ‘meat products’, ‘dairy products’, 
‘vegetables and vegetable products’. To highlight, in particular, the contribution of specific fermented 
products, these classes were further divided into sub-categories. 
‘Alcoholic beverages’ was divided in ‘beer’, ‘fortified and liqueur wines’, ‘wine, red’, ‘wine white 
sparkling’.  
The category ‘sauces’ was divided in ‘fish sauce’ and ‘other savoury sauces’. The latter includes 
mainly meat sauce and soya sauces, but these samples have been pooled together given the small 
number of available samples and the similarity of the occurrence values. 
The category ‘fish and fish products’ was divided into two main sub-categories ‘fermented fish’ and 
‘other fish and fish products’. The food items that could be recognised as fermented were classified into 
the former class. The classification of the reported fish samples was performed based on the ‘product 
text’ and ‘product treatment’ variables of the Standard Sample Description (EFSA, 2010b) reporting 
format. The category ‘other fish and fish products’, mainly includes fresh, frozen or canned fish meat 
not undergoing a fermentation process. Only for histamine, an additional category of food with high 
values was identified: ‘dried anchovies’. 
The class ‘meat products’ has also been split into ‘fermented sausages’, ‘other ripened meat products 
(including dry-cured ham, dry-cured loin)’  and ‘other meat products (including cooked ham, 
mortadella-type of sausages)’. The classes ‘fermented sausages’ and ‘other ripened meat products’ were 
separated since the process of mincing the meat in the ‘fermented sausages’, allows bacteria to 
penetrate  the surface of the product, which normally is more difficult to occur with a whole muscle. 
The ‘fermented sausages’ are therefore expected to show higher values of biogenic amines in 
comparison to the other classes.  
The category ‘dairy products’ includes mainly cheese. Therefore, a sub-category cheese has been 
identified. ‘Cheese’ has been then further divided into four sub-categories: ‘fresh cheese’, ‘hard 
cheese’, ‘washed rind cheese’ (cheese ripened with bacteria on the rind such as Brevibacterium linens), 
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‘blue cheese’ (cheese with the addition of mould in the curd such as Penicillium roqueforti) and acid 
curd cheese (e.g. Harzer cheese, Mainzer cheese). Although only limited samples are available for acid 
curd cheese, the high values shown have lead to keep them separate from the other cheese classes. 
‘Dairy products’ contains samples of ‘yoghurt’ and ‘other dairy products’ (e.g. cream, sour cream). 
Table 8:  Number of analytical results for biogenic amines by data provider 
   Biogenic amines 
Country Organisation providing the 
data 
H
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Austria Österreichische Agentur für 
Gesundheit und 
Ernährungssicherheit GmbH 
(AGES) 
155 29 27 64 30     
 Lebensmittelversuchsanstalt 
GmbH (LVA) 
165         
 University of Natural 
Resources and Applied Life 
Sciences Vienna 
58 58 58 58 58 58 58 58  
Total for Austria  378 87 85 122 88 58 58 58  
Cyprus State General Laboratory  3174        
Germany LAV Sachsen-Anhalt 100 101 101 101 99  99 99  
Hungary Central Agricultural Office 97         
 Budapest University of 
Technology and Economics 
439 439 439 439 26 26 439 439 260 
Total for Hungary  536 439 439 439 26 26 439 439 260 
Ireland Food Safety Authority of 
Ireland (FSAI) 
2008 1213 1213 1213 233 233 233 233  
Italy Stazione sperimentale per 
l’industria delle conserve 
alimentari (SSICA) 
90 90 90 90  90 90 90  
 University of the Studies of 
Teramo 
28 28 28 28 28  28 28 95 
 Istituto Zooprofilattico 
Sperimentale Umbria e Marche 
146         
Total for Italy  264 118 118 118 28 90 118 118 95 
Netherlands Voedsel en Waren Autoriteit 1922 1922 1922 1922  1922 1922 1922  
Slovakia Univerzita  veterinárskeho 
lekarstva a farmácie 
9 9 9 9      
 Food research Institute 671 246        
Total for 
Slovakia 
 680 255 9 9      
Spain University of Barcelona 1061 1061 761 761 761 761 761 752  
Total  10123 5196 4648 4685 1235 3090 3630 3621 355 
 
Less than 35 results are available for vegetables, where it is possible to identify some fermented 
products mainly represented by sauerkraut. The rest of the vegetables comprise data on leafy vegetables 
and sprouts of different plants. 
Less than 7 samples were analysed in the categories ‘cereal products’, ‘chocolate’, ‘coffee’, ‘fruit’ and 
‘juices’. The number of samples in these categories was not sufficient to produce a reliable estimation 
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of biogenic amine occurrence values, therefore they are excluded from further analyses. Also the 
‘composite food’ category was excluded since the class is composed by diverse food sub-classes 
ranging from pizzas to soups. Again, a sufficient number of samples in these sub-classes is not 
available to produce reliable statistical estimates. The remaining data provide an adequate overview 
mainly of fermented products which were the main objective of this opinion.  Data on spermidine, 
spermine and the other amines not explicitly listed in the mandate were also excluded from the final 
occurrence tables since they are outside the scope of this opinion. 
 
Table 9:  Number of analytical results for biogenic amines by food class 
 Biogenic amines 
Food group 
H
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Alcoholic beverages 786 781 481 487 208 182 
Cereal products 7      
Chocolate 1      
Coffee 1 1 1 1   
Composite food 35 12 7 13 4 1 
Sauces 99 98 98 99 95 90 
Fish and fish products 6454 1351 1349 1359 361 309 
Fruit 5 5 5 5   
Juices 3 1 1 1   
Meat products 543 536 536 537 382 429 
Dairy products 2154 2388 2147 2160 175 2079 
Vegetables and vegetable products 35 23 23 23 10  
Total 10123 5196 4648 4685 1235 3090 
 
Most data submitted were on histamine and fish products since they were generated by control 
activities required by Commission Regulation (EC) No 2073/2005. Data on cheese and fermented meat 
instead mainly originated from ad-hoc studies.  
Some data senders providing data from control activities on fishery products, in many cases, submitted 
up to 9 sub-samples, analysed for each data sample as requested by the regulation. After considering 
that the sampling is frequently done in different parts of a batch, these samples were considered as 
individual samples. 
Data, in general, comprise food samples meant for human consumption taken mainly from retail shops 
or from border controls and are therefore assumed to be representative of the concentrations of BAs at 
the point of consumption. 
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4.1.3. General considerations on occurrence data  
The “bounding” approach was applied for non-detected or non-quantified values to reflect the 
uncertainty originated by these values on the calculated statistics. The lower bound (LB) was obtained 
by assigning a value of zero to all the samples reported as non-detected or non-quantified. The upper 
bound (UB) was obtained by assigning the value of the limit of detection (LOD) to values reported as 
non-detected and the value of the limit of quantification (LOQ) to values reported as non-quantified. 
Therefore, each reported statistics is presented as interval between the upper and lower bound 
estimates.  
In order to simplify the tables presented in the following paragraphs, the following notation was 
applied:  
• When the lower bound is zero, only the upper bound was reported prefixed by the sign below 
‘<’ (e.g. < 0.5).  
• When lower bound and upper bound are coincident, only one value was reported (e.g. 0.5).  
• When lower bound and upper bound are different both values were reported (e.g. 0.1 – 0.5). 
4.1.3.1. Occurrence data for histamine  
Table 10 summarises the data received on histamine. Among ‘alcoholic beverages’ the higher levels of 
histamine were identified for red wine with a mean value between 3.6 and 3.7 mg/kg (or mg/l).  
High levels of histamine are present for ‘fish sauce’ with a mean of 196 – 197 mg/kg, while in other 
type of sauces (e.g. soya and meat) analytical results are mainly non-quantified (96%) with a mean 
concentration of 0.5 – 10.1 mg/kg. The high spread is due to the percentage of non detected values in 
this food category. 
‘Dried anchovies’ is the subgroup of fish products with highest mean values of histamine (mean 348 
mg/kg). This group was listed separately in the Table 10 because of the high occurrence values 
identified in comparison with the other fish subgroups. The data do not show higher values of histamine 
in ‘fermented fish’ compared to ‘other fish and fish products’ as expected. This behaviour may be 
depending on missing information on the fermentation process in some samples or may be linked to 
issues in the processing or transportation of the raw product. In fact, this second hypothesis is supported 
by the fact that the six highest results for the class (ranging between 3,100 mg/kg and 8,900 mg/kg) do 
not include fish that could be potentially fermented but only canned or fresh fish.  
For ‘meat products’ the higher values are recorded in ‘fermented sausages’ (mean value of 23.0 – 23.6 
mg/kg) followed by ‘other ripened meat products’ (mean value of 5.9 – 6.4 mg/kg). Finally the group 
‘other meat products’ shows the lowest concentration inside the broader ‘meat products’ category 
(mean value of 3.9 - 4.4 mg/kg). ‘Fermented sausages’ shows also high 95-percentiles (P95) of 
histamine concentration, comparable with the levels shown for some sub-classes of ‘cheese’, although 
the maximum values reached for ‘cheese’ are not recorded for ‘fermented sausages’. 
The class ‘cheese’ shows a high percentage of non-quantified (>80%) results. This causes large gaps 
between lower bounds (LB) and upper bounds (UB) values. It can be noticed that for the class ‘dairy 
products’,  high values of histamine and in general of biogenic amines, are mainly occurring for 
cheeses. In fact, both the class ‘yoghurt’ (mean 0.5 mg/kg) and ‘other dairy products’ (mean 0.3 mg/kg) 
show lower occurrence values. 
Finally, the class ‘fermented vegetables’ shows higher mean values for histamine (39.4 – 42.6 mg/kg) 
in comparison with the class ‘other vegetables’ (2.9 -3.1 mg/kg).  
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In summary, the food categories showing the highest mean values of histamine are: ‘dried anchovies’ 
(348 mg/kg), ‘fish sauce’ (196-197 mg/kg), ‘fermented vegetables’ (39.4 - 42.6 mg/kg), ‘cheese’ (20.9 – 
62 mg/kg), ‘other fish and fish products’ (26.8 - 31.2 mg/kg) and ‘fermented sausages’ (23.0 – 23.6 
mg/kg) . 
Table 10:   Occurrence data on histamine (mg/kg) 
Food category Sub-category n ND Mean P5 Median P95 Max 
Alcoholic beverages Beer 188 9.6% 1.4 <0.5 0.7 4.8 21.6 
 Fortified and liqueur wines 28 32% 1.1 <0.1 0.7 2.8 2.9 
 Wine, red 300 10% 3.6 – 3.7 <0.1 1.4 – 1.5 12.3 – 12.4 34.3 
 Wine, white 225 22% 0.8 – 0.9 <0.1 0.3 2.6 55 
 Wine, white, sparkling 45 73% 1 <0.1 <0.1 5.2 9.8 
Total for alcoholic beverages 786 18% 2 – 2.1 <0.1 0.6 – 0.7 8.8 – 9.2 55 
Sauces Fish sauce 72 14% 196 – 197 <10 180 597 758 
 Other savoury sauces 27 96% 0.5 – 10.1 <10 <10 <13.3 16 
Total for sauces 99 36% 142 – 146 <10 108 547 758 
Fish and fish 
products 
Dried anchovies 54 50% 348 <0.1 10.4 – 10.5 1440 2860 
 Fermented fish products 71 45% 7.7 – 11.4 <1.5 1.5 – 4 34.9 163 
 Other fish and fish products 6329 73% 26.8 – 31.2 <0.1 <2.5 60.5 – 100 8910 
Total for fish and fish products 6454 73% 29.3 – 33.6 <0.1 <2.5 67.7 – 100 8910 
Meat products Fermented sausages  374 43% 23.0 – 23.6 <0.1 0.6 – 1.4 149 400 
 Other ripened meat products 94 28% 5.9 – 6.4 <0.1 1 35 150 
 Other meat products 75 80% 3.9 – 4.4 <0.1 <1 4.8 212 
Total for meat products 543 45% 17.4 – 17.9 <0.1 0.5 – 1 119 400 
Dairy products Cheese 2143 85% 20.9 – 62 <5.5 <50 130 1850 
 Fresh cheese 98 93% 3.2 – 38.5 <0.3 <50 20 – 50 119 
 Hard cheese 1067 83% 25.2 – 65.1 <3.5 <50 140 1240 
 Washed rind cheese 296 93% 8.5 – 54.4 <50 <50 46 – 50 392 
 Blue cheese 678 85% 21.8 – 63.8 <45 <50 153 1850 
 Acid curd cheese 4 25% 51.3 – 55.3 <9.1 51.6 – 55 102 102 
 Yoghurt 7 14% 0.5 <0.1 0.4 1 1 
 Other dairy products 4 50% 0.3 <0.1 0.2 0.6 0.6 
Total for dairy products 2154 85% 20.8 – 61.6 <4 <50 130 1850 
Vegetables and 
vegetable products 
Fermented vegetables 9 44% 39.4 – 42.6 <4 61 92 92 
Other vegetables 26 96% 2.9 – 3.1 <0.1 <0.3 <0.5 75.7 
Vegetables and vegetable products 35 83% 12.3 – 13.3 <0.1 <0.5 77 92 
The statistics are presented using a bounded approach for the handling of non-detected/non-quantified data, therefore they are 
displayed as ranges. The upper bound of the range estimates the non-detected/non-quantified values using the reported limit of 
detection (LOD) or limit of quantification (LOQ) respectively. The lower bound of the range instead assumes the non-
detected/non-quantified values as zero. When the lower bound and the upper bound of the range are coincident, only one 
number is presented. When the lower bound is zero, the range is represented by the upper bound prefixed by ‘<’. The table 
contains the number of samples (n), the percentage of non detected (ND), the mean, several percentiles to describe the 
occurrence distribution (P5, P50 or median, P95 and max). 
4.1.3.2. Occurrence data for tyramine  
Occurrence data on tyramine are presented in Table 11. Among alcoholic beverages, the highest values 
of tyramine are reached for ‘beer’ and ‘fortified and liqueur wines’ with a mean value of 6 mg/kg (or 
mg/L).  As for histamine, fish sauce also presents high concentrations of tyramine with a mean of 105 – 
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107 mg/kg. The ‘other savoury sauces’ have low concentrations with a 93% of non-quantified values 
providing a measured value for the 95-percentile of 18.6 mg/kg.  For tyramine, the categories ‘fish and 
fish products’, ‘meat products’ and ‘vegetables and vegetables products’, show higher occurrence 
values for fermented products in comparison with non-fermented ones.  The broad category ‘cheese’, 
‘acid curd cheese’ (335 mg/kg), ‘hard cheese’ (82.9 – 113 mg/kg) and ‘blue cheese’ (63.2 – 104 mg/kg) 
present higher mean concentrations compared to the other. 
In summary, the food categories showing the highest mean values of tyramine are ‘fermented sausages’ 
(136 mg/kg), ‘fish sauce’ (105 -107 mg/kg), ‘cheese’ (68.5 – 104 mg/kg), ‘fermented fish’ (47.2 -47.9 
mg/kg) and ‘fermented vegetables’ (45 – 47.4 mg/kg).  
Table 11:  Occurrence data on tyramine (mg/kg) 
Food category Sub-category n ND Mean P5 Median P95 Max 
Alcoholic 
beverages 
Beer 188 0% 6.1 1.4 3.2 24.7 46.8 
Fortified and liqueur wines 28 3.6% 6 0.1 1.5 21.3 22.5 
 Wine, red 296 12% 2.7 – 2.9 <0.2 1.6 – 1.8 7.8 – 8.5 18.5 
 Wine, white 224 17% 1.1 – 1.2 <0.1 0.8 4.3 – 4.5 10 
 Wine, white, sparkling 45 56% 4.9 <0.1 <0.1 26.4 47.3 
Total for alcoholic beverages 781 13% 3.3 – 3.4 <0.1 1.7 11.5 – 11.6 47.3 
Sauces Fish sauce 71 15% 105 – 107 <10 69.3 421 741 
 Other savoury sauces 27 93% 1.5 – 10.5 <10 <10 18.6 21 
Total for sauces 98 37% 76.7 – 80.4 <10 55 355 741 
Fish and fish 
products 
Fermented fish meat 70 26% 47.2 – 49.1 <4.5 17.4 – 
18 
251 627 
Other fish and fish products 1281 86% 6.8 – 14.6 <1 <10 33.4 634 
Total for fish and fish products 1351 83% 8.9 – 16.4 <1 <10 43.3 634 
Meat products Fermented sausages  369 22% 136 <0.1 99 397 1740 
 Other ripened meat products 92 18% 44 – 44.2 <0.3 25.7 149 387 
 Other meat products 75 27% 16.1 – 16.2 <0.1 4.9 67 292 
Total for meat products 536 22% 104 <0.1 49 361 1740 
Dairy products Cheese 2377 75% 68.5 – 104 <5 <50 440 2130 
 Fresh cheese 98 91% 12.8 – 48 <0.3 <50 89 457 
 Hard cheese 1303 66% 82.9 – 113 <5 <50 475 1450 
 Washed rind cheese 296 92% 31.6 – 76.1 <50 <50 240 1900 
 Blue cheese 676 83% 63.2 – 104 <50 <50 453 2130 
 Acid curd cheese 4 0% 335 100 380 480 480 
 Yoghurt 7 29% 1.9 <0.1 1 5.2 5.2 
 Other dairy products 4 25% 0.3 <0.1 0.3 0.4 0.4 
Total for dairy products 2388 75% 68.1 – 103 <5 <50 433 2130 
Vegetables and 
vegetable products 
Fermented vegetables 9 22% 45 – 47.4 <5 44 91 91 
Other vegetables 14 93% 1.8 <0.1 <0.1 25.4 25.4 
Total for vegetables and vegetable products 23 65% 18.7 – 19.7 <0.1 <0.1 91 91 
The statistics are presented using a bounded approach for the handling of non-detected/non-quantified data, therefore they are 
displayed as ranges. The upper bound of the range estimates the non-detected/non-quantified values using the reported limit of 
detection (LOD) or limit of quantification (LOQ) respectively. The lower bound of the range instead assumes the non-
detected/non-quantified values as zero. When the lower bound and the upper bound of the range are coincident, only one 
number is presented. When the lower bound is zero, the range is represented by the upper bound prefixed by ‘<’. The table 
contains the number of samples (n), the percentage of non detected (ND), the mean, several percentiles to describe the 
occurrence distribution (P5, P50 or median, P95 and max). 
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4.1.3.3. Occurrence data for putrescine  
Descriptive statistics of data regarding putrescine are provided in Table 12. For ‘alcoholic beverages’ 
the highest mean values of putrescine concentrations are present for ‘wine, white, sparkling’ (5.2 mg/kg 
or mg/l), followed by ‘wine, red’ (4.2 – 4.8 mg/kg of mg/l) and ‘beer’ (3.3 – 3.5 mg/kg or mg/l). 
Table 12:  Occurrence data on putrescine expressed in mg/kg 
Food category Sub-category n ND Mean P5 Median P95 Max 
Alcoholic beverages Beer 188 32% 3.3 – 3.5 <0.4 3.3 8.3 17.8 
 Fortified and liqueur wines 28 0% 1.4 0.3 0.9 3.6 4.3 
 Wine, red 120 5.0% 4.2 – 4.8 0.3 – 1 3.4 – 3.7 9.5 – 11.5 21.6 
 Wine, white 100 3.0% 1.4 – 1.5 0.2 1 3.9 – 4.3 5.7 – 10
 Wine, white, sparkling 45 11% 5.2 <0.1 2.4 15 46.4 
Alcoholic beverages 481 16% 3.2 – 3.4 <0.4 2.3 – 2.4 8.6 – 9 46.4 
Sauces Fish sauce 71 11% 98.1 – 99.3 <10 82 167 1220 
 Other savoury sauces 27 70% 6 – 13.6 <10 <10 24.2 27.4 
Total for sauces 98 28% 72.7 – 75.7 <10 53.4 163 1220 
Fish and fish 
products 
Fermented fish meat 70 41% 13.4 – 17 <1.6 2.5 – 5 75.1 244 
 Other fish and fish products 1279 81% 4.1 – 11.7 <0.2 <10 26.4 337 
Total for fish and fish products 1349 79% 4.6 – 12 <0.2 <10 26.4 337 
Meat products Fermented sausages 369 24% 84.2 – 84.6 <0.1 26.9 334 1550  
 Other ripened meat products 92 3.30% 32.8 1 12.1 136 406 
 Other meat products 75 27% 17.4 – 17.6 <0.1 1.2 123 305 
Total for meat products 536 21% 66 – 66.3 <0.1 12.9 – 13.9 284 1550 
Dairy products Cheese 2136 82% 25.4 – 65 <6.2 <50 143 1560 
 Fresh cheese 98 85% 5.5 – 41.3 <0.2 <50 4 – 50 348 
 Hard cheese 1062 82% 26.6 – 65.5 <3.9 <50 132 1560 
 Washed rind cheese 296 82% 32.3 – 72.3 <20 <50 182 816 
 Blue cheese 676 83% 20.9 – 62.2 <21.8 <50 149 701 
 Acid curd cheese 4 0% 449 50 550 648 648 
 Yoghurt 7 0% 0.7 0.1 0.8 1.1 1.1 
 Other dairy products 4 0% 0.7 0.4 0.8 0.9 0.9 
Total for dairy products 2148 82% 25.3 – 64.7 <4.8 <50 143 1560 
Vegetables and 
vegetable products 
Fermented vegetables 9 0% 264 33 249 549 549 
Other vegetables 14 7.1% 37.2 <0.1 12.9 310 310 
Total for vegetables and vegetable products 23 4.3% 126 1.8 33 415 549 
The statistics are presented using a bounded approach for the handling of non-detected/non-quantified data, therefore they are 
displayed as ranges. The upper bound of the range estimates the non-detected/non-quantified values using the reported limit of 
detection (LOD) or limit of quantification (LOQ) respectively. The lower bound of the range instead assumes the non-
detected/non-quantified values as zero. When the lower bound and the upper bound of the range are coincident, only one 
number is presented. When the lower bound is zero, the range is represented by the upper bound prefixed by ‘<’. The table 
contains the number of samples (n), the percentage of non detected (ND), the mean, several percentiles to describe the 
occurrence distribution (P5, P50 or median, P95 and max). 
For ‘fish sauce’ (98.1 – 99.3 mg/kg), similarly to the other amines reported in previous tables, the 
concentration of putrescine is higher compared to ‘other savoury sauces’ (6 – 13.6 mg/kg). This 
difference is also present in fish and meat, where ‘fermented fish meat’ (13.4 – 17 mg/kg) and 
‘fermented sausages’ (84.2 – 84.6 mg/kg) have higher values in comparison to the other food items in 
the respective groups. 
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Among cheese subclasses, slight differences in putrescine concentration were observed.  
In the class vegetables, the difference between fermented vegetables (mean value of 264 mg/kg) and 
‘other vegetables’ (mean value of 37.2 mg/kg) was observed (with the exception of ‘acid curd cheese’ 
presenting again very high values (mean 449 mg/kg). 
In summary, the food categories showing the highest mean values for putrescine were ‘fermented 
vegetables’ (264 mg/kg), ‘fish sauce’ (98.1 – 99.3 mg/kg), ‘fermented sausages’ (84.2 – 84.6 mg/kg), 
‘cheese’ (25.4 – 65 mg/kg) and ‘fermented fish’ (13.4 – 17 mg/kg).  
4.1.3.4. Occurrence data for cadaverine 
The data on cadaverine are presented in Table 13. For ‘alcoholic beverages’ the highest values of 
cadaverine were detected for ‘beer’ with a mean of 1.3 – 1.5 mg/kg (or mg/l). As the other biogenic 
amines, high values of cadaverine are measured for ‘fish sauce’. The mean value ranges between 180 
mg/kg and 182 mg/kg. It should be noticed that for the group ‘other savoury sauces’ (including mainly 
meat sauce and soya sauce), there is a very high percentage of non-quantified results. 
In the category ‘fish and fish products’ no large difference between fermented and non-fermented items 
was observed, in particular when looking at the mean. The food item ‘other fish and fish products’ 
presented a higher maximum value of 1690 mg/kg which was obtained from a single sample of 
mackerel were the processing was not specified.  
For meat, fermented sausages the highest concentration of cadaverine (mean 37.4 – 38 mg/kg) were 
reported, followed by ‘other ripened meat products’ had higher concentrations of cadaverine (mean 
17.2 -17.5 mg/kg) with respect to ‘other meat products’ (6.7 mg/kg – 6.8 mg/kg). 
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Table 13:  Occurrence data on cadaverine expressed in mg/kg 
Food category Sub-category n ND Mean P5 Median P95 Max 
Alcoholic 
beverages 
Beer 188 46% 1.3 – 1.5 <0.4 0.4 5.3 31.4 
Fortified and liqueur wines 28 57% 0.1 <0.1 <0.1 0.3 0.4 
 Wine, red 126 26% 0.2 – 0.5 <0.1 0.1 – 0.2 0.6 – 1.6 5 
 Wine, white 100 30% 0.1 – 0.2 <0.1 <0.1 0.3 – 0.4 10 
 Wine, white, sparkling 45 91% <0.1 <0.1 <0.1 0.2 0.5 
Total for alcoholic beverages 487 43% 0.6 – 0.8 <0.1 <0.3 2 – 3.9 31.4 
Sauces Fish sauce 71 15% 180 – 182 <10 164 502 1150 
 Other savoury sauces 28 96% 2.9 – 13 <10 <10 <20 82.1 
Total for sauces 99 38% 130 – 134 <10 103 317 1150 
Fish and fish 
products 
Fermented fish meat 70 44% 14 – 17.3 <1.3 1.6 – 7.7 34.5 356 
Other fish and fish products 1289 73% 24 – 30.8 <0.2 <10 130 1690 
Total for fish and fish products 1359 72% 23.5 – 30.1 <0.2 <10 126 1690 
Meat products Fermented sausages 370 28% 37.4 – 38 <0.1 5.4 – 6.8 154 1250 
 Ripened meat products 92 11% 17.2 – 17.5 <0.7 5 – 5.7 84.1 305 
 Other meat products 75 21% 6.7 – 6.8 <0.1 2.4 25 64 
Total for meat products 537 24% 29.6 – 30.1 <0.1 5 – 5.4 137 1250 
Dairy products Cheese 2149 77% 72 – 109 <4.5 <50 470 3170 
 Fresh cheese 98 85% 10.7 – 45 <0.2 <50 33.8 – 
50 
389 
 Hard cheese 1071 76% 47.8 – 83.5 <2 <50 240 3170 
 Washed rind cheese 299 78% 146 – 184 <50 <50 989 2460 
 Blue cheese 677 77% 83.1 – 121 <44.1 <50 519 3120 
 Acid curd cheese 4 0% 628 86 723 980 980 
 Yoghurt 7 29% 3.2 <0.1 0.9 10.3 10.3 
 Other dairy products 4 0% 1.9 0.6 2 3 3 
Total for dairy products 2160 76% 71.7 – 108 <3.1 <50 464 3170 
Vegetables and 
vegetable products 
Fermented vegetables 9 56% 26 – 35.4 <17 <17 94 94 
Other vegetables 14 64% 17 <0.1 <0.1 85 85 
Total for vegetables and vegetable products 23 61% 20.5 – 24.2 <0.1 <17 85 94 
The statistics are presented using a bounded approach for the handling of non-detected/non-quantified data, therefore they are 
displayed as ranges. The upper bound of the range estimates the non-detected/non-quantified values using the reported limit of 
detection (LOD) or limit of quantification (LOQ) respectively. The lower bound of the range instead assumes the non-
detected/non-quantified values as zero. When the lower bound and the upper bound of the range are coincident, only one 
number is presented. When the lower bound is zero, the range is represented by the upper bound prefixed by ‘<’. The table 
contains the number of samples (n), the percentage of non detected (ND), the mean, several percentiles to describe the 
occurrence distribution (P5, P50 or median, P95 and max). 
 
Among cheese subclasses, the class ‘washed rind cheese’ (mean 146 – 184 mg/kg) presented higher 
values of cadaverine in comparison with the others (with the exception of ‘acid curd cheese’ which 
shows again very high values (628 mg/kg)).  
Finally, cadaverine shows closer levels of occurrence between ‘fermented vegetables’ and ‘other 
vegetables’ in comparison with the other biogenic amines. 
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In summary, the food categories showing the highest mean values of cadaverine were ‘fish sauce’ (180 
– 182 mg/kg), ‘cheese’ (72 – 109 mg/kg), ‘fermented sausages’ (37.4 – 38 mg/kg), ‘fermented 
vegetables’ (26 – 35.4 mg/kg) and ‘fermented fish meat’ (14 – 17.3 mg/kg).  
4.1.3.5. Occurrence data for phenylethylamine 
Phenylethylamine data are presented in Table 14. In several food groups, phenylethylamine has 100% 
non-quantified values. Among alcoholic beverages, phenylethylamine had quantified values only for 
beer (65% non-quantified) with a mean 0.3- 0.5 mg/kg. Fish sauce had a mean phenylethylamine 
concentration between 17.2 mg/kg and 20.9 mg/kg, while for other savoury sauces the values were 
entirely non-quantified. 
Table 14:  Occurrence data on phenylethylamine expressed in mg/kg 
Food class Sub-category n ND Mean P5 Median P95 Max 
Alcoholic beverages Beer 182 65% 0.3 - 0.5 <0.4 <0.4 0.9 8.4 
 Wine, red 24 100% <2.4 <1.5 <1.5 <5 <5 
 Wine, white 2 100% <1.5 <1.5 <1.5 <1.5 <1.5 
Total for alcoholic beverages 208 70% 0.2 - 0.7 <0.4 <0.4 0.8 - 1.5 8.4 
Sauces Fish sauce 68 37% 17.2 - 20.9 <10 12.3 - 12.5 58.6 172 
 Other savoury sauces 27 100% <9.6 <5 <10 <10 <10 
Total for sauces 95 55% 12.3 - 17.7 <10 <10 44.6 172 
Fish and fish products Fermented fish meat 68 65% 0.9 - 3.9 <0.2 <5 5.7 - 9.2 9.2 - 18 
 Other fish and fish products 293 89% 2.3 - 7.1 <0.2 <10 12.2 180 
Total for fish and fish products 361 84% 2 - 6.5 <0.2 <5 6.7 - 
10.8 
180 
Meat products Fermented sausages 297 48% 6.2 - 7 <0.1 0.3 - 2.1 34.7 182  
 Other ripened meat products 34 68% 0.5 - 1.9 <0.4 <1 3.3 - 10 3.7 - 10 
 Other meat products 51 92% 0.1 - 1.1 <0.6 <1 1 - 1.1 1.4 - 5.5
Total for meat products 382 55% 4.9 - 5.7 <0.1 <1 28.5 182 
Dairy products Cheese 175 66% 3.4 - 5 <0.2 <2 18.8 61.3 
 Fresh cheese 23 100% <1.4 <0.2 <0.2 <5 <18 
 Hard cheese 113 59% 4.2 - 5.5 <0.2 <2 22 61.3 
 Washed rind cheese 9 100% <2.9 <2 <2 <10 <10 
 Blue cheese 26 46% 5.1 - 5.6 <0.2 1.3 - 2.3 17.4 39.5 
 Acid curd cheese 4 100% <10.8 <2 <11.5 <18 <18 
Total for dairy products 175 66% 3.4 - 5 <0.2 <2 18.8 61.3 
Vegetables and 
vegetable products 
Fermented vegetables 9 100% <5 <5 <5 <5 <5 
 Other vegetables 1 100% <9.3 <9.3 <9.3 <9.3 <9.3 
Total for vegetables and vegetable products 10 100% <5.4 <5 <5 <9.3 <9.3 
The statistics are presented using a bounded approach for the handling of non-detected/non-quantified data, therefore they are 
displayed as ranges. The upper bound of the range estimates the non-detected/non-quantified values using the reported limit of 
detection (LOD) or limit of quantification (LOQ) respectively. The lower bound of the range instead assumes the non-
detected/non-quantified values as zero. When the lower bound and the upper bound of the range are coincident, only one 
number is presented. When the lower bound is zero, the range is represented by the upper bound prefixed by ‘<’. The table 
contains the number of samples (n), the percentage of non detected (ND), the mean, several percentiles to describe the 
occurrence distribution (P5, P50 or median, P95 and max). 
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In fish, phenylethylamine presented lower values in ‘fermented fish’ (0.9 – 3.9 mg/kg) in comparison 
with ‘other fish and fish products’ (2.3 – 7.1 mg/kg). 
The class ‘fermented sausages’ had a mean concentration of 6.2 - 7 mg/kg in comparison to the 0.5 - 1.9 
mg/kg for the other meat products. 
In cheese, only one sample was available for the food class ‘washed rind cheese’. Fresh cheese and acid 
curd cheese were entirely non-quantified. Quantified values are present only for hard cheese and blue 
cheese, with a concentration of around 5 mg/kg.   
For phenylethylamine in vegetables, only a few samples were reported, entirely non-quantified.  
In summary, the food categories showing the highest mean values of phenylethylamine were ‘fish 
sauce’ (17.2 - 20.9 mg/kg), ‘fermented sausages’ (6.2 – 7 mg/kg), ‘cheese’ (3.4 - 5mg/kg) and ‘other 
fish and fish products’ (2.3 - 7.1 mg/kg). 
4.1.3.6. Occurrence data for tryptamine 
Table 15 contains descriptive statistics for data received on tryptamine. In the ‘alcoholic beverages’ 
group data are available only on beer with a mean ranging between 0.2 mg/kg and 0.7 mg/kg. 
Table 15:  Occurrence data on tryptamine expressed in mg/kg 
Food class Sub-category n ND Mean P5 Median P95 Max 
Alcoholic 
beverages 
Beer 182 86% 0.2 - 0.7 <0.5 <0.5 1.7 5.4 
Total for alcoholic beverages 182 86% 0.2 - 0.7 <0.5 <0.5 1.7 5.4 
Sauces Fish sauce 65 54% 88.1 - 93.5 <10 <10 244 2280 
 Other savoury sauces 25 100% <10 <10 <10 <10 <10 
Total for sauces 90 67% 63.7 - 70.3 <10 <10 224 2280 
Fish and fish 
products 
Fermented fish meat 36 61% 1 - 1.2 <0.2 <0.2 6.5 10.1 
Other fish and fish products 273 89% 3.1 - 7.7 <0.2 <10 15.5 362 
Total for fish and fish products 309 86% 2.9 - 7 <0.2 <1.9 14.4 362 
Meat products Fermented sausages 286 52% 8.3 - 8.5 <0.1 <1 42.9 194 
 Other ripened meat products 78 97% 0.1 - 0.4 <0.2 <0.2 <1 2.9 
 Other meat products 65 89% 0.2 - 0.9 <0.2 <1 1.1 5.1 
Total for meat products 429 66% 5.6 - 5.9 <0.1 <1 29.9 194 
Dairy products Cheese 2079 96% 1 - 46.8 <3.3 <50 <50 312 
 Fresh cheese 92 98% 0.8 - 38.8 <0.2 <50 <50 40 - 50 
 Hard cheese 1021 94% 1.4 - 45.7 <3.3 <50 1.9 - 50 312 
 Washed rind cheese 290 99% 0.5 - 49.2 <50 <50 <50 84.5 
 Blue cheese 675 98% 0.5 - 48.6 <50 <50 <50 128 
 Acid curd cheese 1 0% 134 134 134 134 134 
Total for dairy products 2079 96% 1 - 46.8 <3.3 <50 <50 312 
The statistics are presented using a bounded approach for the handling of non-detected/non-quantified data, therefore they are 
displayed as ranges. The upper bound of the range estimates the non-detected/non-quantified values using the reported limit of 
detection (LOD) or limit of quantification (LOQ) respectively. The lower bound of the range instead assumes the non-
detected/non-quantified values as zero. When the lower bound and the upper bound of the range are coincident, only one 
number is presented. When the lower bound is zero, the range is represented by the upper bound prefixed by ‘<’. The table 
contains the number of samples (n), the percentage of non detected (ND), the mean, several percentiles to describe the 
occurrence distribution (P5, P50 or median, P95 and max). 
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In the ‘fish and fish products’ class, ‘fermented fish meat’ (1 – 1.2 mg/kg) does not have higher values 
in comparison to the ‘other fish and fish products’ (3.1 – 7.7 mg/kg), while among  ‘meat products’ 
‘fermented sausages’ (8.3 – 8.5 mg/kg) had higher values in comparison with ‘other ripened meat 
products’ (0.1 – 0.4 mg/kg) and ‘other meat products’ (0.2 – 0.9 mg/kg). 
For tryptamine, the class ‘cheese’ shows large numbers of non-quantified values in all the sub-
categories: The average concentration of tryptamine for this class is less than 50 mg/kg. 
In summary, the food categories showing the highest mean values of tryptamine was ‘fish sauce’ (88.1 - 
93.5 mg/kg), ‘cheese’ (1 - 46.8 mg/kg), ‘fermented sausages’ (8.3 - 8.5 mg/kg). The large spread in the 
values for cheese was due to the high percentage of non-quantified values in this class (96 %).  
4.1.3.7. Sum of biogenic amines 
The sum of biogenic amines can be calculated only for those samples analysed for all relevant 
substances (Table 16). It is necessary, then, to restrict the number of compounds otherwise the lower 
number of samples available for tryptamine and phenylethylamine would limit the number of samples 
available for the calculation of the sum. Therefore, the sum of biogenic amines is taking into account 
only samples with values for histamine, tyramine, cadaverine and putrescine. In addition, food 
categories for which the mean values were significantly different from the one provided in the tables 
above (‘wine red’, ‘wine white’ and ‘other fish products’) were also not included for the calculation of 
the sum of biogenic amines. Cumulative values for the categories were also excluded for the same 
reason. 
The sum of biogenic amines is presented in the occurrence section for completeness and it was not used 
for exposure assessment. 
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Table 16:  Sum of biogenic amines in samples with available concentrations of histamine, tyramine, putrescine and cadaverine 
  Biogenic amines 
  Histamine Tyramine Putrescine Cadaverine Sum of BAs 
Food class Sub-category n Mean 
(mg/kg) 
P95 
(mg/kg) 
Mean 
(mg/kg) 
P95 
(mg/kg) 
Mean 
(mg/kg) 
P95 
(mg/kg) 
Mean 
(mg/kg) 
P95 
(mg/kg) 
Mean 
(mg/kg) 
P95 
(mg/kg) 
Alcoholic beverages  Beer 188 1.4 4.8 6.1 24.7 3.3 - 3.5 8.3 1.3 - 1.5 5.3 12.1 – 12.4 36.7 
Fortified and liqueur wines 28 1.1 2.8 6 21.3 1.4 3.6 0.1 0.3 8.6 26.4 
  Wine, white, sparkling 45 1 5.2 4.9 26.4 5.2 15 <0.1 0.2 11.1 46.1 
Condiment Fish sauce 71 198 - 199 597 105 - 107 421 98.1 - 99 167 180 - 182 502 582 - 588 1500 
  Other savoury sauces 27 0.5 - 10.1 <13.3 1.5 - 10 18.6 6 - 13.6 24.2 3 - 12.7 <17 11 - 47 24.2 - 56 
Fish and fish products Fermented Fish products 68 7.7 - 11.4 31.5 45.5 - 47 136 12.2 - 15 75.1 14.4 - 17 34.5 79.8 - 91 552 - 572 
Meat products Fermented sausages 369 23.2 - 23 149 136 397 84.2 - 84 334 37.4 - 38 154 281 - 283 889 
  Other ripened meat products 92 6 - 6.2 35 44 - 44.2 149 32.8 136 17.2 - 17 84.1 100 - 101 342 
  Other meat products 75 3.9 - 4.4 4.8 16.1 - 16 67 17.4 - 17 123 6.7 - 6.8 25 44 - 45 151 
Dairy products Cheese 2136 20.6 - 61 127 59 - 98 420 25.4 - 65 143 72.2 - 109 472 177 - 334 1050 
 Fresh cheese 98 3.2 - 38 20 - 50 12.8 - 48 89 5.5 - 41 4 - 50 10.7 - 45 33.8 - 
50 
32.1 - 172 323 - 464 
   Hard cheese 1062 25 - 65 136 67.1 - 103 475 26.6 - 65 132 47.8 - 83 235 167 - 318 940 - 1030 
   Washed rind cheese 676 8.5 - 54 46 - 50 31.6 - 76 240 32.3 - 72 182 147 - 186 989 220 - 388 1420 - 
1516 
    Blue cheese 296 21.3 - 63 149 63.2 - 10 453 20.9 - 62 149 83.1 - 12 519 188 - 351 1100 - 
1184 
  Acid curd cheese 4 51.3 - 55 102 335 480 449 648 628 980 1460 2140 
  Yoghurt 7 0.5 1 1.9 5.2 0.7 1.1 3.2 10.3 6.3 12 
  Other dairy products 4 0.3 0.6 0.3 0.4 0.7 0.9 1.9 3 3.1 4.8 
Vegetables and 
vegetable products  
Fermented vegetables 9 39.4 - 42 92 45 - 47.4 91 264 549 26 - 35.4 94 375 - 390 747 
Other vegetables 14 5.4 75.7 1.8 25.4 37.2 310 17 85 61.4 422 
The statistics are presented using a bounded approach for the handling of non-detected/non-quantified data (therefore they are displayed as ranges). The upper bound of the range estimates the 
non-detected/non-quantified values using the reported limit of detection (LOD) or limit of quantification (LOQ) respectively. The lower bound of the range instead assumes the non-
detected/non-quantified values as zero. When the lower bound and the upper bound of the range are coincident, only one number is presented. When the lower bound is zero, the range is 
represented by the upper bound prefixed by ‘<’. The table contains the number of samples (n), the mean and the 95-percentile (P95). 
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‘Beer’ and ‘wine, white, sparkling’ contains the higher mean values for the category beverages for the 
sum of biogenic amines (11.1 mg/kg and 12.1 – 12.4 mg/kg). For this class the major contributors to 
the sum were tyramine and putrescine. 
For the category ‘condiments’ the difference in concentration values between ‘fish sauce’ (582 -588 
mg/kg) and ‘other savoury sauces’ (24.2 – 56 mg/kg) is maintained as for the individual substances. 
All the amines equally contribute to the sum. 
The category ‘fermented sausages’ (281 – 283 mg/kg) records higher values in the ‘meat products’. 
This food class is followed by ‘ripened meat products’ (100 – 101 mg/kg). For these classes, tyramine 
is the higher contributor to the sum. 
‘Cheese’ records high values for the sum of biogenic amines. Overall this food class recorded mean 
values of 177 -334 mg/kg. ‘Acid curd cheese’ reaches the higher mean values (1460 mg/kg), however 
only four samples were available for this class. This subclass is followed by ‘washed rind cheese’ 
(220 - 388 mg/kg), blue cheese (188 -351 mg/kg), hard cheese (167 – 318 mg/kg) and fresh cheese 
(32.1 – 172 mg/kg). For sum concentrations for ‘cheese’, there was an equal contribution from 
tyramine and cadaverine followed by putrescine and histamine. 
Also for ‘fermented vegetables’ the sum of biogenic amines reached high values (375 – 390 mg/kg). 
In this case, this value was mainly influenced by the contribution of putrescine (264 mg/kg). 
In summary, the food categories showing the highest mean values for the sum of biogenic amines 
were ‘fish sauce’ (582 - 588 mg/kg), fermented vegetables (375 – 390 mg/kg ), ‘cheese’ (177 – 334 
mg/kg) and ‘fermented sausages’ (281 – 283 mg/kg).  
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4.1.3.8. Summary of occurrence data 
Table 17 provides a summary of 95-percentiles (P95) statistics, calculated for each food category and 
for each biogenic amine. The P95 was used to represent high occurrence values. Higher percentiles 
were not considered reliable due to the limited number of samples available in some food categories 
as presented in Tables 10 – 15. For the selected occurrence values, the following remarks should be 
highlighted: 
In the food category ‘fish and fish products’, ‘dried anchovies’ data are available only for histamine. 
All ‘cheese’ subclasses were aggregated, since P95 occurrence values were comparable, mitigating 
the impact of some subclasses such as ‘acid curd cheese’ where the number of samples was 
insufficient to have a reliable estimation of the statistics. 
Table 17:  Summary table of 95-percentile for biogenic amines expressed in mg/kg 
 Occurrence of biogenic amines (95-Percentile) mg/kg 
Food class Sub-category Histamine Tyramine Putrescine Cadaverine Phenyl- ethylamine Tryptamine
Alcoholic 
beverages 
Beer 4.8 24.7 8.3 5.3 0.9 1.7 
Fortified and liqueur wines 2.8 21.3 3.6 0.3 - - 
 Wine, red 12.3 - 12.4 7.8 - 8.5 9.5 - 11.5 0.6 - 1.6 <5 - 
 Wine, white 2.6 4.3 - 4.5 3.9 - 4.3 0.3 - 0.4 <1.5 - 
 Wine, white, sparkling 5.2 26.4 15 0.2 - - 
Sauce Fish sauce 597 421 167 502 58.6 244 
 Other savoury sauces <13.3 18.6 24.2 <20 <10 <10 
Fish and fish 
products 
Dried anchovies 1440 - - - - - 
Fermented fish meat 34.9 251 75.1 34.5 5.7 - 9.2 6.5 
 Other fish and fish products 60.5 - 100 33.4 26.4 130 12.2 15.5 
Meat products Fermented sausages 149 397 334 154 34.7 42.9 
 Other ripened meat products 35 149 136 84.1 3.3 - 10 <1 
 Other meat products 4.8 67 123 25 1 - 1.1 1.1 
Dairy products Cheese 130 440 143 470 18.8 <50 
 Yoghurt 1 5.2 1.1 10.3 - - 
 Other dairy products 0.6 0.4 0.9 3 - - 
Vegetables and 
vegetable 
products 
Fermented vegetables 92 91 549 94 <5 - 
Other vegetables <0.5 25.4 310 85 <9.3 - 
The statistics are presented using a bounded approach for the handling of non-detected/non-quantified data, therefore they 
are displayed as ranges. The upper bound of the range estimates the non-detected/non-quantified values using the reported 
limit of detection (LOD) or limit of quantification (LOQ) respectively. The lower bound of the range instead assumes the 
non-detected/non-quantified values as zero. When the lower bound and the upper bound of the range are coincident, only one 
number is presented. When the lower bound is zero e.g. Tables 18 and 19 the range is represented by the upper bound 
prefixed by ‘<’. The table contains P95 statistics of occurrence values. ( - ) indicates not reported 
 
4.1.4. Consumption data 
The EFSA Comprehensive European Food Consumption Database (Comprehensive Database) has 
been built from existing national information on food consumption at a detailed level. Competent 
organisations in the European Union’s Member States have provided EFSA with data from those most 
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recent national dietary surveys in their countries, at the level of consumption by the individual 
consumer. All food consumption data were codified according to the ‘FoodEx classification system’ 
which has been developed by the DATEX Unit in 2009 (EFSA, 2011a). 
The Comprehensive Database includes methodological differences making these data not fully 
suitable for country-to-country comparisons, particularly for chronic long term exposure. Overall, the 
food consumption data gathered at EFSA in the Comprehensive Database are the most complete and 
detailed data currently available in the EU. Based on the detailed structure of the food classification 
(FoodEx) the “Comprehensive European Food Consumption Database” will allow intake estimation 
from more detailed food categories. The guidance for ‘use of the EFSA Comprehensive European 
Food Consumption Database in Exposure Assessment’ describes the usage of this database for 
exposure assessment (EFSA, 2011b). 
The exposure calculation performed for the exposure assessment of biogenic amines is an acute 
exposure. In such cases, the intake should be calculated on a meal or day basis. In the consumption 
database, the individual meals are recorded only for a few countries. Therefore, the exposure was 
calculated at a day level.  The preferred option is therefore to use individual consuming days. Only 
the days where these food categories were consumed were considered. Consumption surveys spread 
from one up to seven days per individual. The usage of individual consuming days allows taking into 
account high consumption occurred by a subject in a specific day, if in the survey more days were 
recorded. Consuming days offer a conservative estimate of the exposure, since it will summate the 
contribution of more meals occurred on the same day. Table 18 shows the 95-percentiles (P95) of 
consuming days for the relevant food categories.  The estimate of high values of consumption are 
provided using the 95-percentiles, since the P95 statistic is sufficiently safe to exclude outliers, which 
may be present in the food consumption surveys. In addition, it is necessary to split the consumption 
data by country and survey because of heterogeneity factors occurring during the consumption 
surveys. In fact, based on the calculation of high values of consumption, the table presents ranges, 
which describe the minimum and the maximum P95 calculated for each country and survey. In the 
Appendix the data for individual MSs are collated (Appendix B).  
Looking at the consumption database it was not possible to find exact matching categories compared 
to these used in the occurrence part of this opinion (data are summarised in the chapter 4.1.3.7). The 
major issues were to identify “fermented” products, since this information is not explicitly considered 
in the FoodEx classification system. This information can only be deduced sometimes by the original 
food name. Therefore the following assumptions have been applied for in the different food 
categories: 
• The category ‘alcoholic beverage’ has good consumption data coverage also at sub-category level.  
• The category ‘fish sauce’ is not available in the consumption database. The FoodEx class ‘soya 
sauce’ was assumed to have a similar mode of use in the single meals and will thus be used for 
estimating these consumptions.  Under this assumption, the other savoury sauces will not be 
considered for exposure, since the occurrence levels are lower than for ‘fish sauce’. 
• Consumption data for ‘fermented fish’ are not included in the database.  Therefore the overall 
consumption for the general food category ‘fish products’ was used. As a consequence of this the 
exposure of the category ‘fermented fish products’ may be overestimated. The consumption of 
‘fish meat’ has been used for ‘other fish and fish products’ since from the occurrence data, this 
category contains mainly fish meat. Data on ‘dried anchovies’ was also not available and given 
the specificity of this food, it will not be included in the exposure calculation. 
• The class ‘fermented sausage’, containing higher occurrence values of biogenic amines in the 
entire category ‘meat products’ is linked with the FoodEx categories of ‘semi-dried sausages’ and 
‘dried sausages’ available in the consumption database. 
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• In the category ‘dairy products’ the consumption data for ‘cheese’ and ‘yoghurt’ were available.  
• The category ‘fermented vegetables’ was linked instead with the consumption of ‘vegetable 
products’, since information on consumption of fermented vegetables was rarely reported. The 
category ‘other vegetables and vegetable products’ containing mainly leafy vegetables and sprouts 
was linked with the FoodEx class ‘leafy vegetables’.  
 
Table 18:  Amounts of high food consumption in the EU209 (minimum and maximum 95-percentile 
(P95) of consumption days when the food was consumed).  
Food category Sub-category High consumption amount  
(g/day; P95 min – P95 max) 
Alcoholic beverages Beer 750 - 5040 
  Fortified and liqueur wines 50 - 400 
  Wine, red 200 - 1000 
  Wine, white 50 - 1500 
  Wine, white, sparkling 250 - 740 
Savoury sauces Fish sauce 0.7 – 50 
Fish and fish products Fermented fish products 8 – 360 
 Other fish and fish products 145 – 414 
Meat products Fermented sausages 43.4 – 250 
 Other ripened meat products 39 – 284 
  Other meat products 170 – 300 
Dairy products Cheese 100 – 247 
  Yoghurt 250 – 796 
  Other dairy products 300 – 954 
Vegetables and vegetable products Fermented vegetables 8.9 – 300 
 Other vegetables 43.2 – 302 
Amounts of food eaten by high consumers in one day, extracted from the “Comprehensive European Food Consumption 
Database”. The amounts are expressed in gram/day. The statistics reflects only the adult population and the actual days of 
consumption for the food categories presented. The 95-percentile statistics of the consuming days was used to quantify the 
high consumption amounts. The range represents the minimum and maximum P95 consumption (g/day) of each food 
categories between countries  
 
4.1.5. Exposure assessment 
The first objective of the exposure analysis was to calculate the exposure for the biogenic amines in 
all identified food categories and to conclude on the food categories which pose a major risk for 
consumers.  
The amount of food representing the majority of consumers for each food category of interest was 
extracted from the consumption database in relation to P95, as presented in 4.2. These data will be 
combined with the occurrence data described in 4.1.3.7. For the occurrence data, the P95 statistics for 
the concentration of biogenic amines for each food category of interest was used to estimate values of 
                                                     
 
9  Consumption data at countries and surveys level is reported in Appendix B. 
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occurrence for foods containing high amounts of biogenic amines. The combination of these data is 
provided in Table 19, showing high exposure values for the food categories of interest. The exposure 
values are provided in mg/day. The ranges shown reflect the combination of the lower bound of 
occurrence and of the upper bound of occurrence multiplied respectively with the ranges of P95 
consumption presented in Table 18. 
For histamine, the highest exposure values were calculated for ‘other fish and fish products’ (8.8 – 
41.4 mg/day), followed by ‘fermented sausages’ (6.4 – 37.1 mg/day), ‘cheese’ (13 – 32.1 mg/day) and 
‘fish sauces’ (0.4 – 29.9 mg/day). 
For tyramine, the class with highest values were calculated for ‘beer’ (18.5 – 124.6 mg/day). The 
reason can be mainly attributed to the occasional high values recorded in the consumption database. 
‘Cheese’ also shows high exposure (44 – 108.7 mg/day) to this biogenic amine. ‘Fermented sausages’ 
(17.2 – 99.3mg/day) and ‘fermented fish meat’ (2 – 90.4 mg/day) can lead to very high exposure to 
this biogenic amine.  
For putrescine, the food categories with the highest exposures are different from those for the other 
biogenic amines and are ‘fermented vegetables’ (4.9 – 164.7 mg/day) and ‘other vegetables’ (13.4 – 
93.6 mg/day). After vegetables, the category providing the highest exposure values is ‘ fermented 
sausages’ (14.5 – 83.6 mg/day), ‘other meat products’ (20.9 – 36.9 mg/day) and ‘cheese’ (14.3 – 35.3 
mg/day) follows with relative lower values. 
For cadaverine, ‘cheese’ is the top contributor with 47 – 116.1 mg/day followed by the category 
‘other fish and fish products’ (18.9 -53.8 mg/day).  
For phenylethylamine and tryptamine, occurrence data were not available for all the categories of 
interest. It can, however, be concluded that the exposure levels are lower than for other biogenic 
amines.  
For phenylethylamine the higher exposure levels were calculated for ‘fermented sausages’ (1.5 – 8.7 
mg/day) and ‘cheese’ (1.9 – 4.6 mg/day).  
For tryptamine, the highest exposure levels are calculated for ‘cheese’ (0.1 – 12.3), ‘fish sauce’ (0.2 – 
12.2mg/day) and ‘fermented sausages’ (1.9 – 10.7 mg/day). 
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Table 19:  Biogenic amines high exposure values per day of consumption of relevant food  
  Biogenic amines high exposure for relevant food categories (mg/day) 
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Alcoholic 
beverages  
  
Beer 3.6 - 24.2 18.5 - 124.6 6.2 - 41.9 4 - 26.7 0.6 - 4.3 1.3 - 8.6 
Fortified and liqueur wines 0.1 - 1.1 1.1 - 8.5 0.2 - 1.4 <0.1 - 0.1 - - 
Wine, red 2.5 - 12.4 1.6 - 8.5 1.9 - 11.5 0.1 - 1.6 <0.1 - 5 - 
  Wine, white 0.1 - 3.9 0.2 - 6.8 0.2 - 6.5 <0.1 - 0.6 <0.1 - 2.3 - 
  Wine, white, sparkling 1.3 - 3.8 6.6 - 19.5 3.8 - 11.1 0.1 - - 
Fish and fish 
products 
Fermented fish meat 0.3 - 12.6 2 - 90.4 0.6 - 27 0.3 - 12.4 <0.1 - 3.3 0.1 - 2.3 
Other fish and fish products 8.8 - 41.4 4.8 - 13.8 3.8 - 10.9 18.9 - 53.8 1.8 - 5 2.2 - 6.4 
Meat products Fermented sausages 6.4 - 37.1 17.2 - 99.3 14.5 - 83.6 6.7 - 38.5 1.5 - 8.7 1.9 - 10.7
 Other ripened meat products 1.4 - 9.9 5.8 - 42.1 5.3 - 38.6 3.3 - 23.9 0.1 - 2.8 <0.1 - 0.3
 Other meat products 0.8 - 1.4 11.4 - 20.1 20.9 - 36.9 4.3 - 7.5 0.2 - 0.3 0.2 - 0.3 
Dairy products Cheese 13 - 32.1 44 - 108.7 14.3 - 35.3 47 - 116.1 1.9 - 4.6 0 - 12.3 
 Yoghurt 0.3 - 0.8 1.3 - 4.1 0.3 - 0.9 2.6 - 8.2 - - 
  Other dairy products 0.2 - 0.6 0.1 - 0.4 0.3 - 0.9 0.9 - 2.9 - - 
Savoury sauces Fish sauce 0.4 - 29.9 0.3 - 21 0.1 - 8.3 0.4 - 25.1 <0.1 - 2.9 0.2 - 12.2
Vegetables and 
vegetable products 
Fermented vegetables 0.8 - 27.6 0.8 - 27.3 4.9 - 164.7 0.8 - 28.2 <0.1 - 1.5 - 
Other vegetables <0.1 - 0.2 1.1 - 7.6 13.4 - 93.6 3.7 - 25.6 <0.1 - 2.8 - 
Exposure calculation in the food categories of interest considering high amounts of biogenic amines (P95 occurrence) and 
high consumption of food (P95 of consumption days). The results are provided in mg/day. When the lower bound and the 
upper bound of the range are coincident, only one number is presented. When numbers where below 0.1 they are reported 
using the sign below (“<”) as “<0.1”. ( - ) not reported 
 
The second objective of the exposure analysis was to calculate an overall exposure per day to 
biogenic amines from the relevant food categories. It should be pointed out that a complete one day 
cumulative exposure cannot be calculated, since the available occurrence data cover only part of the 
diet. However, a cumulative exposure of mg per day, related to the food categories of interest can be 
calculated. This may represent an estimate of the total cumulative exposure per day only if the 
contributions of the other food categories, for which occurrence data are not available, are negligible.  
As anticipated, the exposure calculations performed in Table 19 are high exposure values for each 
food category reported in the table. The calculation of a cumulative exposure per day as the sum of 
the figures reported in this table would represent an unrealistic overestimation, since high 
consumptions levels of the food categories by the same person/consumer are not independent but 
correlated; in fact it is unlikely that a person would be consuming high amounts of all food categories 
in the same day.  
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Therefore, the calculation of the cumulative exposure per day (Table 20) was performed taking into 
account the combinations of foods eaten on the same day by the same consumer, based on data 
available in the consumption database at an individual level. The exposure to highly contaminated 
food (4.1.3.8) was combined for each day of consumption, for all subjects available in the 
consumption database. The 95-percentile statistics was used to represent high levels of exposure. 
It is important to note that, due to the assumptions made for matching the occurrence data with the 
consumption data and the use of all consuming days, the statistics provided are only an estimation of 
an high exposure scenario and do not reflect a specific percentile of the actual population. In addition, 
values in Table 20 may be higher than values for cumulative exposures, since those consuming high 
amounts of food in one category do not automatically match with high consumption of food 
combinations. 
Table 20:  One day cumulative exposure (P95) of all considered food categories calculated for 
consuming day.  
 Cumulative exposure for relevant food categories by country/survey 
(mg/day) 
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Country       
Austria  30.3 - 32.3 88.7 - 88.8 78 80.3 - 80.5 4.9 - 5.7 4.7 - 9.3 
Belgium  29.4 - 32.7 89.9 - 90 60.7 - 61 87.4 - 87.5 4.6 - 5.7 3.6 - 9.7 
Bulgaria  23.4 - 28.2 68.3 75.3 - 75.4 70.5 3.8 - 4.6 3.7 - 7.5 
Czech Republic  34.2 - 37 106 108 78.1 5.3 - 6.2 6.3 - 9.8 
Denmark  21.7 - 24.1 67.8 40.3 - 40.6 57.4 - 57.5 3.2 - 4.6 3.1 - 6.6 
Estonia  28 - 30.8 91.6 53.6 88.4 4 - 4.7 3.5 - 9.8 
Finland  26.9 - 30.4 77.3 - 77.5 67.2 73 - 73.2 3.8 - 4.6 3.5 - 7.9 
France  30 - 32.9 88.9 - 89 68.6 - 68.8 93.4 4.3 - 5.6 2.9 - 9.6 
Germany  29.8 - 32.1 90.9 91.2 - 91.3 82.8 - 82.9 4.3 - 5.4 3.9 - 8.9 
Hungary  30.7 - 32 72.7 138 64.8 3.9 - 4.4 4.3 - 7.1 
Ireland  23.7 - 27.7 82.2 47.3 - 47.4 53 3.7 - 4.6 5.2 – 7 
Italy  31 - 36.7 91.6 - 91.7 80.6 - 80.9 101 4.9 - 6.4 3.8 - 10.2 
Latvia  25.6 - 26.3 77.9 - 78.1 46 72.1 3.9 - 4.2 3.7 – 8 
Netherlands  28.5 - 29.1 94.1 72 75.5 4 - 4.9 4.2 - 9.3 
Poland  33.5 - 37.1 88 128 90.5 - 90.7 3.9 - 4.6 2.6 - 8.9 
Slovakia  29.8 - 30.1 84.1 97.2 57.4 5.2 - 5.6 6 - 8.4 
Slovenia  23.3 - 23.4 60 90.5 - 90.7 57 3.5 - 4.4 2.8 - 5.8 
Spain survey I AESAN  28.2 - 34.2 75.7 - 75.8 68.9 76.8 4.9 - 5.8 5.1 - 8.7 
Spain survey II AESAN FIAB  27.4 - 36.2 64.6 67.7 - 67.8 71.8 - 71.9 4.9 - 6.2 5.3 - 7.7 
Sweden  18.6 - 22.6 57.8 - 57.9 35.3 - 35.4 52.5 - 52.7 2.8 - 3.7 2.7 - 5.6 
United Kingdom  22.5 - 26.5 70.9 - 71 47.9 - 48.1 55.1 - 55.3 3.3 - 4.3 4.1 - 6.6 
When the lower bound and the upper bound of the range are coincident, only one number is presented. 
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As already performed for the exposure calculation at food category level, to highlight eventual 
differences between the consumption behaviours in different countries and to highlight potential 
influences of the consumption survey design, the 95-percentile of cumulative exposure was calculated 
for each country and survey separately. 
The variability in the ranges of Table 20 represents the difference between lower bound and upper 
bound in the occurrence data. It is of note that overall, this difference is not broad. 
Calculating the minimum lower bound and maximum upper bound for each biogenic amine in Table 
20, Figure 3 can be derived, showing a summary of the partial cumulative exposure to each biogenic 
amine.  
 
 
Figure 3:  Summary of cumulative exposure P95 range between the countries for biogenic amines 
presented of all considered food categories. 
As anticipated, summary exposure values presented in Figure 3 and Table 19 reflect P95 of biogenic 
amine occurrence combined with high food consumption data (P95 of one day consumption). The 
cases of intoxication reported in the literature and in the RASFF database are due to a single food 
consumption event and in some cases exceeding the P95 of occurrence used for the exposure 
calculation. It is important therefore to calculate concentration levels of biogenic amines resulting in 
an exposure from a single food consumption within the toxicological threshold. An approach for this 
calculation is to use the BA thresholds - histamine (50 mg for healthy individuals; section 3.1.3.3.) or 
tyramine (600 mg for healthy individuals and 50 mg for individual under RIMA medications; 3.2.3.1.) 
- and the high values for the consumption of the relevant food categories in Table 18. 
These results are presented in the Table 21. It is of note that the levels calculated for tyramine are 
higher then the occurrence data received, in fact no sample exceeded these levels. For histamine there 
is small percentage of samples exceeding these indicative levels. The categories where this 
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exceedence is more evident are ‘other fish and fish products’ (3.7% samples), ‘cheese’ (3.0% 
samples), ‘beer’ (2.1 %) and ‘other ripened meat products’ (2.1%). 
Table 21:  Percentage of mainly fermented food concentrations of concern calculated from BA 
threshold estimates (sections 3.1.3.3. and 3.2.3.1) and consumption data (Table 18).  
  Histamine Tyramine 
   Healthy population Sensitive population under RIMA
Food category Sub-category Concentration 
based on 
estimated 
threshold  
(mg/kg of food) 
% samples 
exceeding   
calculated 
concentration
Concentration 
based estimated 
threshold  
(mg/kg of food) 
% samples 
exceeding  
calculated 
concentration 
Concentration
based on 
estimated 
threshold  
(mg/kg of food)
% samples 
exceeding  
calculated 
concentration
Alcoholic 
beverages 
Beer 10 2.1 119 - 10 13 
Fortified and liqueur wines 125 - 1500 - 125 - 
 Wine, red 50 - 600 - 50 - 
 Wine, white 33 0.4 400 - 33 - 
 Wine, white, sparkling 68 - 811 - 68 - 
Savoury sauces Fish sauce 1000 - 12000 - 1000 - 
Fish and fish 
products 
Fermented fish products 139 1.4 1667 - 139 7.1 
Other fish and fish 
products 
121 3.7 1449 - 121 1.2 
Meat products Fermented sausages 200 - 2400 - 200 24 
 Other ripened meat 
products 
176 2.1 2113 - 176 3.3 
 Other meat products 167 1.3 2000 - 167 1.3 
Dairy products Cheese 202 3.0 2429 - 202 11 
 Yoghurt 63 - 754 - 63 - 
 Other dairy products 52 - 629 - 52 - 
Vegetables and 
vegetable products 
Fermented vegetables 167 - 2000 - 167 - 
Other vegetables 166 - 1987 - 166 - 
( - ) not reported 
Sensitive consumers taking RIMA drugs (estimated threshold of 50 mg) may tolerate some tyramine 
containing food (Table 21). From the data received the consumption of ‘fermented sausages’,’ 
fermented fish products’ and ‘cheese’ appear to be more likely to exceed the estimated threshold of 50 
mg. The high consumption of ‘beer’ will also allow the exceeding of this estimated threshold. Since 
this sensitive population is aware of constraints on consumption of food, some consideration of 
‘moderate’ consumption can be done. In fact, considering a moderate consumption of beer of 500 ml 
per meal, the calculated concentration in the food becomes 100 mg/kg, therefore the estimated 
threshold of 50 mg is not exceeded by any of the samples collected. In the same way, moderate 
consumption of around 130 g of other ripened meat products, where the maximum tyramine 
concentration in the data is 387 mg/kg, would result in an exposure to tyramine within the estimated 
threshold. For ‘fresh cheese’, which has a maximum concentration of 457 mg/kg, a portion of 110 g 
would reach the estimated threshold. The same consideration of reducing the portion size can be 
applied also to the other foods, although it may result in considering too small amounts consumed. It 
is important to keep in mind that these considerations were done on the basis of the consumption of 
each food taken on its own. 
For most sensitive consumers taking classical MAOI drugs (estimated threshold level 6 mg) such 
calculation can not be reliably done due to the low threshold and the uncertainties linked to the 
tyramine occurrence and food consumption data. Nevertheless, from the occurrence data (Table 11) it 
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is clear that the fermented foods are of particular concern for these individuals, which is consistent 
with advice given with medical prescription of classical MAOI drugs to follow a ‘tyramine free diet’ 
(Mariné-Font et al., 1995). 
4.2. Uncertainty 
The evaluation of the inherent uncertainties in the assessment of exposure to biogenic amines has 
been performed following the guidance of the Opinion of the Scientific Committee related to 
Uncertainties in Dietary Exposure Assessment (EFSA, 2006). In addition, the report on 
“Characterizing and Communicating Uncertainty in Exposure Assessment” has been considered 
(WHO/IPCS, 2008). According to the guidance provided by the EFSA opinion (EFSA, 2006) the 
following sources of uncertainties have been considered: assessment objectives, exposure scenario, 
exposure model, and model input (parameters). 
4.2.1. Assessment objectives 
The objectives of the assessment were clearly specified in the terms of reference. The BIOHAZ Panel 
assessed the occurrence data that were collected by EFSA, and carried out an exposure assessment for 
the general adult population. The uncertainty in the assessment objectives is considered to be 
negligible. 
4.2.2. Exposure scenarios/Exposure model 
In response to EFSA’s request to submit biogenic amines occurrence data in food, nine European 
countries submitted data and a different number of samples was available for the different biogenic 
amines. For histamine, EFSA received data for 10123 samples while for phenylethylamine only data 
for 1235 samples were submitted. The food products for which data were provided varied between 
submissions from the different European countries, but most samples belonged to the ‘fish and fish 
product’ category, followed by ‘cheese’ and ‘meat products’. Most of the providers did not submit a 
complete coverage of the categories of interest, but in most cases they covered only some of these 
classes. Moreover, there are differences in the number of biogenic amines reported. The majority of 
the analyses were for histamine in fish and fish products.  
Data for a complete coverage of the diet was not available, therefore it was not possible to perform a 
complete exposure but the exposure was calculated in reference to the food categories of interest for 
which data was available. In any case, it is assumed that the food categories presented cover most of 
the exposure. The presence of low level of preformed BAs in some food classes not included in the 
exposure assessment such as fruits and fruit juices should not impact on the overall exposure 
particularly for histamine and tyramine which provide the major source of risk.  
There is uncertainty in possible regional differences in biogenic amines contamination of food 
commodities, particularly due to the differences in food processing in the different regions. In 
addition, due to the presence of targeted data coming from control and monitoring programs 
particularly on fish and fish products, the data should be considered not fully representative of food 
on the EU market. The presence of targeted data would lead to overestimate exposure. 
The high proportion of samples having levels below the LOD or LOQ may have introduced 
uncertainties to the overall estimate. The use of the upper bound, for risk characterisation in this 
opinion tends to overestimate the dietary exposure. The usage of P95 of the occurrence concentration 
combined the P95 of one day consumption by food consumers of the categories of interest should also 
provide an overestimate of the one meal exposure to BAs which was the target of the exercise. 
Uncertainty also originates from the fact that some consumption food groups were not available and 
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some assumptions were made to match occurrence figures. Mainly, more frequently consumed 
categories were used which should lead to overestimation of the exposure. 
4.2.3. Model input (parameters) 
As outlined in section 7.2.2.2, the HPLC method is cited as the reference method for histamine in 
European Commission Regulation (EC) No 2073/2005 (microbiological criteria for foodstuffs) for 
fishery products, however there is considerable methodological variation likely to be present for 
analysis of histamine in all other foods, in addition to other BAs where there are no prescribed fixed 
official methods provided it can be demonstrated in a traceable manner that they fulfil the 
requirements according to European Regulation (EC) No 882/2004 for Official Laboratories to 
operate and be accredited in accordance with the relevant Standards (e.g. ISO/IEC 17025). Inter-
laboratory methodological differences for the analysis of BAs may have contributed to the uncertainty 
in the analytical results. The lack of certified reference materials, and suitable external quality 
assessment schemes is a further limitation in assessment of the overall uncertainty in the analytical 
results 
Vidal-Carou et al. (2009) compared the accuracy (percentage recovery) and precision (percentage 
relative standard deviation (RSD)) for chromatographic procedures applied to meat and meat 
products. Accuracy for histamine and tryptamine varied between 76->100% and for putrescine, 
cadaverine, phenylethylamine and tryptamine 82->100%. For precision histamine and tryptamine 
varied between 2.5-10.8% and for putrescine, cadaverine, phenylethylamine and tryptamine 2.6 -18%.  
Few studies have compared the performance and the concordance between analytical methods for 
biogenic amines in meat and meat products. In an examination of Czech dry fermented sausages, 
HPLC procedures after precolumn derivatization of dansyl chloride and o-phtalaldehyde gave similar 
results in terms of detection limit, repeatability, recovery, and accuracy (Smela et al., 2004). However, 
these authors reported that o-phtalaldehyde derivatization was faster and much simpler in terms of 
sample pretreatment, which can be fully automated by the auto-sampler. In another study (Ansorena et 
al., 2002), the application of modifications of DnCl-based methodologies by three laboratories 
significantly affected the results obtained on biogenic amine accumulation in European fermented 
sausages. Two laboratories used 0.4 M perchloric acid as the extractant and 1,7-diaminoheptane as the 
internal standard, the derivatization was carried out for 40 min, after which the sample was dissolved 
in acetonitrile (Eerola et al., 1993). The third laboratory used acetone and 5% trichloroacetic acid as 
extractant solvent and 1,8-diaminooctane as internal standard. The derivatization was performed for a 
longer period (4 h), followed by a further extraction of the amines with diethyl ether before the 
sample was dissolved in acetonitrile. The amines most affected by the method of analysis were 
tryptamine and tyramine (Ansorena et al., 2002). 
4.2.4. Other uncertainties 
Overall, the sensitivity against biogenic amines is increased due to a weakened enzymatic amine 
degradation caused by genetic, physiological or acquired impairment of MAO, DAO, HNMT function 
(see section 3.4).  
For histamine, some toxicological data are available from experiments with healthy volunteers and 
sensitive individuals. These studies do not provide the body weights of the test persons. Furthermore 
the results are not always reproducible due to the intra- and interindividual variations in sensitivity. 
Nevertheless, the studies give some indication for dose-response-relationship and a toxicological 
threshold level as an acute reference dose can be estimated. Data from outbreaks show big variation in 
concentrations leading to adverse effects in the consumer. Variations in sensitivity may also be the 
result of interaction with other biogenic amines, other diet constituents such as alcohol or medication 
with DAO inhibitors. These uncertainties may lead either to an underestimation of the adverse effect 
to occur in sensitive people or to an overestimation of the risk in healthy people. 
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For tyramine, toxicological data is derived from some clinical studies dealing with the interaction 
between dietary tyramine and MAOI drugs (see section 3.2.3.1). These studies are usually performed 
in healthy volunteers without MAOI medication (i.e. placebo group). The results allow the amount of 
tyramine needed to provoke a clinically significant increase of systolic blood pressure, of at least 30 
mmHg (PD30). Besides inter- and intraindividual variability, the sensitivity to oral tyramine may also 
vary depending on the diet composition. Lipids but also proteins seem to significantly reduce the 
tyramine bioavailability (Audebert et al., 1992), though other substances such as alcohol or other 
biogenic amines can increase tyramine absorption and thus altering/enhancing its vasopressor effect. 
This uncertainty leads to both underestimation of the adverse vasopressor effect or to an 
overestimation of the risk. 
For putrescine and cadaverine, only a few in vitro and in vivo experimental data are available about 
their potentiating effect on the toxicity of histamine and tyramine. Also some data from experiments 
with humans are available. However no dose-response relationship could be determined and no 
conclusions could be drawn from these experiments. Therefore, no assessment about their 
potentiating effect on the toxicity of histamine and tyramine can be conducted. This uncertainty may 
lead to an underestimation of the risk due to biogenic amines, since only the risk assessment of the 
individual biogenic amines is feasible at the moment. 
4.2.5. Summary of uncertainties 
In Table 22 a summary of the uncertainty evaluation is presented, highlighting the main sources of 
uncertainty and indicating an estimate whether the respective source of uncertainty might have led to 
an over- or underestimation of the exposure or the resulting risk. 
Table 22:  Summary of qualitative evaluation of the impact of uncertainties on the risk assessment 
of the dietary exposure to biogenic amines. 
Sources of uncertainty  Direction 
Measurement uncertainty of analytical results  +/- (a) 
Limited number of food categories and availability of food consumption data   +/- 
Extrapolation of occurrence data from a limited countries to whole Europe  +/- 
Influence of upper-bounds for non-detects on exposure estimate  + 
Lack of information on the impact of food processing and storage  +/- 
Limited information on the dose-response-relationship for histamine and tyramine to cause 
adverse health effects 
 +/- 
Limited information on the toxicity of putrescine and cadaverine to potentiate adverse health 
effects of other biogenic amines e.g. histamine and tyramine 
 - 
(a): + indicates uncertainty with potential to cause over-estimation of exposure/risk; - indicates uncertainty with potential to 
cause under-estimation of exposure/risk. 
The impact of the uncertainties on the risk assessment of exposure to biogenic amines is considerable. 
These uncertainties may lead either to an underestimation of the adverse effect to occur in sensitive 
people or to an overestimation of the risk in healthy people. However, the approach used including 
high percentiles (P95) should reasonably provide an overestimation and counter balances potential 
underestimates. 
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5. Qualitative risk characterisation related to fermented foods 
Risk ranking has been performed in two steps: first according to the occurrence levels and then 
through consumption of the most relevant foods.  
5.1. Healthy individuals 
Overall, healthy individuals can detoxify dietary biogenic amines by acetylation and oxidation 
reactions mediated by the enzymes, MAO, DAO and HNMT. 
However, very high amounts of biogenic amines ingested with food may present a risk to all 
individuals (Taylor, 1986; Bardocz, 1995). Toxic effects of biogenic amines can develop through both 
increased availability (due to high amounts ingested with food) and/or impaired biogenic amine 
degradation (due to increased sensitivity of individuals). 
According to the dose-response relationship estimated in experiments with healthy volunteers, no 
toxicologic effects were reported for histamine up to 50 mg histamine per person. The ingestion of 
amounts of 75 mg histamine and above may cause symptoms of flushing, diarrhoea and headache. In 
relation to histamine fish poisoning data, fish containing less than 50 mg/kg seems to be safe for 
human consumption, whereas concentrations between 50 and 200 mg/kg may cause adverse health 
effects and levels above 200 mg/kg histamine are reported to cause toxic effects in humans.  
According to the literature (section 3.2.3.1) from 600 mg up to 2000 mg of tyramine administrated in 
a meal would be needed to cause a minimal pressure increase (of at least 30 mmHg) (Korn et al., 
1988a,b; Berlin et al., 1989; Zimmer et al., 1990; Patat et al., 1995). A dose-response curve was 
drawn by Patat et al. (1995), in which 1100 mg of tyramine corresponded to the effective dose (ED50) 
as the tyramine dose at which 50% of the individuals responded. 
5.2. Individuals with increased sensitivity 
For patients with histamine intolerance and chronic headache, a histamine-free diet is the treatment of 
choice, because even small amounts of histamine may cause adverse health effects (Jarisch, 2004). 
A recent critical review regarding health effects for tyramine in food was carried out by McCabe-
Sellers et al. (2006) which concluded that the presence of 6 mg in one or two usual servings is thought 
to be sufficient to cause a mild adverse event while 10–25 mg will produce severe adverse effects in 
patients treated with classical MAOI treatment (McCabe, 1986). Other reports conclude that from 50 
up to 150 mg of tyramine would be well tolerated by patients under new generation MAOI treatment, 
so called RIMA (reversible inhibitors of MAO-A) (Table 4; Korn et al., 1988a,b; Dingemanse et al., 
1998; Patat et al., 1995). 
5.3. Risk ranking  
5.3.1. Histamine 
According to occurrence data presented in Table 10, the food categories showing the highest mean 
values of histamine are ‘dried anchovies’ (348 mg/kg), ‘fish sauce’ (196-197 mg/kg), ‘fermented 
vegetables’ (39.4 - 42.6 mg/kg), ‘cheese’ (20.9 – 62 mg/kg), ‘other fish and fish products’ (26.8 - 31.2 
mg/kg) and ‘fermented sausages’ (23.0 – 23.6 mg/kg) . 
For histamine, the high exposure values were calculated for ‘other fish and fish products’ (8.8 – 41.4 
mg/day) followed by ‘fermented sausages’ (6.4 – 37.1 mg/day), ‘cheese’ (13 – 32.1 mg/day) and ‘fish 
sauces’ (0.4 – 29.9 mg/day). 
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Table 23:  Comparison of histamine intake levels from the five most relevant food categories with 
the estimated toxicological threshold of 50 mg per person  
Food category Histamine intake (mg/kg) Percentage of threshold (%) 
Other fish and fish products 41.4 83 
Fermented sausages 37.1 74 
Cheese 32.1 64 
Fish sauce 29.9 60 
Fermented vegetables 27.6 55 
 
The individual intake of the main food categories that contribute to histamine intake does not exceed 
the toxicological threshold of 50 mg. The food category being closest to the threshold is ‘other fish 
and fish products’ with an exhaustion of the threshold up to 83%. Consumption of ‘fermented 
sausages’, ‘cheese’, ‘fish sauce’ and ‘fermented vegetables’ leads to an exhaustion of the threshold of 
74%, 64%, 60% and 55%, respectively (Table 23). Nevertheless, the threshold may be exceeded by 
the intake of more than one food item containing high amounts of histamine during the same meal. 
5.3.2. Tyramine 
According to the occurrence values presented in Table 24, the food categories showing the highest 
mean values of tyramine were ‘fermented sausages’ (136 mg/kg), ‘fish sauce’ (105 -107 mg/kg), 
‘cheese’ (68.5 - 104 mg/kg), ‘fermented fish’ (47.2 -47.9 mg/kg) and ‘fermented vegetables’ (45 – 
47.4 mg/kg).  
For tyramine the class with high exposure values were calculated for ‘beer’ (18.5 – 124.6 mg/day). 
‘Cheese’ also showed high exposure (44 – 108.7 mg/day) for this biogenic amine. ‘Fermented 
sausages’ (17.2 – 99.3 mg/day) and ‘fermented fish meat’ (2 – 90.4 mg/day) can lead to very high 
exposure to this biogenic amine.  
Table 24:  Comparison of tyramine intake levels from the five most relevant food categories with 
the estimated toxicological thresholds  
Food category 
Tyramine intake 
(mg/kg) 
Percentage of threshold* 
(%) 
(for 600 mg threshold) (for 50 mg threshold) 
Beer 124.6 20.8 249.2 
Cheese 108.7 18.1 217.4 
Fermented sausages 99.3 16.6 198.6 
Fermented fish meat 90.4 15.1 180.8 
Other ripened meat products 42.1 7.0 84.2 
*600 mg for healthy individuals; 50 mg for patients taking RIMA drugs  
The individual intake of the main food categories that contribute to tyramine intake does not exceed 
the toxicological threshold of 600 mg. Even if the five main sources were combined at the same meal, 
their contribution would be of 77% of the 600 mg tyramine threshold (Table 24).  
The high exposure values estimated for beer, cheese, fermented sausages and fermented meat fish 
substantially exceed (from 180.8 to 249.2%) the 50 mg threshold for individuals taking reversible and 
selective (3rd generation) MAOI drugs. 
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For highly sensitive consumers, i.e. those under classical MAOI medication, the estimated threshold 
level 6 mg is easily reached by the consumption of fermented foods. Therefore, these sensitive 
individuals should avoid all tyramine containing food. 
6. Control options 
Biogenic amine in food are mainly produced by amino acid decarboxylase-positive microorganisms, 
therefore biogenic amines can accumulate in a wide variety of foods and beverages that have allowed 
the microbial growth and activity during its manufacture, handling and/or storage. Efforts to reduce 
the occurrence of biogenic amines in food deserve a priority and justify the challenge to the food 
industry to provide products with biogenic amine levels as low as possible. 
The total contents of the different amines strongly depend upon the nature of the product, the 
microorganisms that are present and the environmental conditions. Overall, aminogenesis processes 
depend on multiple and complex variables, all of which interact, making it difficult to characterize the 
effects of each technological factor on aminogenesis during food fermentation, ripening and/or 
storage. Although the influence of these environmental factors is not always well characterised, they 
constitute the basis of the mitigation options to prevent or limit biogenic amine accumulation in foods. 
Overall the current control of biogenic amine accumulation in food and beverages is based on two 
approaches: 
1. Assurance and maintenance of hygienic quality of raw materials and production processes in 
order to limit the contamination of fermented food products with aminogenic microorganisms. 
2. Implementation of specific conditions and/or production techniques aiming to: 
2a. Inhibit (eliminate) microorganisms with aminogenic potential,  
2b. Prevent the growth and minimize the decarboxylase activity of microorganisms.  
In the literature, attempts to destroy biogenic amines have been described. However they are not 
according to general principles of food hygiene which relay on prevention rather than eliminating 
problems after they appeared; they have not been proven as effective and feasible. 
The current control options to minimise biogenic amine occurrence in foods are mainly focussed on 
the food processing level, including raw materials handling and the fermentation process, as they 
constitute the most important factors for the biogenic amine accumulation in fermented products. 
During the storage of fermented food, the risk of biogenic amine accumulation is less important and is 
dependent on the above mentioned previous stages.  
6.1. Raw material 
In raw materials (i.e. fresh commodities), biogenic amine production generally results as a 
consequence of product mishandling. Therefore, aminogenesis should be prevented by improving 
food handling standards through a preventative strategy from harvest/slaughtering to the consumer.  
To this respect, food quality and safety management relying on HACCP should be regarded as the 
primary approach (Hungerford, 2010).  
Within the HACCP process, good hygienic and manufacturing practices (GHP/GMP) along with 
proper cleaning and disinfection procedures should be carefully implemented from primary 
production. Aminogenic organisms originating from animals (i.e. intestines, skin, fish gills, etc) can 
be spread to other sites, surfaces and equipments during handling of fresh raw materials (such as 
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during degutting and filleting of fish, slaughtering, cutting and mincing of meat) and consequently 
promote the accumulation of biogenic amines during further processing (i.e. fermentation) and/or 
storage. Furthermore, any additional source of aminogenic microorganisms, decarboxylase enzymes 
or preformed biogenic amines should be minimised, for instance assuring an optimal quality of water, 
brine for salting, raw materials as well as of spices and ingredients used during product manufacturing 
(Innocente et al., 2009, Latorre-Moratalla et al., 2007). 
The routes of contamination are not well identified, which makes the implementation of efficient 
measures difficult to avoid contamination of raw material. To control biogenic amine accumulation, 
the hygiene of raw materials should be improved and optimised through the reduction of the levels of 
microbial contamination. Intervention strategies to improve the hygiene of raw materials should 
include, whenever possible, thermal treatments. Clearly, pasteurisation of milk for cheese 
manufacture is commonly applied in the dairy industry and has proved to limit biogenic amine 
accumulation in comparison to production of cheese from raw milk (Novella-Rodríguez et al., 
2004,a,b Ordóñez et al., 1997, Schneller et al., 1997). For certain commodities (fish and meat) thermal 
treatments are not possible due to detrimental changes to raw materials. In these situations, alternative 
non-thermal technologies, such as irradiation and high hydrostatic pressure, offer a potential as shown 
in studies dealing with fish, meat and milk hygiene (Latorre-Moratalla et al., 2007, Novella-Rodríguez 
et al., 2002, Ruiz-Capillas and Jimenez Colmenero, 2010, Vidal-Carou et al., 2007). However, these 
measures deserve further research to be applied to the industrial food chain. Freezing of meat and fish 
cannot be considered as a measure of microbial inactivation, although several reports show that when 
thawed, frozen meat and fish are less susceptible to biogenic amine accumulation than unfrozen 
counterparts, probably because the microbiota are reduced to some extent as a result of the freezing 
process (Bover-Cid et al., 2006a, Flick and Granata, 2005). 
Attempts to eliminate biogenic amines once formed in raw materials have been undertaken, for 
instance by the use of amine-oxidase positive organisms (Gardini et al., 2002, Leuschner and 
Hammes, 1998b) or by gamma-irradiation (Kim et al., 2004). However, the effectiveness of these 
procedures has not been fully demonstrated in industrial food production systems. Alternatively, they 
may be controversial because elimination of biogenic amines could mask improper hygienic and 
manufacturing practices (Vidal-Carou et al., 2007). 
It is generally accepted now that the reduction of growth of strong amine-producing bacteria through 
the optimisation of handling, processing and storage conditions and processing are the most effective 
methods (Dalgaard et al., 2008, Ruiz-Capillas and Jimenez Colmenero, 2010, Vidal-Carou et al., 
2007). 
The time/temperature binomial is the most important risk factor for the formation of histamine and 
other biogenic amines during handling and storage of fresh commodities (e.g. meat and seafood 
products). For this reason, low temperatures should be applied during storage to inhibit proteolytic 
and decarboxylase activity of bacteria (Hernández-Orte et al., 2008; Rezaei et al., 2007). However, 
proteolysis inhibition is not applicable for cheeses or fermented sausage manufacture because it is an 
essential process for coagulation and ripening. 
Apart from mesophilic aminogenic organism which can be controlled by preventing time-temperature 
abuse, psychrotolerant bacteria are also relevant in relation to biogenic amine production in fish 
stored at chill temperature (Emborg and Dalgaard, 2006, Emborg et al., 2006). Freezing and 
temperatures near 0 ºC inhibit growth and activity of aminogenic organisms and therefore constitute 
the most effective way to prevent biogenic amine accumulation if fresh products, and thus also in raw 
materials (Ruiz-Capillas and Jimenez Colmenero, 2010).  
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6.2. Fermentation 
During fermentation, besides the contribution of contaminating bacteria, the microbiota responsible 
for fermentation can also show aminogenic activity. Moreover, the proteolytic activities, yeast lysis 
and acidification usually accompanying fermentation processes increase the availability of precursor 
free amino acids and favour decarboxylation reactions (ten Brink et al., 1990). Although biogenic 
amine contents in fermented products are highly variable, from not detected to more than 1000 mg/kg, 
the available data indicate that it is possible to produce fermented food without or with very low 
levels of biogenic amines. Therefore, the implementation of specific technological measures should 
mainly aim to control aminogenic microorganisms participating in the fermentation and ripening 
process. 
The so-called "low histamine technology" (Bodmer et al., 1999) has been described based on both the 
preventive approach (through GHP, GMP and HACCP) as well as the implementation of specific 
technological measures. This technology has been successfully implemented for the manufacturing of 
traditional alcoholic beverages in certain countries (Bodmer et al., 1999). The challenge is to broaden 
this integrated approach to other biogenic amines to all types of food, whilst keeping the typical 
characteristics of the products (i.e. organoleptic, nutritional, etc.) expected by the consumers.  
To control the fermentation, environmental conditions favouring a proper selection of desired 
fermentative (non-aminogenic) microorganisms and inhibition of undesired (aminogenic) microbiota 
should be managed. To this aim, principles of microbial ecology of food fermentation must be applied 
on the basis of product formulation (salt, sugar, preservatives, spices) and technological processing 
parameters (temperature, relative humidity, time, diameter/size, etc). The complexity of the 
fermentation enables the occurrence of a variety of additives, synergic or even antagonistic effects 
among ecological factors. Moreover, a given ecological factor can simultaneously show multiple 
targets or mechanisms of action. This is the case for the typical acidification accompanying nearly all, 
or most of, the fermentation processes. While a rapid and sharp decrease in pH is recognised as a key 
factor to reduce the growth of contaminating microbiota, it can also stimulate decarboxylation 
reactions in surviving microbiota as a response against unfavourable acidic environments (Vidal-
Carou et al., 2007). Other technological variables such as the modification of the type or 
concentration of fermentable sugar, the addition of non-therapeutic antimicrobials (sulphite, etc.), or 
the use of relatively low processing temperatures have been presented as appropriate measures to 
prevent the accumulation of biogenic amines, not only during manufacture but also during storage of 
fermented products (Latorre-Moratalla et al., 2010a; Pinho et al., 2001, Suzzi and Gardini, 2003). 
Unfortunately, a common rule cannot be defined for each type of product because each food type 
needs specific formulation and processing parameters, which have to be assessed on a case-by-case 
basis. 
Nowadays, the use of selected starter cultures is recognised as the most reliable approach to control 
the fermentation process, for both the large-scale and traditional small productions of fermented foods 
and beverages. However, microorganisms must be appropriately selected for each type of product and 
variety (i.e. substrate) taking into account their technological competence (competitiveness, influence 
on organoleptic characteristics, etc.) and safety requirements, including the inability to produce 
biogenic amines which is not a usual criteria for starter culture selection (Buckenhüskes, 1993, 
Holzapfel, 2002). Starter cultures should be ideally free of the potential to form biogenic amines, even 
if some bacterial starter cultures commercially used for food fermentation have been proved to 
produce biogenic amines (ten Brink et al., 1990).  
For example, Oenococcus oeni the LAB that occurs naturally in wine, is the dominant bacterial 
species found during the malolactic fermentation (MLF), and it possesses the finest oenological 
malolactic characteristics. However, the main histamine producers in wine have been determined to 
belong to the species O. oeni. Therefore, prior to inoculation, MLF starters should be checked for 
their ability to produce histamine. According to the literature, L. sakei and S. xylosus can be suitable 
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starter cultures for fermented sausages since they are adapted to meat fermentation conditions and 
usually lack of aminogenic potential (Bover-Cid et al., 2000b,c; Latorre-Moratalla et al., 2009; 
Latorre-Moratalla et al., 2010b). However, given the heterogeneous distribution of amino acid 
decarboxylases among strains of a given species, it is necessary to proceed on a case-by-case basis 
and test the potential decarboxylase activity of any strain intended to be used as a starter culture. 
Moreover, the performance of the selected strain/s must be assessed in the real product under the 
actual processing conditions. 
Starter cultures interact between different background microbial populations and thus they can 
influence the biogenic amine accumulation by the competitive suppression of amine-producing 
bacteria, limiting their growth and/or minimising their activity, resulting in the dominant microbial 
group without producing biogenic amines. Starter cultures could also modify the factors influencing 
biogenic amine formation (availability of precursor amino acids, acidification, etc.). Starter bacteria 
could even bear amine-degrading enzymes (MAO/DAO) contributing to biogenic amine catabolism in 
situ if they find proper conditions.  
The protective performance of starter culture to prevent BA accumulation will strongly be 
conditioned by several features, including: 
• Adaptation of strains to the particular fermentation ecology which can be better if strains are 
isolated from the same product or type of product. Standardized commercial preparations can be 
less effective than indigenous starters, although the influence is strain dependent (Latorre-
Moratalla et al., 2010b). As an example: in fermented sausages, L. sakei and L. curvatus are well 
adapted to the meat fermentation environment, which make them good candidates for starter 
cultures since they are highly competitive to outgrow spontaneous fermenting flora and can 
efficiently inhibit Gram-negative contaminating bacteria (Hugas and Monfort, 1997). Indeed, the 
literature confirms that starter cultures including decarboxylase-negative strains of L. sakei are the 
most protective as they reduce the overall amine accumulation by up to 95 % in comparison with 
30%-40% achieved with other commercial starters consisting of L. plantarum and Pediococcus 
spp. Mixed starter cultures, not only of lactic acid bacteria, but with other species involved in 
meat fermentation (e.g. staphylococci) will contribute to control a wider variety of aminogenic 
microorganisms (Vidal-Carou et al., 2007).  
• The hygienic quality (initial microbial loads) of raw materials and ingredients, as discussed 
earlier. Optimal hygienic standards should be assured in order to facilitate the dominance of 
starter bacteria from the early stages of the fermentation (Bover-Cid et al., 2001b, Maijala et al., 
1995a, Novella et al., 2004a,b). 
• Optimization of the technological conditions to favour a proper implantation and development of 
the starter. The extent of aminogenesis reduction also depends on the formulation, including the 
type and amount of fermentable carbohydrate(s) (González-Fernández et al., 2003), the use of 
additives, including essential oils (Bozkurt and Erkmen, 2002, Latorre-Moratalla et al., 2010b), as 
well as the temperature and relative humidity of the ripening conditions (Bover-Cid et al., 2001a, 
Maijala et al., 1995b). 
Therefore, it is of crucial importance to know the type of product and its productive process to find 
optimal intervention strategies. Since aminogenesis in fermented food and beverages is the result of 
complex phenomena affected by multiple factors, specific product/processor measures should be 
designed assessing and considering the particularities of the product, production process and 
processing environment characteristics. 
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7. Analytical methods 
Detection of biogenic amines are important as part of investigating incidents of potential food-
poisoning, for verification of the food production processes (including HACCP) and as a measure of 
quality (freshness) of both raw materials and finished products. Analytical methods for determination 
of BA in foods are reviewed in Rogers and Staruszkiewics (1997), Vale and Glória (1997), Önal 
(2007) and Sarkadi (2009). 
7.1. Extraction techniques 
Prior to detection, most analytical techniques require some form of extraction, although this has been 
reported as either matrix dependent or not necessary for some matrices (Önal 2007). Reported 
extraction procedures consist of the use of acids (trichloracetic acid, hydrochloric, perchloric, 
thiodipropionic, or methansulfonic acids), solvents (petroleum ether, chloroform, or methanol) and 
filtration. The complexity of the varied food matrices is a critical consideration in obtaining adequate 
recoveries of all biogenic amines. 
7.2. Biological methods 
Since the consumer is unlikely to intentionally consume spoiled food, it has to be noted that seafood 
associated with histamine poisoning often appears organoleptically ‘normal’, even when containing 
high histamine concentrations, hence unacceptable and toxic levels of histamine are undetectable 
prior to consumption. This observation is in agreement with laboratory studies in that histamine 
concentrations above 500 mg/kg in seafood were organoleptically acceptable (Fletcher, 1995; Hwang 
et al., 1995; Lopez-Sabater et al., 1996).  
The original analytical methods for biogenic amines in food relied detecting in vivo biological activity 
(AOAC, 1995a). For example, elevated levels of histamine in raw and canned sardines and mackerel 
using contraction of guinea pig ileum were reported (Geiger 1944; Geiger et al. 1944). However, 
these methods have now been superseded by in vitro methods largely based on chromatography, 
fluorometry or immunassays.  
7.2.1. Rapid and semi-quantitative methods 
7.2.1.1. Immunoassays 
Immunoassays for histamine are commercially available from a variety of manufacturers (Appendix 
A). These assays are predominantly validated for application to seafood, applicable with minimal 
extraction, claimed to have varying levels of sensitivity (usually with a detection limit of around 0.5 
mg/kg), are qualitative or quantitative, and usually relatively rapid. There are no commercially 
available assays for determining other BA in foods at the time of preparation of this document.  
Immunoassays have the advantage of providing semi-quantitative data and can simultaneously analyse 
multiple samples within 20 minutes to 2 hours. This format provides a suitable alternative for 
screening for histamine (but not other biogenic amines) without the need to invest in additional 
equipment necessary for the fully quantitative assays.  
7.2.1.2. Flow injection analysis (FIA) 
A flow injection analysis system for the determination of histamine using fluorimetric detection was 
developed to provide rapid screening of fish samples (Hungerford et al., 1990). The analytical 
technique is based on microfluidic manipulation of samples and reagents whereby samples are 
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injected into a carrier/reagent solution which transports the sample into a detector. During this 
transport the desired biochemical reactions takes place. For quantification of the target analyte a 
calibration curve for a given detector response (absorbance, fluorescence, sensor, etc.) is used. The 
technique does not require pre-treatment of the extract and care has to be taken to select the 
appropriate reagent concentrations and ensure that the carrier/reagent flow rate to maintain specificity 
for the histamine derivative (Hungerford et al., 1990). More recently, commercial FIA systems have 
been tested for screening of fishery products the method performance is satisfactory, with detection 
and quantitation limit from 0.8 mg/kg, and linearity to approximately 340 mg/kg (Hungerford et al., 
2001). 
7.2.1.3. Colorimetric method 
A colorimetic assay for histamine has recently been described based on the formation of a red 
complex between histamine and copper ions (Patange et al., 2005). The assay provides a detection 
limit of around 5 mg/kg and quantified either visually or by measuring the absorbance with a 
spectrophotometer at 496 nm. The assay is relative rapid (45 minutes), is inexpensive and does not 
require specialised laboratory equipment.  
7.2.2. Quantitative methods 
7.2.2.1. Fluorometric methods 
Fluorometric assay, as the AOAC Official Method (AOAC, 1995b) was widely used for 
determination of histamine in foods (usually fishery products) before the chromatographic procedures 
were described, and remains in the Codex Alimentarius list of methods of analysis (CODEX STAN 
234-1999, amended in 2007) and is the reference method for the US Food and Drug Administration 
(Codex Alimentarius Commission, 1999; FDA, 2001). This method remains commonly in use in the 
US, Australia (Anonymous, 2001a) and South Africa (Anonymous, 2001b) as well as in some 
European laboratories. The method comprises a methanol extraction from fish which are subjected to 
an organic extraction. Histamine is derivatised with o-phthaladehyde (sometimes after removal of 
interferences with an ion exchange column), to produce a fluorometric product which can be 
quantitatively determined on a spectrofluorometer (Taylor et al., 1978). This method is not suitable 
for the determination of biogenic amines other than histamine, and there is very limited validation 
data on this use of this method for matrices other than fish. The fluorometric assay has a detection 
limit around 0.5 mg/kg, provides linear sensitivities over wide ranges and has been subject to 
successful inter-laboratory trails. Although widely used in some parts of the world, the fluorometric 
assays require specialised equipment and should, where possible, be substituted for HPLC based 
methods which can quantify all biogenic amines. 
7.2.2.2. Chromatographic methods 
Various chromatographic methods have been reported for determination of biogenic amines in foods 
including thin layer, capillary electrophoretic, gas, and high pressure liquid chromatography (HPLC). 
The HPLC is probably the most common technique used for biogenic amine determination in food. In 
Europe, the reference method specified in the European Commission Regulation (EC) No 2073/2005 
(microbiological criteria for foodstuffs) for determination of histamine in fresh and treated fishery 
products is high pressure liquid chromatography (HPLC) after dansyl-derivatisation (Malle et al., 
1996; Duflos et al., 1999). Various reagents for derivatization are also used (either pre or post column 
are used) including dansyl and dansyl chloride, benzoly chloride, fluoresceine, 9 fluorenylmethyl 
chlorormate, o-phthaladehyde (OPA), naphthalene-2,3-dicarboxaldehyde, N-acetylcyteine, 2-
mercaptoethanol. Dansyl chloride is probably the most widely used reagent for pre-column 
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derivatisation, while OPA is mostly used for post-column derivatisation. For detection, fluorescence, 
UV and electrochemical detection are most usually used.    
HPLC based assay has a detection limit around 0.1 mg/kg, provides linear sensitivities over wide 
ranges and has been subject to successful inter-laboratory trails. The method requires specialised 
equipment and skills. Since HPLC method is cited as the reference method for histamine in 
Regulation (EC) No 2073/2005 (microbiological criteria for foodstuffs) and can quantify all biogenic 
amines, this should be the analytical method of choice for Official Control.  
7.2.3. Detection of amino acid decarboxylase-positive microorganisms 
Methods for the detection of biogenic amine producing microorganisms were initially based on the in 
vitro use of differential growth media containing specific substrates and a pH indicator to detect 
biogenic amine accumulation after the medium changes colour. Other alternative in vitro detection 
methods have also been described including CO2 measurement, enzymatic or chemical analysis of 
biogenic amines (Marcobal et al., 2006c). The methods based on differential media have been 
reported as unreliable because of the generation of false negative and false positive results, as well as 
requiring the isolation and subsequent growth of the BA-producing microorganism, being time-
consuming to perform. The chemical analysis of biogenic amine production in a decarboxylase broth 
constitutes a proper procedure to characterise and quantify the phenotypic expression of potentially 
aminogenic microorganisms. 
A relationship between the presence of the gene encoding the decarboxylase and the capacity to 
synthesise BA has been shown by several authors. The characterization of the genes encoding 
decarboxylating enzymes led the development of sensitive and specific methods based on PCR, hence 
the detection of these genes by PCR enable to identify organisms with a potential to produce BA more 
rapidly than other in vitro tests. However, PCR based tests have the disadvantages that they only 
indicate the potential for BA production (and not production of biologically active enzyme) as well 
still requiring in vitro culture, equipment and trained analysts for DNA extraction, amplification and 
PCR product detection. PCR has also been used to quantify and detect decarboxylase genes directly in 
food. However, the amplified PCR fragments may suggest the presence of BA producing 
microorganisms but it does not allow identifying the production source (microorganism). Therefore a 
multiphasic approach (isolation of microorganisms and detection of genes involved in BA production) 
it is always suggested.  
Decarboxylase genes suitable for the design of specific primers for detecting potential BA producing 
strains by PCR have been undertaken (Landete et al., 2007a). PCR based protocols have been 
described, both using ‘block-based’ as well as real time PCR assays. The latter having the advantage 
of being able to more readily quantify the amount of target in the original sample. Monoplex as well 
as multiplexed assays for different genes have also been described (Landete et al., 2007a). Because of 
the high sequence diversity of genes encoding decarboxylases, a diverse range of PCR assays is 
required to amplify and detect fragments from all major enzyme groups (see section 2.2.1). However 
assays for the seven broad classes of enzymes have been described which include: i. pyridoxal 
phosphate-dependent histidine decarboxylase (Gram-negative bacteria); ii. pyruvoyl-dependent 
histidine decarboxylase (Gram-positive bacteria); iii. pyridoxal-dependent tyrosine decarboxylase 
(Gram-positive bacteria); iv and v. ornithine decarboxylases, one for Gram-positive and Gram 
negative bacteria and a second, and rarer enzyme confined to Gram-negative bacteria; vi and vii. two 
lysine decarboxylases (one confined to Gram-positives the other to Gram-negative bacteria) (de las 
Rivas et al., 2006; Marcobal et al., 2005; Landete et al., 2007b,c). For example, a multiplex PCR 
method for the simultaneous detection of LAB with the potential to produce histamine-, tyramine and 
putrescine- has been described (Marcobal et al., 2005). Furthermore, a quantitative real-time PCR for 
histamine-producing LAB (Fernández et al., 2006; Lucas et al., 2008) and for tyramine-producing 
bacteria (Torriani et al., 2008) has also been successfully applied to different stages of cheese 
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manufacture including the final product (Ladero et al., 2008; Ladero et al., 2010b; Gardini et al., 
2008). Molecular methods have also been designed to study histidine- and tyrosine- decarboxylase 
gene expression under conditions relevant for food fermentation (Rossi et al., 2011), including cheese 
making and sausage fermentation (Gardini et al, 2008), respectively. 
These PCR methods may be used for the characterization and selection of starter cultures but have 
also been used for the early detection of BA producers within a food production process. In the latter 
situation, because of the high sequence diversity of genes encoding decarboxylases, several false 
positive arise from PCR based reactions. Therefore, sequence analysis of PCR fragments potentially 
related to BA coding genes, is recommended. 
7.3. Monitoring and surveillance  
Monitoring and surveillance of food poisoning is undertaken by Competent Bodies in each MS 
although the exact mechanisms for this vary considerably between MSs. The majority of incidents of 
food poisoning due to BA are reported by passive surveillance, and comprise reports of sporadic or 
outbreaks of compatible human disease associated with elevated levels of histamine in fishery 
products. Reporting of human disease takes place from clinical laboratories and /or public health 
organisations and surveillance data may be made available in a collated form. These surveillance data 
is complemented by analysis of food which is carried out by Official Control Laboratories (as defined 
in European Regulation (EC) No 882/2004). The Official Control Laboratories are also involved with 
statutory food control. The presence of histamine in fishery products is covered under European 
Commission Regulation (EC) No 2073/2005 (microbiological criteria for foodstuffs, see previous 
section) and adverse incidents are reported by Competent Bodies through RASFF reporting, as 
outlined in Section 4.1.1. The public health organisations involved in human disease surveillance may 
differ from the Competent Bodies in some MSs. Under Directive 2003/99/EC on the monitoring of 
zoonoses and zoonotic agents the Competent Body in each MS is required to report food-borne 
outbreaks to the European Centre for Disease Prevention and Control (ECDC), who collates data on 
cases of zoonoses, antimicrobial resistance and foodborne outbreaks. The EFSA is then responsible 
for preparing the Community Summary Report (EFSA, 2010a) on the basis of the zoonoses data. This 
includes foodborne outbreaks due to histamine poisoning, which also includes data on locations, 
settings and contributory factors. No reports of intoxications due to BA other than histamine have 
been reported through the Zoonoses Monitoring process. 
7.3.1. EU legislative requirements and guidances 
Specific legislation which includes microbial criteria for BA in foods only covers histamine in fishery 
products (which is not within the scope of this document): criteria for other BA or other food products 
do not occur in any national legislation. In the EU, European Commission Regulation (EC) No 
2073/2005 (as well as its amendments such as Regulation (EC) No 1441/2007 and Regulation (EU) 
No 365/2010) sets food safety criteria for histamine in two different fishery products. The first is for 
fish species (particularly within the families Scombridae, Clupeidae, Engraulidae, Coryphenidae, 
Pomatomidae, and Scombreresosidae) placed on the market during their shelf life and, with a 
sampling plan comprising nine units, two of the units may be between 100 and 200 mg/kg of 
histamine, and none above the limit of 200 mg/kg. This regulation also applies to fishery products 
(particulary for the families given above) which have undergone enzyme maturation treatment in brine 
and placed on the market during their shelf life and, with a sampling plan of nine units, two of the 
units may be between 200 and 400 mg/kg of histamine, and none above the limit of 400 mg/kg.  For 
both these products, the analytical method specified in Commission Regulation (EC) No 2073/2005, 
is by HPLC (Malle et al., 1996; Duflos et al., 1999).    
The USFDA (Anonymous, 2001c) considers that although “chemical testing is an effective means of 
detecting the presence of histamine in fish flesh, the validity of such testing is dependent upon the 
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design of the sampling plan. The amount of sampling required to accommodate such variability is 
necessarily quite large. For this reason, chemical testing alone will not normally provide adequate 
assurance that the hazard has been controlled. Because histamine is generally not uniformly 
distributed in a decomposed fish, a guidance level of 50 ppm (50 mg/kg) has been set. If 50 ppm is 
found in one section, there is the possibility that other sections may exceed 500 ppm (500 mg/kg).” 
The analytical method is the official fluorimetric method (AOAC, 1995b). The Australian and New 
Zealand Food Standards Code (Volume 2, Standard 2.2.3 (Page 22301, September 2002) states that 
‘the level of histamine in fish or fish products must not exceed 200 mg/kg’ (Bremer et al., 2003).  
The Codex Alimentarius Standards for fish provide histamine levels as indicators for (1) 
decomposition and (2) hygiene and handling. For decomposition, the relevant standards state”: ‘The 
products shall not contain more than 10 mg/100 g (100 mg/kg) of histamine based on the average of 
the sample unit tested. This applies only to species of Clupeidae, Scrombridae, Scromberesocidae, 
Pomatomidae and Coryphaenidae families.’ For hygiene and handling, the relevant standards state: 
‘No sample unit shall contain histamine that exceeds 200 mg/kg. This applies only to species of the 
families Scrombridae, Clupeidae, Coryphaenidae, Scrombreresocidae and Pomatomidae.’ These 
Codex Standards cover: quick frozen fish fillets, quick frozen blocks of fish fillet, minced fish flesh 
and mixtures of fillets and minced fish flesh, eviscerated and uneviscerated quick frozen finfish, quick 
frozen fish sticks (fish fingers), fish portions and fish fillets - breaded or battered, canned sardines and 
sardine type products, and canned tuna and bonito (Bremer et al., 2003). 
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CONCLUSIONS 
ToR1: Carry out a review of the available published scientific information on biogenic amines in 
foods with regards to production, processing, transport, storage/retail (i.e. during the shelf-life of the 
products) until consumption; including on consumer exposure and potential health implications.  
• The present knowledge and data on toxicity of biogenic amines (BA) individually and in 
combination(s) are limited: nevertheless, histamine and tyramine are considered as most toxic and 
particularly relevant for food safety. 
• The main pre-requisites for the presence of BA in foods include: availability of free amino acids, 
the presence of microorganisms producing BA enzymes (mainly from raw materials and/or added 
starter cultures), and conditions allowing their growth (particularly temperature, pH), as well as 
conditions affecting the enzyme production and activity (particularly low pH). 
• Fermentation of foods provides the conditions indicated above allowing intensive microbial 
activity and therefore has the potential for BA formation.  
• Storage and distribution conditions (in particular temperature) for fermented foods are variable in 
practice and may be relevant for BA accumulation.   
 
ToR2: Carry out a risk profiling of relevant fermented foods regarding biogenic amine formation 
from production to consumption (within their ‘use-by’ date). Include data from additional sources 
where applicable. The profiling should also result in identification of data needs to support a 
quantitative risk assessment.  
• Among groups of foods and within each group indicated below there is variability in amounts of 
BA found. Data are inadequate for differentiating individual products within each group. 
• Based on the mean content of the most toxic BA (histamine and tyramine), the food safety 
relevance of the considered food categories can be ranked in following decreasing order:   
for histamine: ‘dried anchovies’, ‘fish sauce’, ‘fermented vegetables’, ‘cheese’, ‘other fish 
and fish products’ (as indicated on page 31 in section 4.1.2.) and ‘fermented sausages’; 
for tyramine: ‘fermented sausages’, ‘fish sauce’, ‘cheese’, ‘fermented fish’ and ‘fermented 
vegetables’. 
• Based on the consumer exposure to the most toxic BA, the food safety relevance of the 
considered food categories can be ranked in following decreasing order:   
for histamine: ‘other fish and fish products’, ‘fermented sausages’, ‘cheese’, ‘fish sauces’ 
and ‘fermented vegetables’; 
for tyramine: ‘beer’, ‘cheese’, ‘fermented sausages’, ‘fermented fish meat’ and ‘preserved 
meat’. 
• For quantitative risk assessment, further information and data on BA (individually and in 
combination(s)) including toxicity, concentration and consumption of fermented foods are 
required. 
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ToR3: Identify and rank possible risk mitigation options and their anticipated impact to prevent or 
limit biogenic amines formation in fermented foods.  
• BA accumulation in fermented foods is a complex process affected by multiple factors and their 
interactions, the combinations of which are numerous, variable and product-specific. Hence, risk 
mitigation options, which are based on controlling those factors/interactions, could not be 
considered and ranked individually. Rather, they were considered at general principles level: 
o Minimizing the occurrence of BA-producing microorganisms can be achieved through 
ensuring the good hygienic status of the raw material and, where possible, additional 
microbial controls. 
o Microorganisms intended to be used as starter cultures in any fermented food should be 
confirmed as not producing BA and able to outgrow autochtonous microbiota under 
conditions of production and storage.    
o All aspects of fermented food processing (including ingredients, fermentation and 
ripening regimes), distribution and storage should be adjusted and balanced in each 
particular product to avoid/minimize potential enhancing effects on BA formation and to 
enable dominance of starter culture(s) where used. 
ToR4: Characterise concentration levels of biogenic amine in relevant fermented foods that are not 
associated with adverse health effects to defined consumer groups including susceptible consumers. 
• Estimating safe levels of the total amounts of BA ingested is the key issue to understand health 
effects to consumers. Consumption data and the exposure assessment were used by the Panel to 
define the concentrations in food that would be allowable, however these will vary between 
individuals, regions and countries. Therefore, for the purpose of this document, the focus was on 
total amounts of BA ingested in relation to estimated threshold levels for BA.  
Histamine  
Currently, available information needed for establishing NOAEL and ARfD in humans is based only 
on limited number of healthy and sensitive individuals.  
• Based on limited published information, no adverse health effects have been observed in healthy 
volunteers exposed to a level of 25 to 50 mg of histamine per person per meal. This level may be 
occasionally exceeded by consumption of one or more food items containing high amounts of 
histamine during the same meal.  
• In patients with histamine intolerance, even small amounts of histamine in ingested food may 
cause adverse health effects, so only levels below detectable limits can be considered as safe. 
Tyramine 
There is currently insufficient information related to establishing a NOAEL in humans.  
• Based on limited published information, no adverse health effects have been observed in healthy 
individuals not taking monoamino oxidase inhibitor (MAOI) drugs exposed to  a level of 600 mg 
of tyramine per person per meal. This level would not be exceeded even by a combined high 
intake of the five main food sources of tyramine during the same meal.  
• In individuals taking third generation MAOI drugs, no adverse health effects have been observed 
after exposure to a level of 50 mg of tyramine per person per meal. High consumption of some 
Biogenic amines in fermented foods
 
 
68 EFSA Journal 2011;9(10):2393 
fermented foods (beer, cheese, fermented sausages and fermented fish meat) can lead to tyramine 
exposure exceeding this level.   
• For individuals taking classical MAOI drugs, no adverse health effects have been observed after 
exposure to a level of 6 mg of tyramine per person per meal. This would be easily exceeded by 
the consumption of fermented food.   
Putrescine and cadaverine 
• For putrescine and cadaverine, presently available information is insufficient to identify 
concentrations that directly cause acute adverse health effects and/or potentiate the toxic effects 
of histamine and other biogenic amines. 
ToR5: Give advice regarding the analytical method to measure biogenic amine concentrations in 
fermented foods. 
• Presently, high-performance liquid chromatography (HPLC)-based methods are the only methods 
which reliably and with high sensitivity can simultaneously quantify concentrations of all BA in 
fermented food, therefore, are most suitable for analysis of fermented foods.  
ToR6: Recommend the monitoring methods in fermented foods that are most relevant from the public 
health point of view. These recommendations may refer to, among other aspects, the fermented food 
categories, the stages during food production until consumption within the shelf-life of a product to 
be sampled, as well as the type of sample to be collected. 
• Currently, there is insufficient information in order to recommend detailed monitoring schemes 
and methods.  
• Monitoring of BA concentrations in fermented food during the production process could be used 
as one of the parameters for the process hygiene assessment.   
• Monitoring of raw materials and products at multiple points along the food chain is necessary to 
evaluate the relevance of various factors contributing to BA formation and accumulation in 
fermented foods.  
RECOMMENDATIONS 
• Further research is needed on: 
o the toxicity and associated concentrations of histamine and tyramine in different foods, as 
well as related potentiating effects of putrescine and cadaverine,  in particular concerning 
food involved in outbreaks and sporadic cases; 
o the consumption data of fermented foods, especially cheese; 
o the production process-based control measures for BA in fermented food including 
monitoring and verification aspects and the development of challenge tests;  
o the evaluation of the need for and, if/where necessary, development of process hygiene 
criteria for histamine and tyramine in fermented foods, as well as food safety criteria for 
histamine in fermented foods other than fish.   
• Validation of methods for BA analysis is recommended for all relevant food types including 
standardisation and harmonisation of procedures, external quality assessment and availability of 
certified reference materials.  
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APPENDICES 
A.  APPENDIX  EXAMPLES OF COMMERCIALLY AVAILABLE IMMUNOASSAYS FOR HISTAMINE 
Test*  Analytical Technique Approx. 
Total Test 
Time 
Supplier*  
ALERT®  for Histamine   
[Sensitivity: 2.5 ppm]  
ELISA 35 min Neogen Corporation 
www.neogen.com 
EIA for Histamine in Fish Extract, K1-HTM 
[Sensitivity: 2.5 ppm, quantitative 1-50 ppm] 
Enzyme immunoassay 90 min Immuno-Diagnostic Reagents 
www.idr-usa.com 
EIA for Histamine Fishmeal and Bonemeal, 
K2-HTM  [Sensitivity: 5 ppm, qualitative]  
Enzyme immunoassay 35 min Immuno-Diagnostic Reagents 
www.idr-usa.com 
EIA for Histamine in Raw and Canned fish, 
K3-HTM  [Sensitivity: 5 ppm, qualitative]  
Enzyme immunoassay 35 min Immuno-Diagnostic Reagents 
www.idr-usa.com 
HISQUICK™ Histamine (BA-20-3000 - 48 
Columns) [Sensitivity: 20 ppm, quantitative] 
Color test 12 min. Rocky Mountain Diagnostics, Inc. 
www.rmdiagnostics.com 
Histamine EIA Food (BA-10-3100 - 96 
Wells) [Sensitivity: 0.5 ppb, quantitative] 
Enzyme immunoassay 2 h Rocky Mountain Diagnostics, Inc. 
www.rmdiagnostics.com 
Histamarine Test Kit1 (AOAC Approved) 
[Sensitivity: 0.5 ppm, quantitative from 1 to 
500 ppm] 
Enzyme immunoassay 1 h Immunotech  (Beckman Coulter) 
www.immunotech.cz 
HistaMeter  
[Sensitivity: 0-50 ppm, qualitative]  
Enzyme immunoassay 1 h Biomedix  
E-mail: cb4biomedx@aol.com  
HistaQuant  
[Sensitivity: 0-500 ppm, quantitative] 
Enzyme immunoassay 1-1/2 h Biomedix 
E-mail: cb4biomedx@aol.com  
HistaSure Dipstick Assay  
[5ppm Pass/Fail] 
Fluorescence Labeled 
Optical-Read Immuno 
Dipstick Assay 
(F.L.O.R.I.D.A.) 
5 min Rocky Mountain Diagnostics  
www.rmdiagnostics.com  
RIDASCREEN® Histamin R1602  
[Sensitivity: 2.5 ppm; quantitative] 
ELISA 2-5/6h R-Biopharm, Inc. 
www.r-biopharm.com/main.php? 
RidaQuick Histamin (R1603-96 Wells) 
[Sensitivity 20 ppm; quantitative] 
ELISA 12 min R-Biopharm, Inc. 
www.r-biopharm.com/main.php? 
Transia Tube Histamine ELISA 1 h Diffchamb AB 
www.bestlab.com.au/diffchamb.htm 
Veratox® for Histamine  [Sensitivity: < 2.5 
ppm, quantitative from 0 to 50 ppm] 
ELISA 35 min Neogen Corporation 
www.neogen.com 
*Information based on http://seafood.ucdavis.edu/haccp/compendium/chapt27.htm#Commercial%20Test%20Products  
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B.  APPENDIX CONSUMPTION DATA EXTRACTED FROM THE EFSA COMPREHENSIVE FOOD CONSUMPTION DATABASE  
Further information on the surveys listed here, identified by their respective acronyms, can be found in the ‘Use of the EFSA Comprehensive European Food 
Consumption Database in Exposure Assessment’(European Food Safety Authority; Use of the EFSA Comprehensive European Food Consumption Database 
in Exposure Assessment. EFSA Journal 2011;9(3):2097. [34 pp.] doi:10.2903/j.efsa.2011.2097. Available online: www.efsa.europa.eu/efsajournal.htm) 
  Austria Belgium Bulgaria 
  Survey ASNS Diet_National_2004 NSFIN 
    Cons. 
days 
% total 
days 
Amount 
(g/day) 
Cons. 
days 
% total 
days 
Amount 
(g/day) 
Cons. 
days 
% total 
days 
Amount 
(g/day) 
Food category Sub-category   mean P95   mean P95   mean P95 
Alcoholic beverages Beer 274 12.91% 648.16 1500 485 18.32% 689.39 2000 111 16.06% 572.97 1500 
  Fortified and liqueur wines . . . . 89 3.36% 105.02 250 . . . . 
  Wine, red 267 12.58% 176.29 500 477 18.01% 280.36 633.2 20 2.89% 52.3 270 
  Wine, white 30 1.41% 275.17 630 176 6.65% 235.18 500 19 2.75% 231.38 1500 
  Wine, white, sparkling 23 1.08% 135.87 300 31 1.17% 179.44 400 . . . . 
Fish and fish products Fermented fish products 210 9.89% 135.88 293 617 23.30% 99.46 246.8 71 10.27% 193.56 413.6 
  Other fish products 25 1.18% 8.96 8 96 3.63% 54.47 180 . . . . 
Meat and meat products Fermented sausages 653 30.76% 57.36 145 293 11.06% 46.42 142.5 37 5.35% 60.13 150 
  Other ripened meat products 451 21.24% 51.74 150 956 36.10% 52.83 135 85 12.30% 44.31 100 
  Other meat products 825 38.86% 90.65 240 487 18.39% 90.58 227.5 123 17.80% 109.85 300 
Milk and milk products Cheese 1335 62.88% 63.06 174 1641 61.97% 69.06 200 381 55.14% 57.06 150 
  Yoghurt 620 29.20% 210.08 500 593 22.39% 167.66 347.6 331 47.90% 173.33 498.5 
  Other dairy products 1528 71.97% 123.47 489 1564 59.06% 158.26 515 273 39.51% 115.88 327.5 
Savoury sauces Fish sauce 36 1.70% 9.33 21 30 1.13% 19.57 50 . . . . 
  Other savoury sauces 6 0.28% 81.33 148 427 16.13% 72.52 192 . . . . 
Vegetables and vegetable 
products 
Fermented vegetables 516 24.31% 32.62 121 252 9.52% 38.98 140 202 29.23% 11.45 20 
  Other vegetables 1003 47.24% 54.4 108 622 23.49% 49.98 160 226 32.71% 103.71 301.7 
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  Czech Republic Denmark Estonia 
 Survey SISP04 Danish_Dietary_Survey NDS_1997 
  Cons. 
days 
% total 
days 
Amount (g/day) Cons. 
days 
% total 
days 
Amount (g/day) Cons. 
days 
% total 
days 
Amount (g/day) 
Food category Sub-category   mean P95    mean P95     mean P95 
Alcoholic beverages Beer 1170 35.11% 1108.46 3000 4813 24.40% 791.05 2640 218 11.68% 1027.09 3000 
  Fortified and liqueur wines . . . . 306 1.55% 74.99 150 7 0.38% 164.29 300 
  Wine, red 187 5.61% 328.29 700 4553 23.09% 353.58 700 59 3.16% 323.31 1000 
  Wine, white 212 6.36% 307.26 800 1414 7.17% 273.55 560 2 0.11% 210 300 
  Wine, white, sparkling . . . . . . . . 25 1.34% 246 700 
Fish and fish products Fermented fish products 362 10.86% 145.5 300 7886 39.99% 45.56 145 297 15.92% 130.05 329.4 
  Other fish products 25 0.75% 121.58 300 . . . . 10 0.54% 65 150 
Meat and meat products Fermented sausages 518 15.55% 73.37 198 5585 28.32% 14.13 43.4 . . . . 
  Other ripened meat 
products 
976 29.29% 59.18 200 10713 54.32% 13.68 39 334 17.90% 86.84 283.6 
  Other meat products 1431 42.95% 119.54 294 6479 32.85% 54.53 210.58 903 48.39% 98.26 280 
Milk and milk products Cheese 1587 47.63% 65.14 150 15655 79.38% 39.33 108 648 34.73% 75.79 246.95 
  Yoghurt 694 20.83% 201.98 500 6304 31.96% 149.1 380 366 19.61% 291.33 750 
  Other dairy products 2450 73.53% 134.11 500 18302 92.80% 320.13 954 1388 74.38% 277.27 772.7 
Savoury sauces Fish sauce 52 1.56% 11.25 30.77 117 0.59% 3.38 19.2 112 6.00% 7.89 16 
  Other savoury sauces . . . . . . . . . . . . 
Vegetables and vegetable 
products 
Fermented vegetables 1187 35.62% 65.44 200 1774 9.00% 3.5 8.86 128 6.86% 49.56 210 
  Other vegetables 168 5.04% 84.52 177.4 8096 41.05% 27.2 68 323 17.31% 18.44 43.2 
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  Finland France Germany 
 Survey FINDIET_2007 INCA2 National_Nutrition_Survey_II 
  Cons. 
Days 
% total 
days 
Amount (g/day) Cons. 
days 
% total 
days 
Amount (g/day) Cons. 
days 
% total 
days 
Amount (g/day) 
Food category Sub-category   mean P95    mean P95     mean P95 
Alcoholic beverages Beer 413 13.11% 804.98 2500 1008 6.41% 415.81 1000 4633 22.23% 806.71 2000 
  Fortified and liqueur wines 45 1.43% 25.1 110 384 2.44% 84.65 200 39 0.19% 125.86 350 
  Wine, red 163 5.17% 241.15 720 3382 21.50% 264.51 600 2689 12.90% 282.11 700 
  Wine, white 72 2.29% 193.63 480 777 4.94% 187.44 450 864 4.15% 287.69 625 
  Wine, white, sparkling . . . . 461 2.93% 205.77 450 . . . . 
Fish and fish products Fermented fish products 796 25.27% 102.34 245.27 4472 28.44% 95.58 224 2682 12.87% 115.93 285 
  Other fish products 10 0.32% 20.4 45 517 3.29% 94.45 200 326 1.56% 136.65 285 
Meat and meat products Fermented sausages 269 8.54% 26.23 70 1298 8.25% 35.15 88 4329 20.77% 36.83 91 
  Other ripened meat 
products 
1228 38.98% 38.67 100 5385 34.24% 49.06 133 5960 28.60% 39.29 100 
  Other meat products 858 27.24% 96.89 280 4025 25.59% 73.9 200 8878 42.60% 89.93 244.5 
Milk and milk products Cheese 2302 73.08% 50.54 134 10561 67.15% 70.98 200 13536 64.96% 57.83 172 
  Yoghurt 1415 44.92% 252.88 600 5869 37.32% 172.38 375 5224 25.07% 188.95 500 
  Other dairy products 2843 90.25% 333.4 923.24 8983 57.12% 156.07 450 13782 66.14% 155.37 525.3 
Savoury sauces Fish sauce 142 4.51% 7.36 20.4 106 0.67% 17.2 45 203 0.97% 16.17 45 
  Other savoury sauces . . . . 1403 8.92% 37.88 90 3401 16.32% 65.07 153 
Vegetables and vegetable 
products 
Fermented vegetables 1098 34.86% 39.18 120 1802 11.46% 40.64 200 2220 10.65% 85.68 251.2 
  Other vegetables 1203 38.19% 26.38 72 5579 35.47% 59.29 200 6307 30.27% 90.01 208.4 
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  Hungary Ireland Italy 
 Survey National_Repr_Surv NSIFCS INRAN_SCAI_2005_06 
  Cons. 
days 
% total 
days 
Amount (g/day) Cons. days % total 
days 
Amount (g/day) Cons. 
days 
% total 
days 
Amount (g/day) 
Food category Sub-category   mean P95   mean P95   mean P95 
Alcoholic beverages Beer 268 8.32% 579.89 1000 1118 16.67% 1873.45 5044 702 10.12% 333.47 800 
  Fortified and liqueur wines . . . . 161 2.40% 16.94 50 3 0.04% 120 120 
  Wine, red 109 3.38% 225.51 500 413 6.16% 228.73 562 2141 30.85% 177.64 480 
  Wine, white 162 5.03% 249.72 500 305 4.55% 241.3 625 1727 24.89% 64.36 250 
  Wine, white, sparkling 11 0.34% 222.73 400 11 0.16% 165.91 450 . . . . 
Fish and fish products Fermented fish products 150 4.66% 188.84 400 1127 16.81% 126.75 308.62 2247 32.38% 140.3 361 
  Other fish products . . . . 2 0.03% 62.5 85 58 0.84% 121.27 243.84 
Meat and meat products Fermented sausages 538 16.70
% 
64.08 150 72 1.07% 24.4 87 617 8.89% 29.25 64 
  Other ripened meat 
products 
909 28.21
% 
57.7 200 3119 46.51% 84.94 249.18 2622 37.79% 49.69 106.25 
  Other meat products 1265 39.26
% 
113.98 250 1292 19.27% 81.62 182.93 584 8.42% 100.85 216.94 
Milk and milk products Cheese 1268 39.35
% 
60.77 150 2444 36.44% 45.29 112 5299 76.37% 78.05 196.88 
  Yoghurt 541 16.79
% 
198.83 400 788 11.75% 132.04 250 1002 14.44% 151.28 300 
  Other dairy products 2700 83.80
% 
241.96 650 6400 95.44% 283.4 690.47 4360 62.83% 165.74 300 
Savoury sauces Fish sauce 1 0.03% 20 20 247 3.68% 11.64 35.05 17 0.24% 7.69 27 
  Other savoury sauces 3 0.09% 10 10 1123 16.75% 58.46 120 . . . . 
Vegetables and vegetable 
products 
Fermented vegetables 1289 40.01
% 
111.28 250 933 13.91% 13.04 40 55 0.79% 37.69 128 
  Other vegetables 114 3.54% 92.85 200 1371 20.44% 21.82 60 3743 53.94% 84.56 250 
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  Latvia Netherlands Poland 
 Survey EFSA_TEST DNFCS_2003 IZZ_FAO_2000 
  Cons. 
days 
% total 
days 
Amount (g/day) Cons. 
days 
% total 
days 
Amount (g/day) Cons. 
days 
% total 
days 
Amount (g/day) 
Food category Sub-category     mean P95     mean P95     mean P95 
Alcoholic beverages Beer 243 9.15% 652.9 1200 247 16.47% 1196.86 4320 271 10.72% 615.31 1000 
  Fortified and liqueur 
wines 
1 0.04% 100 100 34 2.27% 29.65 236.3 . . . . 
  Wine, red 46 1.73% 221.3 500 75 5.00% 262.72 613.3 24 0.95% 130.21 200 
  Wine, white 1 0.04% 50 50 46 3.07% 263.19 750 22 0.87% 168.18 500 
  Wine, white, sparkling 13 0.49% 240.77 400 2 0.13% 149.4 253.8 10 0.40% 133 330 
Fish and fish products Fermented fish products 393 14.80% 110.41 250 126 8.40% 72.35 210 298 11.79% 159.49 404 
  Other fish products 39 1.47% 145.9 360 26 1.73% 157.12 300 3 0.12% 38.33 50 
Meat and meat products Fermented sausages 299 11.26% 65.62 160 161 10.73% 35.41 90 43 1.70% 34.3 70 
  Other ripened meat 
products 
173 6.52% 83.15 200 595 39.67% 40.1 100.68 979 38.74% 66.3 175 
  Other meat products 885 33.33% 98.75 240 496 33.07% 72.96 216 1447 57.26% 110.67 300 
Milk and milk products Cheese 1042 39.25% 72.07 200 956 63.73% 58.68 165 1154 45.67% 79.3 200 
  Yoghurt 547 20.60% 242.46 500 560 37.33% 304.25 796.2 250 9.89% 189.13 450 
  Other dairy products 1511 56.91% 108.31 380 1062 70.80% 317.48 873.07 1837 72.69% 152.7 500 
Savoury sauces Fish sauce 1 0.04% 50 50 111 7.40% 13.05 47.91 . . . . 
  Other savoury sauces 249 9.38% 62.55 110 444 29.60% 55.32 150 . . . . 
Vegetables and vegetable products Fermented vegetables 55 2.07% 125.36 300 260 17.33% 39.49 127.79 1277 50.53% 80.93 233.55 
  Other vegetables 40 1.51% 63.13 200 287 19.13% 80.98 263.69 107 4.23% 44.37 135.65 
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  Slovakia Slovenia Spain 
  Survey Survey Survey 
 Survey SK_MON_2008 CRP_2008 AESAN AESAN_FIAB 
  Cons. 
days 
% total 
days 
Amount (g day) Cons. 
days 
% total 
days 
Amount (g day) Cons. 
days 
% total 
days 
Amount (g day) Cons. 
days 
% total 
days 
Amount (g day) 
Food category Sub-category     mean P95     mean P95     mean P95     mean P95 
Alcoholic beverages Beer 292 10.57% 724.16 2000 20 4.91% 552.5 1500 156 18.84% 464.42 1233 297 10.81% 350.78 750 
  Fortified and liqueur wines 1 0.04% 100 100 1 0.25% 66 66 8 0.97% 83.21 200 21 0.76% 106.85 250 
  Wine, red 71 2.57% 258.45 500 39 9.58% 195.5 500 109 13.16% 148.91 400 494 17.98% 154.65 500 
  Wine, white 81 2.93% 258.89 500 19 4.67% 164.59 500 49 5.92% 55.71 240 325 11.83% 94.02 320 
  Wine, white, sparkling 5 0.18% 170 250 . . . . . . . . . . . . 
Fish and fish products Fermented fish products 128 4.63% 126.16 300 41 10.07% 117.84 240 450 54.35% 113.65 292.25 1570 57.13% 131.01 316.2 
  Other fish products 63 2.28% 154.6 200 2 0.49% 35 50 31 3.74% 63.06 200 22 0.80% 70.91 200 
Meat and meat products Fermented sausages 522 18.89% 100.61 250 39 9.58% 59.49 100 185 22.34% 45.23 109.9 894 32.53% 36.71 98 
  Other ripened meat products 515 18.64% 79.02 200 62 15.23% 66.16 170 402 48.55% 58.73 150 1480 53.86% 53.61 135.77 
  Other meat products 573 20.74% 109.01 300 121 29.73% 98.19 220 114 13.77% 75.22 191.4 343 12.48% 67.73 170 
Milk and milk products Cheese 825 29.86% 61.64 150 138 33.91% 58.54 155.4 412 49.76% 54.31 147.5 1298 47.23% 47.43 123.66 
  Yoghurt 667 24.14% 195.6 500 113 27.76% 221.08 500 362 43.72% 171.09 325 995 36.21% 153.91 250 
  Other dairy products 1078 39.02% 179.32 530 213 52.33% 189.21 507.8 726 87.68% 280.9 600 2478 90.17% 336.68 750 
Savoury sauces Fish sauce 9 0.33% 10.89 30 1 0.25% 0.7 0.7 6 0.72% 14.69 25 3 0.11% 17.5 30 
  Other savoury sauces 26 0.94% 143.08 280 28 6.88% 81.07 120 37 4.47% 35.59 100 44 1.60% 44.8 100 
Vegetables and vegetable products Fermented vegetables 550 19.91% 82.79 200 33 8.11% 142.8 274.6 16 1.93% 16.09 30 29 1.06% 20.52 75 
  Other vegetables 105 3.80% 104.58 210 216 53.07% 99.56 181.2 372 44.93% 73.23 159.62 1257 45.74% 87.95 220.9 
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  Sweden United Kingdom 
 Survey Riksmaten_1997_98 NDNS 
  Cons. days % total days Amount (g/day) Cons. days % total days Amount (g/day) 
Food category Sub-category   mean P95    mean P95 
Alcoholic beverages Beer 2367 27.96% 501.34 1200 2019 16.73% 1273.05 3444 
  Fortified and liqueur wines 52 0.61% 135.87 400 231 1.91% 97.6 300 
  Wine, red 1033 12.20% 322.89 600 1226 10.16% 274.22 750 
  Wine, white 8 0.09% 306.25 950 873 7.23% 301.25 750 
  Wine, white, sparkling . . . . 105 0.87% 292.17 740 
Fish and fish products Fermented fish products 2176 25.70% 87.33 210 2707 22.43% 113.67 255 
  Other fish products 379 4.48% 117.77 150 227 1.88% 88.57 200 
Meat and meat products Fermented sausages 22 0.26% 31.41 75 377 3.12% 13.5 50 
  Other ripened meat products 693 8.19% 83.01 150 4003 33.17% 56.25 155 
  Other meat products 5008 59.15% 68.58 180 1704 14.12% 79.19 177 
Milk and milk products Cheese 5824 68.79% 42.46 100 4795 39.73% 51.24 127 
  Yoghurt 2829 33.42% 273.13 500 1863 15.44% 138.82 258 
  Other dairy products 5441 64.27% 371.98 950 10960 90.82% 245.09 601 
Savoury sauces Fish sauce 7 0.08% 15.71 35 383 3.17% 6.4 18 
  Other savoury sauces 996 11.76% 98.92 200 2512 20.82% 76.07 190 
Vegetables and vegetable products Fermented vegetables 362 4.28% 37.63 96 2055 17.03% 24.9 114 
  Other vegetables 312 3.69% 26.41 60 3279 27.17% 39.63 108 
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GLOSSARY AND ABBREVIATIONS 
ACDC  amino acid decarboxylase  
ARfD  acute reference dose 
BA  biogenic amine 
BAI  biogenic amine index 
DAO  diamino oxidase 
ECDC  European Centre of Disease Prevention and Control 
EFSA  European Food Safety Authority 
GHP  good hygiene practice 
GMP  good manufacturing practice 
HdcP  histidine/histamine antiporter 
HDC  histidine decarboxylase 
HNMT  histamine-N-methyltransferase 
HPLC  high pressure liquid chromatography 
LAB  lactic acid bacteria 
LOD  limit of detection 
LOQ  limit of quantification 
MAO  monoamine oxidase 
MAOI  monoamine oxidase inhibitor 
MLF  malolactic fermentation 
MS/MSs Member State / Member States 
NOAEL no observed adverse effect level 
OPA  o-phtalaldehyde 
PLP  pyridoxal-5’-phosphate 
PMF  proton motive force 
P95  95-percentile  
RIMA  reversible inhibitors of MAO-A 
RASFF  Rapid Alert System for Food and Feed 
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RSD  relative standard deviation 
TDC  tyrosine decarboxylase 
ToR  Terms of reference 
UB upper bound: the value assigned to the limit of detection (LOD) to values reported as 
non-detected and the value of the limit of quantification (LOQ) 
